2018 Annual Report
OUR PURPOSE
To be the most innovative integrated
provider of organic ingredients and
healthy food solutions across multiple
channels.
KEY STRATEGIES
• Be a leader in the plant-based bever-
age and fruit categories.
• Leverage our unique organic farm-to-
table capabilities to fuel innovation and
value.
• Build integrated efficient supply
chains.
FINANCIAL HIGHLIGHTS
All dollar amounts in U.S. $ millions, except per share amounts, and in accordance with U.S. GAAP
2019
2018
2017
1,190.0 1,260.9
1,279.6
115.3
9.7%
(2.8)
123.5
9.8%
3.9
(0.8)
(109.2)
145.1
11.3%
0.8
(135.3)
$(1.66)
(12.3)
Revenue
Gross profit
Gross profit percentage
Operating income (loss) (1)
Loss from continuing operations attributable to SunOpta Inc.
Loss per share from continuing operations attributable to SunOpta Inc.
$(0.10) $(1.34)
Adjusted earnings (loss) (2)
(32.4)
(24.5)
Adjusted earnings (loss) per diluted share (2)
$(0.37) $(0.28)
$(0.14)
Adjusted EBITDA (3)
Total assets
Total debt
Working capital (4)
Net cash flows from operating activities
Net cash flows from investing activities
47.3
923.4
490.7
317.8
9.8
27.2
52.9
896.1
509.2
366.0
(11.1)
(28.8)
66.8
982.2
462.1
351.6
31.5
(40.1)
(1)
(2)
(3)
(4)
Operating income is defined as “earnings (loss) from continuing operations before the following” excluding the
impact of other income/expense items and goodwill impairments.
Refer to pages 38, 39, 50 and 51 of the 2019 Form 10-K for a tabular reconciliation of Adjusted earnings (loss)
and Adjusted earnings (loss) per diluted share to the most directly comparable GAAP measure.
Refer to pages 39, 40 and 51 of the 2019 Form 10-K for a tabular reconciliation of Adjusted EBITDA to the most
directly comparable GAAP measure.
Working capital is defined as current assets less current liabilities, excluding cash and cash equivalents, bank
indebtedness, and current portion of long-term debt.
2019 Annual Report
TO OUR SHAREHOLDERS
At SunOpta we are excited about our role as a leader in
creating the future of food. With a portfolio of on-trend
businesses in plant-based foods & beverages, fruit-based
foods & beverages and organic ingredients, we are poised for
strong growth. We are motivated by the fact that our products
are helping make the planet healthier. We are driven to help
people eat healthier and we are humbled that we are making
healthier eating more affordable and accessible to more
people by being a low-cost producer through our innovation
efforts. We are inspired by the culture we are creating at
SunOpta.
After joining the Company in April 2019 three strategies were
identified that would be instrumental in turning around the
business. First, we needed much better portfolio prioritization;
we needed to focus on the biggest opportunities and assure
the people and financial resources were aligned against
these businesses. Our plant-based beverage business has
the potential to double in size in the next 5 years with the
right focus and investment. Second, we needed to increase
our pace of innovation, specifically, our co-created customer
centric innovation. Encouragingly, 60% of the growth in our
plant-based beverage business came from new customers or
new items. Third, we needed to “fix fruit” which has been a
challenged business for us since we acquired it in 2015. Fixing
fruit meant an intense focus on productivity and improving our
price per pound and we made significant progress in the back
half of 2019 around automation and productivity that should
pay dividends in 2020. To support these strategies, we sought
to simplify and flatten the organization which resulted in a
significant SG&A savings and three fully functioning, discrete
business units. These focused teams are at the center of our
turnaround efforts.
I am pleased with the progress we made in 2019 in “bending
the curve” on the turnaround and we have begun to show our
investors and stakeholders the true potential of this Company.
We have solid momentum going into 2020. This momentum
comes from a focus on these strategies and considerable
effort to simplify the business.
Our purpose remains unchanged to be the most innovative,
integrated provider of organic ingredients and healthy food
solutions across multiple channels. We are well aligned with
consumer trends towards organic and non-GMO foods, and
I believe the acceleration in growth that we delivered in
the fourth quarter affirms our right-to-win in this attractive
market.
2019 Annual Report
Our key strategies to accomplish our purpose are:
Portfolio Prioritization
• Recognize and resource plant-based beverage
as our top priority to drive revenue and EBITDA
growth
• Prioritize assets and capabilities that are
structurally advantaged and invest to build long-
term points of differentiation
• Critically evaluate and exit lines of business that
aren’t positioned for long-term success
Speed of Customer Centric Innovation
• Bring value to customers brands through innovative
plant-based and fruit-based solutions
• Leverage our R&D capabilities, multi-channel
category insights, and ability to bring the latest
trends in organic ingredients to market to bring
value enhancing innovation to our customers
Productivity and Pricing in Fruit
• Capital investment and process refinement to lower
cost of manufacturing and supply chain
• Pricing and value enhancing innovation to drive
improved revenue per pound sold
Plant-based beverages has and will continue
to be a key focus of the company, which is
evident in the significant capital investment
announced in the second quarter that
is underway to expand our extraction
capabilities. In addition to this project, our
Board has approved two additional expansion
projects to increase capacity and capabilities
across our national footprint. We expect all
three of these projects to come on-line in late
Q4 2020 and we feel our current customer
pipeline will allow for solid utilization out of
the gates as we look to drive growth in 2021
and 2022.
2019 Annual Report
Before I discuss the year ahead, let me highlight the strategic priorities that we are focused on:
1. Double our plant-based beverage business to roughly $500 million in revenue within 5 years, via a
rapid expansion of our manufacturing, packaging and go to market capabilities;
2. Deliver the fruit margin optimization plan, on time, by the end of 2020 through automation,
diversification and rational pricing;
3. Create, and bring to market, margin accretive innovation in both our fruit and plant-based beverage
businesses;
4. At Tradin Organic, continue to identify and develop new sources of organic ingredients to maintain
our position as a leader in sourcing on-trend ingredients, and to drive sustained high single digit
topline growth over the next five years;
5. Further invest in manufacturing as a mechanism to add value to Tradin Organic’s overall value
proposition, and support attainment of an overall 14% gross margin profile in that business;
6. Quickly identify and leverage both sales and margin synergies by viewing our fruit business as one
synergistic operation, as opposed to operating global fruit sourcing, fruit snacks, fruit juice, frozen fruit
and fruit preps as five independent operations;
7. Further diversify our fruit sourcing by expanding our operations in Mexico while simultaneously
strengthening our California grower relations and expanding our global reach to de-risk the impact
weather can have on fruit supply; and
8. Streamline the organization for faster decision-making, clearer accountability and more
empowerment.
I am pleased with the progress we have made against all of these priorities to date. In summary, we are
executing on the key initiatives we laid out, on or ahead of schedule. Our focus on plant-based beverages
is delivering significant margin accretive growth. Our products and capabilities remain aligned with
on-trend categories and we have the organization to deliver on our opportunities and drive improved
profitability.
THE YEAR AHEAD: FOCUSED ON DELIVERING SUSUSTAINED PROFITABLE GROWTH
As we look ahead to 2020, we expect to see continued improvement in adjusted EBITDA performance as
we capitalize on our strong plant-based food and beverage momentum, execute our margin optimization
strategy in our fruit business, and leverage Tradin’s unique positioning in the organic ingredient supply
chain. Our focus for 2020 will be in the following three key areas:
Invest in Plant-Based Beverages
• Three planned expansion projects to increase capacity and capabilities across our national footprint
Improve Profitability in Fruit
• Recovery after market-wide 2019 crop shortfall
• Continue to execute on initiatives to improve pricing and reduce costs
Deliver Higher Margins in Global Ingredients
• Reduce exposure to low margin categories and reinvest in high margin categories
2019 Annual Report
After a year in this role, I am even more optimistic about the significant growth opportunities for
SunOpta. We have made changes to improve the organization’s speed and effectiveness, driving a
culture of entrepreneurialism, and enhancing accountability. I believe that we have the assets, expertise
and the team to continue to be a low cost, high quality, reliable partner to some of America’s leading
national brands and to retailers. We participate in on-trend, growing categories and are well positioned
to create long-term shareholder value.
I would like to thank all of our shareholders for believing in SunOpta.
Sincerely,
2019 Annual Report
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 28, 2019
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission File No. 001-34198
SUNOPTA INC.
(Exact Name of Registrant as Specified in Its Charter)
CANADA
(Jurisdiction of Incorporation)
Not Applicable
(I.R.S. Employer Identification No.)
2233 Argentia Drive, Suite 401
Mississauga, Ontario L5N 2X7, Canada
(Address of Principal Executive Offices)
(905) 821-9669
(Registrant's telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Common Shares
Common Shares
Trading Symbol(s)
STKL
SOY
Name of each exchange on which registered
The Nasdaq Stock Market
The Toronto Stock Exchange
Securities registered pursuant Section to 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes
No
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes
No
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has
been subject to such filing requirements for the past 90 days. Yes
No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to
Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was
required to submit and post such files). Yes
No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and
“emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
Accelerated filer
Non-accelerated filer
Smaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes
No
Aggregate market value of the common equity held by non-affiliates of the registrant, computed using the closing price as reported on the
NASDAQ Global Select Market for the registrant’s common shares on June 28, 2019, the last business day of the registrant’s most recently
completed second fiscal quarter, was approximately $230 million.
The number of shares of the registrant’s common stock outstanding as of February 21, 2020 was 88,148,363.
Documents Incorporated by Reference: Portions of the SunOpta Inc. Definitive Proxy Statement for the 2020 Annual Meeting of
Shareholders are incorporated by reference into Part III of this Annual Report on Form 10-K.
SUNOPTA INC.
FORM 10-K
For the year ended December 28, 2019
TABLE OF CONTENTS
Basis of Presentation
Forward-Looking Statements
PART I
Item 1
Item 1A
Item 1B
Item 2
Item 3
Item 4
PART II
Item 5
Item 6
Item 7
Item 7A
Item 8
Item 9
Item 9A
Item 9B
PART III
Business
Risk Factors
Unresolved Staff Comments
Properties
Legal Proceedings
Mine Safety Disclosures
Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of
Equity Securities
Selected Financial Data
Management’s Discussion and Analysis of Financial Condition and Results of Operations
Quantitative and Qualitative Disclosures About Market Risk
Financial Statements and Supplementary Data
Changes in and Disagreements With Accountants on Accounting and Financial Disclosure
Controls and Procedures
Other Information
Item 10
Item 11
Item 12
Item 13
Item 14
Directors, Executive Officers and Corporate Governance
Executive Compensation
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder
Matters
Certain Relationships and Related Transactions, and Director Independence
Principal Accounting Fees and Services
PART IV
Item 15
Item 16
Exhibits, Financial Statement Schedules
Form 10-K Summary
2
2
5
10
24
25
25
25
26
28
29
61
62
62
63
64
65
65
65
65
65
65
74
SUNOPTA INC.
1
December 28, 2019 10-K
Basis of Presentation
Except where the context otherwise requires, all references in this Annual Report on Form 10-K for the fiscal year ended
December 28, 2019 (“Form 10-K”) to “SunOpta”, the “Company”, “we”, “us”, “our” or similar words and phrases are to
SunOpta Inc. and its subsidiaries, taken together.
In this report, all currency amounts presented are expressed in thousands of United States (“U.S.”) dollars (“$”), except per
share amounts, unless otherwise stated. Other amounts may be presented in thousands of Canadian dollars (“C$”), euros (“€”)
and Mexican pesos (“M$”). The following table sets forth, for the periods indicated, the rate of exchange for the Canadian
dollar, euro, and Mexican peso, expressed in U.S. dollars, based on Bank of Canada exchange rates. These rates are provided
solely for convenience, and do not necessarily reflect the rates used by us in the preparation of our financial statements.
Canadian Dollar
Euro
Mexican Peso
Year
2019
2018
2017
Closing
0.7646
0.7332
0.7971
Average
0.7534
0.7723
0.7708
Closing
1.1172
1.1446
1.1998
Average
1.1193
1.1812
1.1281
Closing
0.0531
0.0503
0.0509
Average
0.0519
0.0520
0.0530
Forward-Looking Statements
This Form 10-K contains forward-looking statements which are based on management’s current expectations and assumptions
and involve a number of risks and uncertainties. Generally, forward-looking statements do not relate strictly to historical or
current facts and are typically accompanied by words such as “anticipate,” “estimate,” “target,” “intend,” “project,” “potential,”
“predict,” “continue,” “believe,” “expect,” “can,” “could,” “would,” “should,” “may,” “might,” “plan,” “will,” “budget,”
“forecast,” the negatives of such terms, and words and phrases of similar impact and include, but are not limited to, references
to future financial and operating results, plans, objectives, expectations and intentions; our intention to implement business
strategies and operational actions and make structural investments under the Value Creation Plan, and the associated timing
and costs of these actions; expected cost savings from actions completed under the Value Creation Plan; expected synergies,
opportunities, revenues and earnings related to business acquisitions; our plans to expand our aseptic processing capacity and
plant-based ingredient extraction capabilities and related project timing; the anticipated impact of the strawberry crop shortfall
on revenues and margins prior to the 2020 crop cycle; our expectations regarding profitability improvements in our frozen fruit
business in 2020; our expectations regarding customer demand, consumer preferences, competition, sales pricing, and
availability and pricing of raw material inputs; other expectations related to our businesses, including anticipated results of
operations, operational growth and expansion plans, plans to reduce costs and improve profitability, intent and ability to bring
new products and processes to market through innovation, and the exploration of the sale of selected businesses or assets; and
other statements that are not historical facts. These forward-looking statements are made pursuant to the safe harbor provisions
of the Private Securities Litigation Reform Act of 1995, including Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are based on certain
assumptions, expectations and analyses we make in light of our experience and our interpretation of current conditions,
historical trends and expected future developments, as well as other factors that we believe are appropriate in the circumstances.
Whether actual results and developments will be consistent with and meet our expectations and predictions is subject to many
risks and uncertainties. Accordingly, there are important factors that could cause our actual results to differ materially from
our expectations and predictions. We believe these factors include, but are not limited to, the following:
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
failure or inability to implement our value creation strategies to achieve anticipated benefits;
conflicts of interest between our significant investors and our other stakeholders;
disruptions to our business caused by shareholder activism;
product liability suits, recalls and threatened market withdrawals that may arise or be brought against us;
food safety concerns and instances of food-borne illnesses that could harm our business;
litigation and regulatory enforcement concerning marketing and labeling of food products;
significant food and health regulations to which we are subject;
SUNOPTA INC.
2
December 28, 2019 10-K
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
ability to obtain additional capital as required to maintain current growth rates;
the potential for impairment charges for goodwill or other intangible assets;
the highly competitive industry in which we operate;
that our customers may choose not to buy products from us;
the potential loss of one or more key customers;
changes and difficulty in predicting consumer preferences for natural and organic food products;
our ability to effectively manage our supply chain;
volatility in the prices of raw materials, freight and energy;
the availability of organic and non-genetically modified ingredients;
unfavorable growing and operating conditions due to adverse weather conditions;
an interruption at one or more of our manufacturing facilities;
technology failures that could disrupt our operations and negatively impact our business;
the potential for data breaches and the need to comply with data privacy and protection laws and regulations;
the loss of service of our key management;
labor shortages or increased labor costs;
technological innovation by our competitors;
ability to protect our intellectual property and proprietary rights;
changes in laws or regulations governing foreign trade or taxation;
agricultural policies that influence our operations;
substantial environmental regulation and policies to which we are subject;
changes in laws or regulations governing climate change;
the enactment of new climate change laws;
fluctuations in exchange rates, interest rates and the prices of certain commodities;
exposure to our international operations;
increased vulnerability to economic downturns and adverse industry conditions due to our level of indebtedness;
restrictions under the terms of our debt and equity instruments on how we may operate our business;
our ability to renew our revolving asset-based credit facility (the “Global Credit Facility”) when it becomes due on
March 31, 2022, and/or refinance our senior secured second lien notes when they mature on October 9, 2022;
our ability to meet the financial covenants under the Global Credit Facility or to obtain necessary waivers from our
lenders;
SUNOPTA INC.
3
December 28, 2019 10-K
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
our ability to effectively manage our growth and integrate acquired companies;
our ability to achieve the estimated benefits or synergies to be realized from business acquisitions;
exposure to unknown liabilities arising from business acquisitions;
unexpected disruptions in our business, including disruptions resulting from business acquisitions;
our ability to successfully consummate possible future divestitures of businesses;
the volatility of our operating results and share price;
that we do not currently intend to, and are restricted in our ability to, pay any cash dividends on our common shares
in the foreseeable future;
dilution in the value of our common shares through the exchange of convertible preferred stock, exercise of stock
options, participation in our employee stock purchase plan and issuance of additional securities; and
impact of the publication of industry analyst research or reports about our business on the value of our common
shares.
All forward-looking statements made herein are qualified by these cautionary statements, and our actual results or the
developments we anticipate may not be realized. Our forward-looking statements are based only on information currently
available to us and speak only as of the date on which they are made. We do not undertake any obligation to publicly update
our forward-looking statements, whether written or oral, after the date of this report for any reason, even if new information
becomes available or other events occur in the future, except as may be required under applicable securities laws. The foregoing
factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are
included in this report. For a more detailed discussion of the principal factors that could cause actual results to be materially
different, you should read our risk factors in Item 1A, Risk Factors, included elsewhere in this report.
SUNOPTA INC.
4
December 28, 2019 10-K
Item 1. Business
The Company
PART I
SunOpta, a corporation organized under the laws of Canada in 1973, is a leading global company focused on the manufacture
of plant-based and fruit-based food and beverage products for sale to retail customers, foodservice distributors, branded food
companies, and food manufacturers. In addition, our global ingredient sourcing and production platform makes us one of the
leading suppliers of organic and non-GMO ingredients to the food industry worldwide. Our employees and assets, which
include 18 processing facilities, are principally located in North America and Europe, with smaller operations in Africa.
Operating Segments and Principal Products
Effective the fourth quarter of 2019, we changed our segment reporting to reflect changes to our organization and leadership
structure to align with the operational and strategic objectives established by our Chief Executive Officer. As a result, we
established two new segments – a Plant-Based Foods and Beverages segment and a Fruit-Based Foods and Beverages segment
– based on the synergistic nature of the underlying principal product ingredients. In addition, we realigned the Global
Ingredients segment to combine our international organic ingredients operations and our premium juice program, based on
shared raw material sourcing. With these changes, the following is a description of the principal activities and products that
comprise each of our three operating segments:
(cid:120) Global Ingredients – We sell organic and non-GMO ingredients sourced from over 60 origins around the world. Our
portfolio includes fruits, vegetables, oils, fats, coffee, nuts, dried fruits, sugars, liquid sweeteners, seeds, grains, rice
and pulses. In addition, utilizing our own production facilities, we process value-added ingredients including cocoa
liquor, butter and powder, sunflower kernel, oil and cakes, sesame seeds, and avocado oil. We also partner with third-
party co-manufacturers to produce consumer-packaged premium juice products (including private label orange juices,
lemonades, and functional waters), utilizing internally-sourced raw materials.
(cid:120) Plant-Based Foods and Beverages – We offer a full line of plant-based beverages and liquid and dry ingredients
(utilizing almond, soy, coconut, oat, hemp, and other bases), as well as broths, teas and nutritional beverages. In
addition, we package dry- and oil-roasted in-shell sunflower and sunflower kernels, as well as corn-, soy- and legume-
based roasted snacks, and we process and sell raw sunflower inshell and kernel for food and feed applications.
(cid:120) Fruit-Based Foods and Beverages – We offer individually quick frozen (“IQF”) fruit for retail (including strawberries,
blueberries, mango, pineapple, blends, and other berries), IQF and bulk frozen fruit for foodservice (including purées,
fruit cups and smoothies), and custom fruit preparations for industrial use. In addition, we offer fruit snacks, including
bars, twists, ropes and bite-sized varieties.
Additional information regarding our segments is presented in note 24 to the consolidated financial statements at Item 15 of
this Form 10-K.
Sale of Specialty and Organic Soy and Corn Business
On February 22, 2019, our subsidiary, SunOpta Grains and Foods Inc., completed the sale of our specialty and organic soy and
corn business, which was engaged in seed and grain conditioning and corn milling and formed part of Global Ingredients. The
business included five facilities located in Hope, Minnesota, Blooming Prairie, Minnesota, Ellendale, Minnesota, Moorhead,
Minnesota, and Cresco, Iowa. The sale of the soy and corn business was driven by the portfolio optimization strategy of the
Value Creation Plan (see below), which is designed to simplify our business and exit product lines where we are not effectively
positioned to drive long-term profitable growth. Additional financial information related to this transaction and the soy and
corn business can be found in note 4 to the consolidated financial statements at Item 15 of this Form 10-K.
Value Creation Plan
In 2016, we established a Value Creation Plan with the objective of maximizing our ability to deliver long-term value to our
shareholders. Since 2016, we have identified and implemented a series of measures under the Value Creation Plan, including
the sale of the soy and corn business (as described above). In 2019, we appointed a new Chief Executive Officer and new
Chief Financial Officer to continue to drive the Value Creation Plan. Actions taken in 2019 included a workforce reduction
program and other cost-saving initiatives that are expected to result in approximately $8 million to $10 million of savings
SUNOPTA INC.
5
December 28, 2019 10-K
annually beginning in 2020, and we initiated a plan to consolidate certain of our corporate office functions in Edina, Minnesota,
which is expected to be completed in 2020 with the closure of our Placentia, California, office and downsizing of our
Mississauga, Ontario, office. Previous measures taken under the Value Creation Plan have included the consolidation of roasted
snack operations and related disposal of our former roasting facility in Wahpeton, North Dakota, in 2018; the exit from flexible
resealable pouch and nutrition bar product lines and operations initiated in 2017; and the closure of our juice processing facility
in San Bernardino, California, in 2016. In addition, we have made a series of organizational changes within our management
and executive teams, including new leadership additions to many corporate, commercial and operational functions. We have
also added new employees in the areas of quality, food safety, sales, marketing, operations and engineering, and made capital
investments at several of our manufacturing facilities to enhance food safety and production efficiencies.
Raw Materials
Our raw materials primarily consist of agricultural ingredients and packaging materials. We utilize an established global
network of growers, processors and traders of organic and non-GMO raw material ingredients to support our Global Ingredients
sourcing platform. Because weather conditions and other factors can limit the availability of raw materials in a specific
geography, we continue to focus on expanding sourcing projects to other parts of the world to ensure supply in years when
local production is below normal levels. The diversity of our supplier base helps us ensure continual supply by providing
contra-seasonal solutions to mitigate crop and quality risks. The largest ingredient in the products we produce in our food and
beverage operations is strawberries. Fresh and frozen berries are sourced directly from a large number of suppliers throughout
the U.S., Mexico, and globally through Global Ingredients. Our scale and location close to growing areas in Mexico and
California makes us an attractive customer for fruit growers.
We rely on our packaging suppliers to ensure delivery of often unique, portable, and convenient consumer packaging formats.
In our aseptic processing facilities, we specialize in the use of Tetra Pak equipment in a variety of pack sizes and also offer a
variety of opening types and extended shelf life (“ESL”) options. We also partner with third-party fillers to provide ESL and
refrigerated packaging formats to our customers.
Customers
Our organic and non-GMO ingredients are sold to over 400 customers worldwide, including some of the largest U.S. consumer-
packaged food companies. We sell our plant-based and fruit-based food and beverage products through various distribution
channels, including large retailers and club stores, branded food companies, foodservice distributors, quick service and casual
dining restaurants and food manufacturers, located principally in the U.S. We generally conduct our business with customers
on the basis of purchase orders and short-term sales contracts.
In 2019, our largest customer, Starbucks Corporation, accounted for approximately 11% of our consolidated revenues and
approximately 36% of our Plant-Based Foods and Beverages segment revenues. No other customer individually accounted for
more than 10% of our consolidated revenues in 2019. Collectively, our top three customers in 2019, including Starbucks,
accounted for approximately 27% of our consolidated revenues, and 11% of Global Ingredients segment revenues, 43% of
Plant-Based Foods and Beverages segment revenues and 31% of Fruit-Based Foods and Beverages segment revenues.
Competition
The global organic food industry is very competitive due primarily to the limited worldwide supply of organic raw materials.
Global Ingredients competes with worldwide brokers, traders and food processors for the limited supply of organic raw material
ingredients. In many cases, we will enter into exclusive arrangements with growers and/or processors of key strategic raw
material ingredients to control the reliability of our supply chain.
Our plant-based and fruit-based food and beverage operations compete with major branded and private-label food
manufacturers. Our customers do not typically commit to buy predetermined amounts of products and many customers utilize
bidding procedures to select vendors. As a result, price is often a key competitive factor in winning bids and retaining
customers, along with product quality, food safety, innovation and customer service. We believe that our integrated raw
material sourcing capabilities, combined with our in-house processing and packaging capabilities, provides us with a low-cost
advantage over many of our competitors.
Seasonality and Working Capital
Since we are diversified in the global organic and non-GMO ingredients market in terms, there are no material seasonal
fluctuations in overall sourcing volumes, or in regard to the sale and distribution of our ingredient products. However, there
SUNOPTA INC.
6
December 28, 2019 10-K
is seasonality in the procurement, transportation and processing of our principal raw material of strawberries, mainly related to
the peak California and Mexico production seasons, which generally occur during the first two quarters of the year. Similarly,
we purchase the bulk of our annual sunflower crop requirements from North American growers following the harvest in the
fall of each year. As a result, our financing needs are generally highest in those periods due to crop inventory builds, while
cash inflows are typically highest in the fourth quarter as inventories are drawn down. Overall, the demand for our products
has been approximately level throughout the year; however, sales of broth are generally higher in the fourth quarter.
Research and Development
As a leading supplier of organic and non-GMO ingredients in the food industry, we are able to leverage our insights into
emerging consumer tastes and preferences to develop and introduce new and innovative food and beverage products to the
market. Our innovation center located in Edina, Minnesota, supports our product development team of highly trained and
experienced food scientists and technologists that are dedicated to the research and development of new product offerings and
addressing product development opportunities for our customers. These opportunities include new and custom formulations,
innovations in packaging formats, and new production processes and applications. Applications and technical support provided
to our customers include all aspects of product development from concept to commercial launch, as well as ongoing
manufacturing and processing support.
Trademarks
We do not extensively market our own consumer brands under trademarks that we own, which include Sunrich® Naturals and
Pure Nature™.
Employees
As at December 28, 2019, we had a total of approximately 1,900 full-time employees (December 29, 2018 – 2,000). We also
employ up to 2,100 seasonal employees in the U.S. and Mexico during peak fruit seasons each year.
Regulations
We are subject to a wide range of governmental regulations and policies in various countries and regions where we operate, including
the U.S., Canada, Mexico, the Netherlands, and the rest of the European Union (“EU”), Ethiopia, and China. Outside of the U.S.,
regulations concerning the sale or characterization of food ingredients vary substantially from country to country, and we take
appropriate steps to comply with such regulations. These laws, regulations and policies are implemented, as applicable in each
jurisdiction, on the national, federal, state, provincial and local levels. For example, we are affected by laws and regulations related
to: seed, fertilizer and pesticides; the purchasing, harvesting, transportation and warehousing of grain and other products; the
processing, packaging and sale of food, including wholesale operations; and product labeling and marketing, food safety and food
defense. We are also affected by government-sponsored price supports, acreage set aside programs and a number of environmental
regulations.
U.S. Regulations
Our activities in the U.S. are subject to regulation by various governmental agencies, including the Food and Drug Administration
(“FDA”), the Federal Trade Commission (“FTC”), the Environmental Protection Agency (“EPA”), the U.S. Department of
Agriculture (“USDA”), Occupational Safety and Health Administration (“OSHA”), and the Departments of Commerce and Labor,
as well as voluntary regulation by other bodies. Various state and local agencies also regulate our activities.
USDA National Organic Program and Similar Regulations
We currently manufacture and distribute a number of organic products that are subject to the standards set forth in the Organic
Foods Production Act and the regulations adopted thereunder by the National Organic Standards Board. In addition, our organic
products may be subject to various state regulations. We believe that we are in material compliance with the organic regulations
applicable to our business, and we maintain an organic testing and verification process. Generally, organic food products are
produced using:
(cid:120)
(cid:120)
agricultural management practices intended to promote and enhance ecosystem health;
no genetically engineered seeds or crops, sewage sludge, long-lasting pesticides, herbicides or fungicides; and
SUNOPTA INC.
7
December 28, 2019 10-K
(cid:120)
food processing practices intended to protect the integrity of the organic product and disallow irradiation, genetically
modified organisms or synthetic preservatives.
After becoming certified, organic operations must retain records concerning the production, harvesting, and handling of
agricultural products that are to be sold as organic for a period of five years. Any organic operation found to be in violation of
the USDA organic regulations is subject to enforcement actions, which can include financial penalties or suspension or
revocation of their organic certificate.
Food Safety, Labeling and Packaging Regulations
As a manufacturer and distributor of food products, we are subject to the Federal Food, Drug and Cosmetic Act, the Fair
Packaging and Labeling Act and regulations promulgated thereunder by the FDA and the FTC. This regulatory framework
governs the manufacture (including composition and ingredients), labeling, packaging and safety of food in the U.S.
State and local statutes and regulations may impose additional food safety, labeling, and packaging requirements. For instance,
the California Safe Drinking Water and Toxic Enforcement Act of 1986 (commonly referred to as “Proposition 65”) requires,
with a few exceptions, that a specific warning appear on any consumer product sold in California that contains a substance,
above certain levels, listed by that state as having been found to cause cancer or birth defects. We believe we are in material
compliance with state and local statutes and regulations as they apply to our business.
Environmental Regulations
We are also subject to various U.S. federal, state and local environmental regulations. Some of the key environmental regulations
in the U.S. include, but are not limited to, the following:
(cid:120) Air quality regulations – air quality is regulated by the EPA and certain city/state air pollution control groups.
Emission reports are filed annually.
(cid:120) Waste treatment/disposal regulations – solid waste is either disposed of by a third-party or, in some cases, we have a
permit to haul and apply the sludge to land. Agreements exist with local city sewer districts to treat waste at specified
levels of Biological Oxygen Demand (“BOD”), Total Suspended Solids (“TSS”) and other constituents. This can
require weekly/monthly reporting as well as annual inspection.
(cid:120) Sewer regulations – we have agreements with the local city sewer districts to treat waste at specified limits of BOD
and TSS. This requires weekly/monthly reporting as well as annual inspection.
(cid:120) Hazardous chemicals regulations – Various reports are filed with local city/state emergency response agencies to
identify potential hazardous chemicals being used in our U.S. facilities.
(cid:120) Storm water – all of our U.S. facilities are inspected annually and must comply with an approved storm water plan to
protect water supplies.
Employee Safety Regulations
We are subject to certain safety regulations, including OSHA regulations. These regulations require us to comply with certain
manufacturing safety standards to protect our employees from accidents. We believe that we are in material compliance with
all employee safety regulations applicable to our business.
Canadian and Other Non-U.S. Regulations
Outside of the U.S., regulations concerning the sale or characterization of food ingredients vary substantially from country to
country, and we take appropriate steps to comply with such regulations.
In Canada, the sale of food is currently regulated under various federal and provincial laws, principally (but not limited to) the Safe
Food for Canadians Act (“SFCA”), the Food and Drugs Act (“FADA”), the Canada Consumer Product Safety Act (“CCPSA”), the
Canadian Food Inspection Agency Act (“CFIAA”) and the Canadian Environmental Protection Act, 1999 (“CEPA”), along with
their supporting regulations. The following is a brief summary of each of these statutes to the extent that they apply or potentially
apply to the Company and its operations:
SUNOPTA INC.
8
December 28, 2019 10-K
(cid:120)
Safe Food for Canadians Regulations (“SFCR”) (under the SFCA) – the SFCR came into effect on January 15, 2019 and
consolidated 14 sets of existing food regulations into a single set of regulations which governs all imported, exported, or
inter-provincially traded food products. Some provisions of the SFCA and SFCR also apply intra-provincially. Notably,
SFCR replaced the Organic Products Regulations, 2009, the Processed Products Regulations and, to the extent that they
related to food products, the Consumer Packaging and Labeling Act and its supporting regulations. Principal elements of
the SCFR which may impact the Company include licensing requirements, preventative controls, traceability
requirements, commodity specific requirements, reporting requirements and timelines, an export certificate request
process, packaging and labeling requirements to ensure food safety and prevent false or misleading labeling, regulation
of the use of grades and grade names, standards of identity and expansion of the certification process for organic
products, and other requirements. Timelines for complying with the SFCR requirements vary by food, activity, and size
of the food business.
(cid:120) Food and Drug Regulations (under the FADA) – food and drugs are subject to specific regulatory requirements, including
composition (such as food additives, fortification, and food standards), packaging, labeling, advertising and marketing,
and licensing requirements. New requirements regarding nutrition and ingredient labeling and food color were introduced
on December 14, 2016. To the extent the new labeling requirements apply to products manufactured and sold by the
Company, we will have a five-year transitional period to adopt them.
(cid:120) Canada Consumer Product Safety Act (“CCPSA”) – the CCPSA provides oversight and regulation of consumer
products with respect to manufacturers, importers, and retailers. It includes, without limitation, the ability to require
product recalls, mandatory incident reporting, document retention requirements, increased fines and penalties, and
packaging and labeling requirements. While the CCPSA does not apply to food, it does apply to its packaging with
respect to safety. It is possible that there will be amendments introduced to the FADA, to capture the essence of the
regulatory oversight found in the CCPSA. We have no way of anticipating if and when that may occur.
(cid:120) Canadian Food Inspection Agency Act (“CFIAA”) – the CFIAA grants power to the Canadian Food Inspection
Agency (the “CFIA”), which is tasked with the administration and enforcement of certain Canadian food legislation.
By virtue of the CFIAA and the SFCA, the CFIA has the power to inspect and, if deemed necessary, recall certain
products, including fresh fruit and vegetables, processed foods and organic foods, if the Minister of Health believes
that such products pose a risk to the public, animal or plant health.
(cid:120)
Substance Regulations – Various regulations under CEPA regulate the importation and use of certain substances in
Canada. For example, prior to the importation and use in products, the importer must ensure that all ingredients are
found on the Domestic Substances List (“DSL”) maintained by Environment and Climate Change Canada. In the event
that an ingredient is not found on the DSL, then subject to the amount of the substance imported into Canada and used
in products sold in Canada, a filing may become necessary under the New Substances Notification Regulations.
We are subject to Dutch and European Commission (“EC”) regulations and policies. Our European subsidiary, The Organic
Corporation (“TOC”), is involved in the sourcing, supplying, processing, marketing, selling and distribution of organic food
products and, as such, is subject to standards for production, labeling and inspection of organic products contained in EC
Regulation 2092/91 (and its subsequent amendments). TOC is certified by Skal, the inspection body for the production (trading
and selling) of organic products in the Netherlands. Products certified as organic by an EU-recognized inspection body, such
as Skal, can be marketed within the entire EU. In addition, under the terms of an equivalency arrangement between the U.S.
and the EU, organic operations certified to the USDA organic or EU organic standards may be labeled and sold as organic in
both the U.S. and EU.
TOC is also affected by general food legislation both at EU and Dutch level relating to product safety and hygiene, among
others. TOC is BRC Agents and Brokers certified in the Netherlands and manages a fully computerized system that manages
the traceability of each product. In addition, TOC also considers and abides by EU and local legislation with regard to
packaging and packaging waste. TOC is also subject to the regulations and policies of the countries outside of the EU in which
it operates, including China and Ethiopia.
Our frozen fruit processing facility in Mexico is subject to Mexican regulations, including regulations regarding processing,
packaging and sales of food products, labor relations and profit-sharing with employees.
SUNOPTA INC.
9
December 28, 2019 10-K
Environmental Hazards
We believe that, with respect to both our operations and real property, we are in material compliance with environmental laws
at all of our locations.
Intellectual Property
The nature of a number of our products and processes requires that we create and maintain patents, trade secrets and trademarks.
Our policy is to protect our technology, brands and trade names by, among other things, filing patent applications for technology
relating to the development of our business in the U.S. and in selected foreign jurisdictions, registering trademarks in the U.S.,
Canada and selected foreign jurisdictions where we sell products, and maintaining confidentiality agreements with outside
parties and employees.
Our continued success depends, in part, on our ability to protect our products, trade names and technology under U.S. and
international patent laws and other intellectual property laws. We believe that we own or have sufficient rights to use all of the
proprietary technology, information and trademarks necessary to manufacture and market our products; however, there is
always a risk that patent applications relating to our products or technologies will not result in patents being issued, or, if issued,
will be later challenged by a third party, or that current or additional patents will not afford protection against competitors with
similar technology.
We also rely on trade secrets and proprietary know-how and confidentiality agreements to protect certain technologies and
processes. However, even with these steps taken, our outside partners and contract manufacturers could gain access to our
proprietary technology and confidential information. All employees are required to adhere to internal policies, which are
intended to further protect our technologies, processes and trade secrets.
Available Information
Our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those
reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (the “Exchange Act”), are
available free of charge on our website at www.sunopta.com as soon as reasonably practicable after we file such information
electronically with, or furnish it to, the U.S. Securities and Exchange Commission (the “SEC”) and applicable Canadian
Securities Administrators (the “CSA”).
Item 1A. Risk Factors
Our business, operations and financial condition are subject to various risks and uncertainties, including those described below
and elsewhere in this report. We believe the most significant of these risks and uncertainties are described below, any of which
could adversely affect our business, financial condition and results of operations and could cause actual results to differ
materially from the results contemplated by the forward-looking statements contained in this report. Any such adverse effect
could cause the trading price of our common stock to decline, and our shareholders may lose all or part of their investment.
There may be additional risks and uncertainties not presently known to us or that we currently consider immaterial.
Consequently, you should not consider the following to be a complete discussion of all possible risks or uncertainties applicable
to our business. These risk factors should be read in conjunction with the other information in this report and in the other
documents that we file from time to time with the SEC and the CSA.
Risks Related to Strategic Initiatives, Significant Investors and Shareholder Activism
The implementation of our Value Creation Plan could pose a number of risks that could have an adverse impact on our
business, financial condition and results of operations
In 2016, our management and directors developed a Value Creation Plan built on four pillars: portfolio optimization, operational
excellence, go-to-market effectiveness and process sustainability. The Value Creation Plan is a broad-based initiative focused
on increasing shareholder value through strategic investments made to the people and assets of the Company to deliver
sustained profitable growth. We began implementing the Value Creation Plan in 2016, and implementation is ongoing and
could span several more years. In connection with the Value Creation Plan, we will continue to implement operational actions
to improve our profitability and streamline our operations for long-term success. These actions include rationalization or
consolidation of certain of our operations or facilities, reinvestment in certain of our operations or facilities, investments in
personnel, processes and tools, and other cost saving initiatives. These ongoing actions could consume capital resources and
SUNOPTA INC.
10
December 28, 2019 10-K
could also give rise to impairment and other restructuring charges in future periods that would be both cash and non-cash in
nature, and these charges could be material.
The implementation of the Value Creation Plan could have a material impact on our operations, strategy, governance,
management and future prospects. In addition, we cannot predict whether the actions we take will achieve our goals of
improving our profitability and financial performance and delivering long-term value to our shareholders. The ongoing
implementation of our Value Creation Plan could expose us to a number of other risks, including the following:
(cid:120)
(cid:120)
(cid:120)
(cid:120)
distraction of management;
difficulties in hiring, retaining and motivating key personnel as a result of uncertainty generated by the review and the
implementation of any resulting recommendations;
difficulties in maintaining relationships or arrangements with customers, suppliers and other third parties; and
increases in general and administrative expenses associated with the need to retain and compensate business and
recruiting consultants and other advisors.
The occurrence of any one or more of the above risks could have an adverse impact on our business, financial results, liquidity
and financial condition.
Our significant investors may have interests that conflict with those of our debtholders and other stakeholders
As at December 28, 2019, Oaktree Capital Management L.P., a private equity investor (together with its affiliates, “Oaktree”)
held a 19.5% voting interest in the Company through its holdings of 11,333,333 special voting shares and 8,092,699 common
shares of the Company. Oaktree has also nominated two members of our Board of Directors and is entitled to designate two
nominees for election to the Board so long as it beneficially owns or controls at least 11.1% of our common stock on an as-
exchanged basis. If Oaktree beneficially owns or controls less than 11.1% but more than 5% of our common stock on an as-
exchanged basis, it will be entitled to designate one nominee. In addition, as at December 28, 2019, Engaged Capital, LLC
(together with its affiliates, “Engaged Capital”) beneficially owned or controlled approximately 10% of our common stock and
has nominated one member of our Board.
Oaktree is assisting us with our efforts to improve our operations, management and governance. Oaktree’s objectives and
perspectives as an equity investor in SunOpta may not always be aligned with those of other stakeholders, including our
debtholders and smaller shareholders.
The interests of Oaktree and Engaged Capital may differ from the interests of our other stakeholders in material respects. For
example, Oaktree and Engaged Capital may have an interest in directly or indirectly pursuing acquisitions, divestitures,
financings or other transactions that, in their judgment, could enhance their other equity investments, even though such
transactions might involve risks to us, including risks to our liquidity and financial condition. Oaktree and Engaged Capital are
in the business of making or advising on investments in companies, including businesses that may directly or indirectly compete
with certain portions of our business. They may also pursue acquisition opportunities that may be complementary to our
business, and, as a result, those acquisition opportunities may not be available to us.
Our other large investors do not have specific rights beyond those of smaller holders of our common shares. However, a
concentration of ownership within our large investors could potentially be disadvantageous to, or conflict with, interests of our
debtholders or smaller shareholders. In addition, if any significant shareholder were to sell or otherwise transfer all or a large
percentage of its holdings, we could find it difficult to raise capital, if needed, through the sale of additional equity securities.
Our business could be negatively impacted as a result of shareholder activism or an unsolicited takeover proposal or a proxy
contest
In recent years, proxy contests and other forms of shareholder activism have been directed against numerous public companies.
If a proxy contest or an unsolicited takeover proposal was made with respect to us, we could incur significant costs in defending
the Company, which would have an adverse effect on our financial results. Shareholder activists may also seek to involve
themselves in the governance, strategic direction and operations of the Company. Such proposals may disrupt our business
and divert the attention of our management and employees, and any perceived uncertainties as to our future direction resulting
from such a situation could result in the loss of potential business opportunities, be exploited by our competitors, cause concern
to our current or potential customers, and make it more difficult to attract and retain qualified personnel and business partners,
SUNOPTA INC.
11
December 28, 2019 10-K
all of which could adversely affect our business. In addition, actions of activist shareholders may cause significant fluctuations
in our stock price based on temporary or speculative market perceptions or other factors that do not necessarily reflect the
underlying fundamentals and prospects of our business.
Risks Related to Our Business
Product liability suits, recalls and threatened market withdrawals, could have a material adverse effect on our business
Many of our products are susceptible to harmful bacteria, and the sale of food products for human consumption involves the
risk of injury or illness to consumers. Such injuries may result from inadvertent mislabeling, tampering by unauthorized third
parties, faulty packaging materials, product contamination, or spoilage. Under certain circumstances, we or our customers may
be required to recall or withdraw products, which may lead to a material and adverse effect on our business, financial condition
or results of operations. Our customers may also voluntarily recall or withdraw a product we manufactured or packaged, even
without consulting us, which could increase our potential liability and costs and result in lost sales. A product recall or
withdrawal could result in significant losses due to the costs of the recall, the destruction of product inventory, and lost sales
due to the unavailability of product for a period of time. In addition, a recall or withdrawal may cause us to lose future revenues
from, or relationships with, one or more material customers, and the impact of the recall or withdrawal could affect our
customers’ willingness to continue to purchase related or unrelated products from us, or could otherwise hinder our ability to
grow our business with those customers. We could also be forced to temporarily close one or more production facilities.
Even if a situation does not necessitate a recall or market withdrawal, product liability claims might be asserted against us. If
a product recall or withdrawal were to lead to a decline in sales of a similar or related product sold by a customer or other third
party, that party could also initiate litigation against us. While we are subject to governmental inspection and regulations and
believe our facilities and those of our co-packers comply in all material respects with all applicable laws and regulations, if the
consumption of any of our products causes, or is alleged to have caused, a health-related illness in the future, we may become
subject to claims or lawsuits relating to such matters. Even if a product liability claim is unsuccessful or is not fully pursued,
the negative publicity surrounding any assertion that our products caused illness or physical harm could adversely affect our
reputation with existing and potential customers and consumers and our corporate and brand image.
Moreover, future claims or liabilities of this sort might not be covered by our insurance or by any rights of indemnity or
contribution that we may have against others. Further, we may incur claims or liabilities for which we are not insured or that
exceed the amount of our insurance coverage. A product liability judgment against us or a further product recall could have a
material and adverse effect on our business, financial condition and results of operations.
Food safety concerns and instances of food-borne illnesses caused by third parties could harm our business
Our internal processes and training may not be fully effective in preventing contamination of food products that could lead to
food-borne illnesses. We rely on third-party suppliers and distributors, which increases the risk that food-borne illness incidents
(such as e. coli, salmonella or listeria) could occur outside of our control and at multiple locations. If consumers lose confidence
in the safety and quality of our products or organic products generally, even in the absence of a recall or a product liability
case, our business, financial condition and results of operations could be materially and adversely affected. Instances of food-
borne illnesses, whether real or perceived, and whether or not traceable to our operations or a result of our actions or omissions,
could cause negative publicity about us or the products we serve, which could adversely affect sales. Food safety concerns and
instances of food-borne illnesses and injuries caused by contaminated products sold by third parties could cause customers to
shift their preferences, even if no food-borne illnesses or injuries are traced to our products. As a result, our sales may decline.
Loss of customers as a result of these health concerns or negative publicity could harm our business, financial condition and
results of operations.
Litigation and regulatory enforcement concerning marketing and labeling of food products could adversely affect our
business and reputation
The marketing and labeling of any food product in recent years has brought increased risk that consumers will bring class action
lawsuits and that the FTC and/or state attorneys general will bring legal action concerning the truth and accuracy of the
marketing and labeling of the product. Examples of causes of action that may be asserted in a consumer class action lawsuit
include fraud, unfair trade practices, and breach of state consumer protection statutes (such as Proposition 65 in California).
The FTC and/or state attorneys general may bring legal actions that seek to remove a product from the marketplace and/or
impose fines and penalties. Even if not merited, class claims, actions by the FTC or state attorneys general enforcement actions
could be expensive to defend and could adversely affect our reputation with existing and potential customers and consumers
and our corporate and brand image, which could have a material and adverse effect on our business, financial condition and
SUNOPTA INC.
12
December 28, 2019 10-K
results of operations.
We are subject to significant food and health regulations
We are affected by a wide range of governmental regulations in Canada, the U.S., Mexico and several countries in Europe,
among others. These laws and regulations are implemented at the national level (including, among others, federal laws and
regulations in Canada and the U.S.) and by local subdivisions (including, among others, state laws in the U.S. and provincial
laws in Canada). We are also subject to regulations of the EU and the regulatory authority of regulatory agencies in several
different countries. Examples of regulatory agencies influencing our operations include: the USDA, the FDA, the DHS, the
EPA, the CFIA, and Skal, among others.
Examples of laws and regulations that affect us include laws and regulations applicable to:
(cid:120)
(cid:120)
(cid:120)
(cid:120)
the use of seed, fertilizer and pesticides;
the purchasing, harvesting, transportation and warehousing of seeds, grains and other products;
the processing and sale of food, including wholesale operations; and
the product labeling and marketing of food and food products, food safety and food defense.
These laws and regulations affect various aspects of our business. For example, certain food ingredient products manufactured
by SunOpta may require pre-market approval by the FDA that the ingredient is “generally recognized as safe,” or “GRAS.”
We believe that most food ingredients for which we have commercial rights are GRAS. However, this status cannot be
determined until actual formulations and uses are finalized. As a result, we may be adversely impacted if the FDA determines
that our food ingredient products do not meet the criteria for GRAS.
In addition, certain USDA regulations set forth the minimum standards producers must meet in order to have their products
labeled as “certified organic”, and we currently manufacture a number of organic products that are covered by these regulations.
While we believe our products and our supply chain are in compliance with these regulations, changes to food regulations may
increase our costs to remain in compliance. We could lose our “organic” certification if a facility becomes contaminated with
non-organic materials or if we do not use raw materials that are certified organic. The loss of our “organic” certification could
materially and adversely affect our business, financial condition and results of operations.
Our business is also required to comply with the Food Safety Modernization Act (“FSMA”) and the FDA’s implementing
regulations. FSMA requires, among other things, that food facilities conduct contamination hazard analysis, implement risk-
based preventive controls and develop track-and-trace capabilities. If we are found to be in violation of applicable laws and
regulations in these areas, we could be subject to civil remedies, including fines, injunctions or recalls, as well as potential
criminal sanctions, any of which could have a material adverse effect on our business.
Our business is subject to the Perishable Agricultural Commodities Act (“PACA”). PACA regulates fair trade standards in the
fresh produce industry and governs our purchases of fresh produce and sales of frozen produce. We source fresh produce under
licenses issued by the USDA, as required by PACA. Our failure to comply with the PACA requirements could, among other
things, result in civil penalties, suspension or revocation of our licenses to sell produce, and in certain cases, criminal
prosecution, which could have a material and adverse effect on our business, financial condition and results of operations.
Changes in any government laws and regulations applicable to our operations could increase our compliance costs, negatively
affect our ability to sell certain products or otherwise adversely affect our results of operations. In addition, while we believe
we are in material compliance with all laws and regulations applicable to our operations, we cannot assure you that we have
been, or will at all times be, in compliance with all food production and health requirements, or that we will not incur material
costs or liabilities in connection with these requirements. Our failure to comply with any laws, regulations or policies applicable
to our business could result in fines, lawsuits, enforcement actions, penalties or loss of the ability to sell certain products, any
of which could materially and adversely affect our business, financial condition and results of operations.
We may require additional capital, which may not be available on favorable terms or at all
We have grown via a combination of internal growth and acquisitions requiring available financial resources. Our ability to
raise capital, through equity or debt financing, is directly related to our ability to both continue to grow and improve returns
from our operations. Debt or equity financing may not be available to us on favorable terms or at all. In addition, any future
SUNOPTA INC.
13
December 28, 2019 10-K
equity financing would dilute our current shareholders and may result in a decrease in our share price if we are unable to realize
adequate returns. We will not be able to continue to fund internal growth and/or acquire complementary businesses within the
natural and organic food industries without continued access to capital resources.
Impairment charges in goodwill or other intangible assets could adversely impact our financial condition and results of
operations
As a result of business acquisitions, a significant portion of our total assets is comprised of intangible assets and goodwill. We
are required to perform impairment tests of our goodwill and other intangible assets annually, or at any time when events occur
that could affect the value of these assets. We may engage in additional acquisitions, which could result in our recognition of
additional intangible assets and goodwill. If the financial performance of the acquired businesses is not as strong as we
anticipate, we could be required to record significant impairments to intangible assets and/or goodwill, which could materially
and adversely impact our business, financial condition and results of operations.
We operate in a highly competitive industry
We operate businesses in highly competitive product and geographic markets in the U.S., Canada, Europe and various other
international markets. We compete with various U.S. and international commercial grain procurement marketers, major
companies with food ingredient divisions, other food ingredient companies, trading companies, and consumer-packaged food
companies that also engage in the development and sale of food ingredients and other food companies involved in natural and
organic foods. These competitors may have financial resources and staff larger than ours and may be able to benefit from
economies of scale, pricing advantages and greater resources to launch new products that compete with our offerings. We have
little control over and cannot otherwise affect these competitive factors. If we are unable to effectively respond to these
competitive factors or if the competition in any of our product markets results in price reductions or decreased demand for our
products, our business, financial condition and results of operations may be materially and adversely affected.
Our customers generally are not obligated to continue purchasing products from us
Many of our customers buy from us under purchase orders, and we generally do not have long-term agreements with, or
commitments from, these customers for the purchase of products. We cannot provide assurance that our customers will
maintain or increase their sales volumes or orders for the products supplied by us or that we will be able to maintain or add to
our existing customer base. Decreases in our customers’ sales volumes or orders for products supplied by us may have a
material adverse effect on our business, financial condition and results of operations.
Loss of a key customer could materially reduce revenues and earnings
Our relationships with our key customers are critical to the success of our business and our results of operations. Our three
largest customers accounted for approximately 27% of consolidated revenues for the year ended December 28, 2019. The loss,
decrease or cancellation of business with any of our large customers could materially and adversely affect our business,
financial condition and results of operations.
Consumer food preferences are difficult to predict and may change
Our success depends, in part, on our ability and our customers’ ability to offer products that anticipate the tastes and dietary
habits of consumers and appeal to their preferences on a timely and affordable basis. A significant shift in consumer demand
away from our products or products that utilize our integrated foods platform, or a failure to maintain our current market
position, could reduce our sales and harm our business. Consumer trends change based on a number of factors, including
nutritional values, a change in consumer preferences or general economic conditions. Additionally, there is a growing focus
among some consumers to buy local food products in an attempt to reduce the carbon footprint associated with transporting
food products from longer distances, which could result in a decrease in the demand for food products and ingredients that we
import from other countries or transport from remote processing locations or growing regions. Further, failures by us or our
competitors to deliver quality products could erode consumer trust in the organic certification of foods. These changes could
lead to, among other things, reduced demand and price decreases, which could have a material and adverse effect on our
business, financial condition and results of operations.
If we do not manage our supply chain effectively, our operating results may be adversely affected
Our supply chain is complex. We rely on suppliers for our raw materials and for the manufacturing, processing, packaging and
distribution of many of our products. The inability of any of these suppliers to deliver or perform for us in a timely or cost-
SUNOPTA INC.
14
December 28, 2019 10-K
effective manner could cause our operating costs to rise and our margins to fall. Many of our products are perishable and
require timely processing and transportation to our customers. Additionally, many of our products can only be stored for a
limited amount of time before they spoil and cannot be sold. We must continuously monitor our inventory and product mix
against forecasted demand or risk having inadequate supplies to meet consumer demand as well as having too much inventory
that may reach its expiration date. If we are unable to manage our supply chain effectively and ensure that our products are
available to meet consumer demand, our operating costs could increase and our margins could fall, which could have a material
and adverse effect on our business, financial condition and results of operations.
Some of our operations are subject to seasonal supply fluctuations. For example, we purchase strawberries and other fruit from
farmers during the peak California growing season, which occurs during the first two quarters of the year. As a result, our costs
may be higher during these periods. We may not be successful in counteracting or smoothing out the effects of seasonality, and
we expect that certain parts of our operations will continue to remain subject to significant seasonality.
Part of our supply source also depends in part on a seasonal temporary workforce comprised primarily of migrant workers.
Changes in immigration laws or policies that discourage migration to the U.S. and political or other events (such as war,
terrorism or health emergencies) that make it more difficult for individuals to immigrate to or migrate throughout the U.S.
could adversely affect the migrant worker population and reduce the workforce available for farms and production facilities in
the U.S. Additionally, increased competition from other industries for migrant workers could increase our costs and adversely
affect our business, financial condition and results of operations.
Volatility in the prices of raw materials, freight and energy could increase our cost of sales and reduce our gross margins
Raw materials represent a significant portion of our cost of sales. Our cost to purchase services and materials, such as fruits
and other commodities, processing aids, freight, and natural gas, can fluctuate depending on many factors, including weather
patterns, economic and political conditions and pricing volatility. In addition, we must compete for limited supplies of these
raw materials and services with competitors having greater resources than we have. If our cost of materials and services
increases due to any of the above factors, we may not be able to pass along the increased costs to our customers.
We enter into a number of exchange-traded commodity futures contracts to partially hedge our exposure to price fluctuations
on transactions to the extent considered practicable for minimizing risk from market price fluctuations. Futures contracts used
for hedging purposes are purchased and sold through regulated commodity exchanges. Our inventories, however, may not be
completely hedged, due in part to our assessment of exposure from expected price fluctuations and an inability to hedge a
number of raw materials. We also monitor the prices of natural gas and from time to time lock in a percentage of our natural
gas needs based on current prices and expected trends.
An increase in our cost of sales resulting from an increase in the price of raw materials and energy could have a material and
adverse effect on our business, financial condition and results of operations.
Our future results of operations may be adversely affected by the availability of organic and non-GMO ingredients
Our ability to ensure a continuing supply of organic and non-GMO ingredients at competitive prices depends on many factors
beyond our control, such as the number and size of farms that grow organic and non-GMO crops, climate conditions, changes
in national and world economic conditions, currency fluctuations and forecasting adequate need of seasonal ingredients.
The organic and non-GMO ingredients that we use in the production of our products (including, among others, fruits,
vegetables, nuts and grains) are vulnerable to adverse weather conditions and natural disasters, such as floods, droughts, water
scarcity, temperature extremes, frosts, earthquakes and pestilences. Natural disasters and adverse weather conditions (including
the potential effects of climate change) can lower crop yields and reduce crop size and crop quality, which in turn could reduce
our supplies of organic or non-GMO ingredients or increase the prices of organic or non-GMO ingredients. If our supplies of
organic or non-GMO ingredients are reduced, we may not be able to find enough supplemental supply sources on favorable
terms, if at all, which could impact our ability to supply product to our customers and adversely affect our business, financial
condition and results of operations.
Adverse weather conditions and natural disasters could impose costs on our business
Our various food products, from seeds to ingredients, fruits, vegetables and other inputs, are vulnerable to adverse weather
conditions and natural disasters, including windstorms, hurricanes, earthquakes, floods, droughts, fires, and temperature and
precipitation extremes, some of which are common but difficult to predict, as well as crop disease and infestation. Severe
weather conditions may occur with higher frequency or may be less predictable in the future due to the effects of climate
SUNOPTA INC.
15
December 28, 2019 10-K
change. Unfavorable growing conditions could reduce both crop size and crop quality. In extreme cases, entire harvests may
be lost in some geographic areas. Adverse weather conditions or natural disasters may adversely affect our supply of one or
more food products or prevent or impair our ability to ship products as planned. These factors can increase acquisition and
production costs, decrease our sales volumes and revenues, and lead to additional charges to earnings, which may have a
material adverse effect on our business, financial condition and results of operations.
A significant portion of our strawberry supply is sourced from California, which has experienced severe drought conditions
from time to time, resulting in lost crops and water restrictions for growers in California. As strawberry growers are largely
dependent on well water, diminishing groundwater resources could also lead to a reduced strawberry supply. Drought
conditions are a recurring feature of California’s climate, and existing and future water conservation laws could negatively
impact the agricultural industry in California and have a material adverse effect on our business, financial condition and results
of operations.
In recent years, California has experienced numerous wildfires, including the largest wildfires in recorded state history. In
addition to the potential for direct damage to agriculture from wildfires, heavy smoke from large wildfires can adversely affect
crops, delay harvests and adversely affect local agriculture in other ways. Due to recurring drought conditions, California could
continue to experience significant wildfires, which could negatively impact the agricultural industry in California and have a
material adverse effect on our business, financial condition and results of operations.
An interruption at one or more of our manufacturing facilities could negatively affect our business, and our business
continuity plan may prove inadequate
We own or lease, manage and operate a number of manufacturing, processing, packaging, storage and office facilities. We
may be unable to accept and fulfill customer orders as a result of disasters, epidemics, business interruptions or other similar
events. Some of our inventory and manufacturing facilities are located in areas that are susceptible to harsh weather, and the
production of certain of our products is concentrated in a few geographic areas. In addition, we store chemicals used in the
equipment for quick freezing of fruit or used for cooling processes during ingredient processing, and our storage of these
chemicals could lead to risk of leaks, explosions or other events. Although we have a business continuity plan, we cannot
provide assurance that our business continuity plan will address all of the issues we may encounter in the event of a disaster or
other unanticipated issues. Our business interruption insurance may not adequately compensate us for losses that may occur
from any of the foregoing. In the event that a natural disaster, or other catastrophic event were to destroy any part of any of
our facilities or interrupt our operations for any extended period of time, or if harsh weather or epidemics prevent us from
delivering products in a timely manner, our business, financial condition and results of operations could be materially and
adversely affected. In addition, if we fail to maintain our labor force at one or more of our facilities, we could experience delays
in production or delivery of our products, which could also have a material adverse effect on our business, financial condition
and results of operations.
Technology failures could disrupt our operations and negatively impact our business
In the normal course of business, we rely on information technology systems to process, transmit, and store electronic
information. For example, our production and distribution facilities and inventory management utilize information technology
to increase efficiencies and limit costs. Information technology systems are also integral to the reporting of our results of
operations. Furthermore, a significant portion of the communications between, and storage of personal data of, our personnel,
customers, consumers and suppliers depends on information technology. Our information technology systems may be
vulnerable to a variety of interruptions as a result of updating our enterprise platform or due to events beyond our control,
including, but not limited to, natural disasters, terrorist attacks, telecommunications failures, computer viruses, hackers, and
other security issues. These events could compromise our confidential information, impede or interrupt our business
operations, and may result in other negative consequences, including remediation costs, loss of revenue, litigation and
reputational damage.
Our reputation and our relationships with customers, consumers and suppliers would be harmed if our systems are accessed
by unauthorized persons
We maintain certain personal data, including personal data regarding our personnel, customers, consumers and suppliers. This
data is maintained on our own systems as well as that of third parties we use in our operations. If a breach or other breakdown
results in disclosure of confidential or personal information, we may suffer reputational, competitive and/or business harm.
While we have implemented administrative and technical controls and taken other preventive actions to reduce the risk of cyber
incidents and protect our information technology, they may be insufficient to prevent physical and electronic break-ins, cyber-
attacks or other security breaches to our computer systems. The costs relating to any data breach could be material, and we
SUNOPTA INC.
16
December 28, 2019 10-K
currently do not carry insurance against the risk of a data breach. Any data breach or other access of our systems by unauthorized
persons could have a material adverse effect on our business, financial condition and results of operations.
Changes in laws and regulations of privacy and protection of user data could adversely affect our business
We are subject to data privacy and protection laws and regulations that apply to the collection, transmission, storage and use
of proprietary information and personally-identifying information, including the California Consumer Privacy Act of 2018.
The regulatory environment surrounding information security and data privacy varies from jurisdiction to jurisdiction and is
constantly evolving and increasingly demanding. The restrictions imposed by such laws continue to develop and may require
us to incur substantial costs, adopt additional compliance measures, such as notification requirements and corrective actions in
the event of a security breach, and/or change our current or planned business models. We are already subject to strict data
privacy laws in the European Union and other jurisdictions governing the collection, transmission, storage and use of employee
data and personally-identifying information. The General Data Protection Regulation (“GDPR”), which became effective in
Europe in May 2018, creates a range of new compliance obligations and increases financial penalties for non-compliance and
extends the scope of the European Union data protection law to all companies processing data of European Union residents,
regardless of the company’s location. The GDPR and other privacy and data protection laws may be interpreted and applied
differently from country to country and may create inconsistent or conflicting requirements. Such regulations increase our
compliance and administrative burden significantly. While we have developed and are executing comprehensive plans to meet
these requirements and do not currently foresee significant obstacles that would prevent timely compliance, these plans are
subject to many variables that could delay or otherwise affect implementation.
If our current security measures and data protection policies and controls are found to be non-compliant with relevant laws or
regulations in any jurisdiction where we conduct business, we may be subject to penalties and fines, and may need to expend
significant resources to implement additional data protection measures. In addition, we may be required to modify the features
and functionality of our system offerings in a way that is less attractive to customers.
If we lose the services of our key management, our business could suffer
Our prospects depend to a significant extent on the continued service of our key executives, and our continued growth depends
on our ability to identify, recruit and retain key management personnel. We are also dependent on our ability to continue to
attract, retain and motivate our personnel. We do not typically carry key person life insurance on our executive officers. If we
lose the services of our key management or fail to identify, recruit and retain key personnel, our business, financial condition
and results of operations may be materially and adversely impacted.
If we face labor shortages or increased labor costs, our results of operations and our growth could be adversely affected
Labor is a significant component of the cost of operating our business. Our ability to meet our labor needs while controlling
labor costs is subject to external factors, such as employment levels, prevailing wage rates, minimum wage legislation, changing
demographics, health and other insurance costs and governmental labor and employment requirements. In the event of
increasing wage rates, if we fail to increase our wages competitively, the quality of our workforce could decline, while
increasing our wages could cause our earnings to decrease. If we face labor shortages or increased labor costs because of
increased competition for employees from our competitors and other industries, higher employee-turnover rates, unionization
of farm workers or increases in the federal- or state-mandated minimum wage, change in exempt and non-exempt status, or
other employee benefits costs (including costs associated with health insurance coverage or workers’ compensation insurance),
our operating expenses could increase and our business, financial condition and results of operations could be materially and
adversely affected.
Technological innovation by our competitors could make our food products less competitive
Our competitors include major food ingredient and consumer-packaged food companies that also engage in the development
and sale of food and food ingredients. Many of these companies are engaged in the development of food ingredients and other
packaged food products and frequently introduce new products into the market. Existing products or products under
development by our competitors could prove to be more effective or less costly than our products, which could have a material
adverse effect on the competitiveness of our products and our business.
We rely on protection of our intellectual property and proprietary rights
Our success depends in part on our ability to protect our intellectual property rights. We rely primarily on patent, copyright,
trademark and trade secret laws to protect our proprietary technologies. Our policy is to protect our technology by, among
SUNOPTA INC.
17
December 28, 2019 10-K
other things, filing patent applications for technology relating to the development of our business in the U.S. and in selected
foreign jurisdictions.
Our trademarks and brand names are registered in the U.S., Canada and other jurisdictions. We intend to keep these filings
current and seek protection for new trademarks to the extent consistent with business needs. We also rely on trade secrets and
proprietary know-how and confidentiality agreements to protect certain of the technologies and processes that we use.
The failure of any patents, trademarks, trade secrets or other intellectual property rights to provide protection to our technologies
would make it easier for our competitors to offer similar products, which could result in lower sales or gross margins.
Changes in laws or regulations governing foreign trade or taxation could adversely affect our business
Changes in governmental laws or regulations affecting foreign trade or taxation, or the introduction of new laws or regulations,
may have a direct or indirect effect on our business or those of our customers or suppliers. Such changes could increase the
costs of doing business for the Company, our customers, or suppliers, or restrict our actions, causing our results of operations
to be adversely affected.
The current U.S. administration has expressed strong concerns about imports from countries that it perceives as engaging in
unfair trade practices, and it is possible the administration could impose import duties or other restrictions on products,
components or raw materials sourced from those countries, which may include countries from which we import components
or raw materials. Any such import duties or restrictions could have a material adverse effect on our business, results of
operations or financial condition. Moreover, tariffs, or other changes in U.S. trade policy, could trigger retaliatory actions by
affected countries. A “trade war” or other governmental action related to tariffs, sanctions or international trade agreements or
policies has the potential to adversely impact demand for our products, our costs, customers, suppliers and/or the economic
environments in which we operate and, thus, to adversely impact our businesses.
Tax laws are dynamic and subject to change as new laws are passed and new interpretations of the law are issued or applied.
In December 2017, the U.S. enacted significant tax reform, and certain provisions of the law may adversely affect our business.
In addition, governmental tax authorities are increasingly scrutinizing the tax positions of companies. Many countries in the
European Union, as well as a number of other countries and organizations such as the Organization for Economic Cooperation
and Development, are actively considering changes to existing tax laws that, if enacted, could increase our tax obligations in
countries where we do business. If U.S. or other foreign tax authorities change applicable tax laws, our overall taxes could
increase, and our business, financial condition and results of operations may be adversely impacted.
Our operations are influenced by agricultural policies
We are affected by governmental agricultural policies such as price supports and acreage set aside programs and these types of
policies may affect our business. The production levels, markets and prices of the grains and other raw products that we use
in our business are materially affected by government programs, which include acreage control and price support programs of
the USDA. Revisions in these and other comparable programs, in the U.S. and elsewhere, could have a material and adverse
effect on our business, financial condition and results of our operations.
We are subject to substantial environmental regulation and policies
We are, and expect to continue to be, subject to substantial federal, state, provincial and local environmental regulations. Some
of the key environmental regulations to which we are subject include air quality regulations of the EPA and certain city, state
and provincial air pollution control groups, waste treatment/disposal regulations, sewer regulations under agreements with local
city sewer districts, regulations governing hazardous substances, storm water regulations and bioterrorism regulations. For a
more detailed summary of the environmental regulations and policies to which we are subject, see “Item 1. Business—
Regulation” of this report. Our business also requires that we have certain permits from various state, provincial and local
authorities related to air quality, storm water discharge, solid waste, land spreading and hazardous waste.
In the event that our safety procedures for handling and disposing of potentially hazardous materials in certain of our businesses
were to fail, we could be held liable for any damages that result, and any such liability could exceed our resources. We may
be required to incur significant costs to comply with environmental laws and regulations in the future. In addition, changes to
environmental regulations may require us to modify our existing plant and processing facilities and could significantly increase
the cost of those operations.
The foregoing environmental regulations, as well as others common to the industries in which we participate, can present delays
SUNOPTA INC.
18
December 28, 2019 10-K
and costs that can adversely affect business development and growth. If we fail to comply with applicable laws and regulations,
we may be subject to civil remedies, including fines, injunctions, recalls or seizures, as well as potential criminal sanctions,
which could have a material adverse effect on our business, financial condition and results of operations. In addition, any
changes to current regulations may impact the development, manufacturing and marketing of our products, and may have a
negative impact on our future results.
Climate change laws could have an impact on our financial condition and results of operations
Legislative and regulatory authorities in the U.S., Canada and internationally will likely continue to consider numerous
measures related to climate change and greenhouse gas emissions. In order to produce, manufacture and distribute our products,
we and our suppliers use fuels, electricity and various other inputs that result in the release of greenhouse gas emissions.
Concerns about the environmental impacts of greenhouse gas emissions and global climate change may result in environmental
taxes, charges, regulatory schemes, assessments or penalties, which could restrict or negatively impact our operations, as well
as those of our suppliers, who would likely pass all or a portion of their costs along to us. We may not be able to pass any
resulting cost increases along to our customers. Any laws or regulations regarding greenhouse gas emissions or other climate
change laws enacted by the U.S., Canada or any other international jurisdiction where we conduct business could materially
and adversely affect our business, financial condition and results of operations.
Fluctuations in exchange rates, interest rates and commodity prices could adversely affect our business, financial condition,
results of operations or liquidity
We are exposed to foreign exchange rate fluctuations as our non-U.S.-based operations are translated into U.S. dollars for
financial reporting purposes and we also sell product in currencies that are different from the currency used to purchase
materials, or process finished goods. We are exposed to changes in interest rates as a significant portion of our debt bears
interest at variable rates. We are exposed to price fluctuations on a number of commodities as we hold inventory and enter into
transactions to buy and sell products in a number of markets. Additional qualitative and quantitative disclosures about these
risks can be found in “Item 7A. Quantitative and Qualitative Disclosures About Market Risk” of this report. As a result of
these exposures, fluctuations in exchange rates, interest rates and certain commodities could adversely affect our business,
financial condition, results of operations or liquidity.
Our international operations expose us to additional risks
We source our products from numerous suppliers and growers from around the world. Outside of the U.S. and Canada, we
have processing, packaging and warehousing facilities in Mexico, Europe, Africa and Asia. Our international operations and
customers expose us to certain risks inherent in doing business abroad, including:
(cid:120)
exposure to local economic conditions, expropriation and nationalization, foreign exchange rate fluctuations and
currency controls;
(cid:120) withholding and other taxes on remittances and other payments by subsidiaries;
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
investment restrictions or requirements;
export and import restrictions;
compliance with anti-corruption and anti-bribery laws, including the U.S. Foreign Corrupt Practices Act;
compliance with export controls and economic sanctions laws;
increases in working capital requirements related to long supply chains; and
disruptions in our supply chain from unforeseen events, such as natural disasters, terrorism and political and civil
unrest.
For example, we have operations in Mexico, including a facility in the State of Michoacán, near areas where there have been
incidents of unrest, which may heighten the risks of our international operations described above.
As we continue to expand our business globally, we may have difficulty anticipating and effectively managing these and other
SUNOPTA INC.
19
December 28, 2019 10-K
risks that our international operations may face, which may adversely impact our business, financial condition and results of
operations. In addition, any acquisition of businesses with operations outside of the U.S. and Canada may exacerbate this risk.
A significant portion of our assets and certain of our executive officers and directors are located outside of the U.S.; it may
be difficult to effect service of process and enforce legal judgments upon us and certain of our executive officers and
directors
A significant portion of our assets and certain of our executive officers and directors are located outside of the U.S. As a result,
it may be difficult to effect service of process within the U.S. and enforce judgment of a U.S. court obtained against us or our
executive officers and directors. Particularly, our stakeholders may not be able to:
(cid:120)
(cid:120)
(cid:120)
(cid:120)
effect service of process within the U.S. on us or certain of our executive officers and directors;
enforce judgments obtained in U.S. courts against us or certain of our executive officers and directors based upon
the civil liability provisions of the U.S. federal securities laws;
enforce, in a court outside of the U.S., judgments of U.S. courts based on the civil liability provisions of the U.S.
federal securities laws; or
bring an original action in a court outside of the U.S. to enforce liabilities against us or any of our executive officers
and directors based upon the U.S. federal securities laws.
Risks Related to Our Indebtedness
Our level of indebtedness could adversely affect our financial condition and prevent us from fulfilling our debt obligations
Our level of indebtedness could adversely affect our business, financial condition and results of operations, including, without
limitation, impairing our ability to obtain additional financing for working capital, capital expenditures, debt service
requirements or other general corporate purposes. In addition, we will have to use a substantial portion of our cash flow to pay
principal, premium (if any) and interest on our indebtedness, which will reduce the funds available to us for other purposes. If
we do not generate sufficient cash flows to satisfy our debt service obligations, we may have to undertake alternative financing
plans, such as refinancing or restructuring our debt, selling assets, reducing or delaying capital investments or seeking to raise
additional capital. Our level of indebtedness will also make us more vulnerable to economic downturns and adverse industry
conditions and may compromise our ability to capitalize on business opportunities, and to react to competitive pressures as
compared to our competitors.
Our debt and equity agreements restrict how we may operate our business, and our business may be materially and adversely
affected if these restrictions prevent us from implementing our business plan
The agreements governing our debt and preferred equity instruments contain restrictive covenants that limit the discretion of
our management with respect to certain business matters. These covenants place restrictions on, among other things, our ability
to obtain additional debt financing, to create other liens, to complete a merger, amalgamation or consolidation, to make certain
distributions or make certain payments, investments and guarantees and to sell or otherwise dispose of certain assets. These
restrictions may hinder our ability to execute on our growth strategy or prevent us from implementing parts of our business
plan.
Our business may be materially and adversely affected if we are unable to renew the Global Credit Facility and/or refinance
our senior secured second lien notes
On January 28, 2020, we entered into a restatement agreement to, among other things, extend the maturity date of the Global
Credit Facility from February 10, 2021 to March 31, 2022. However, at the extended maturity date, we may not be able to
renew this facility to the same level or size, or on terms as favorable as at present. A reduced facility may impact our ability
to finance our business, requiring us to scale back our operations and our use of working capital. Alternatively, obtaining credit
on less favorable terms would have a direct impact on our profitability and operating flexibility. Our senior secured second
lien notes mature on October 9, 2022. Our ability to refinance these notes upon maturity will depend on the capital markets
and our financial condition at such time. As a result, we may not be able to obtain refinancing on commercially reasonable
terms, which could have a material and adverse impact on our business, financial condition and results of operations.
Alternatively, we may have to undertake alternative financing plans, such as restructuring our debt, selling assets, reducing or
delaying capital investments, or seeking to raise additional capital.
SUNOPTA INC.
20
December 28, 2019 10-K
Our business could be materially and adversely affected if we are unable to meet the financial covenants of the Global
Credit Facility
Our ability to comply with the financial covenants under the Global Credit Facility agreement will depend on the success of
our businesses, our operating results, and our ability to achieve our financial forecasts. Various risks, uncertainties and events
beyond our control could affect our ability to comply with the financial covenants and terms of the Global Credit Facility
agreement. Failure to comply with our financial covenants and other terms could result in an event of default and the
acceleration of amounts owing under this agreement, unless we are able to negotiate a waiver. The lenders could condition any
such waiver on an amendment to the agreement on terms (including, but not limited to, the payment of consent fees) that may
be unfavorable to us. If we are unable to negotiate a covenant waiver or replace or refinance the Global Credit Facility
agreement on favorable terms, our business, financial condition and results of operations will be materially and adversely
impacted.
Risks Related to Business Acquisitions and Divestures
We may not be able to effectively manage our growth and integrate acquired companies
From time to time we may pursue acquisition opportunities that are consistent with our overall growth strategy. Our ability to
effectively integrate past or future business acquisitions, including our ability to realize potentially available marketing
opportunities and cost savings in a timely and efficient manner will have a direct impact on our future results. We may encounter
problems in connection with the integration of any new businesses, such as challenges relating to the following:
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
integration of an acquired company’s products into our product mix;
the amount of cost savings that may be realized as a result of integrating an acquired product or business;
unanticipated quality and production issues with acquired products;
adverse effects on business relationships with suppliers and customers;
diversion of management’s attention;
integrating acquired operations that have management teams and company cultures that differ from our own;
difficulty with personnel and loss of key employees;
implementation of an integrated enterprise-wide accounting and information system and consolidation of back office
accounting;
compatibility of financial control and information systems;
exchange rate risk with respect to acquisitions outside the U.S.;
potential for patent and trademark claims or other litigation against or involving the acquired company;
integration of businesses that operate in new geographic areas, including difficulties in identifying and gaining access
to customers in new markets; and
in the case of foreign acquisitions, uncertainty regarding foreign laws and regulations and difficulty integrating
operations and systems as a result of cultural, systems and operational differences.
If we experience any of these problems in the integration of acquisitions, they could have a material and adverse effect on our
business, financial condition and results of operations.
We may not accurately estimate the benefits or synergies to be realized from business acquisitions
Our expected benefits and synergies from acquired businesses may not be realized if our cash flow estimates associated with
SUNOPTA INC.
21
December 28, 2019 10-K
the assets of those businesses are materially inaccurate or if we fail to identify operating problems or liabilities prior to
acquisition. We perform inspections of the assets to be acquired, which we believe to be generally consistent with industry
practices. However, the accuracy of our assessments of the assets and our estimates are inherently uncertain. There could also
be environmental or other problems that were not discovered in the course of our due diligence and inspections. If problems or
risks are identified after the closing of an acquisition, there may be limited recourse against the former owners.
Business acquisitions may expose us to unknown liabilities
When we acquire a business, we often assume or otherwise become subject to liabilities of acquired businesses, including
contingent liabilities that may depend on the outcome of legal and administrative proceedings or other events. As a result, we
may become subject to liabilities that are unknown to us or that cannot be quantified at the time of the acquisition. If we
become subject to significant liabilities or other obligations as a result of an acquisition, our business could be materially
affected. Moreover, to the extent we have contractual rights to indemnification against losses and liabilities of businesses we
acquire, the amount of indemnification available could be limited and may not be sufficient to cover the actual losses we suffer.
Business acquisitions could result in unexpected disruptions of our business
In response to an acquisition, customers may cease or reduce their business with the combined company, which could
negatively affect our business. Similarly, current or prospective employees may experience uncertainty about their future roles
with the combined company. This may adversely affect our ability to attract and retain key management, marketing and
technical personnel. In addition, the diversion of the attention of our respective management teams away from day-to-day
operations during the pendency of the business acquisition could have an adverse effect on our financial condition and operating
results.
The possible future divestiture of businesses could impact our profitability
We may, from time to time, divest businesses if we determine divestiture is consistent with our long-term strategic goals or our
growth or profitability targets. Our profitability may be impacted by gains or losses on the sales of such businesses, or lost
operating income or cash flows from such businesses. Additionally, we may be required to record asset impairment or
restructuring charges related to divested businesses, or indemnify buyers for liabilities, which may reduce our profitability and
cash flows. We may also not be able to negotiate such divestitures on terms acceptable to us. Such potential divestitures will
require management resources and may divert management’s attention from our day-to-day operations. If we are not successful
in divesting such businesses, our business could be harmed.
Risks Related to Ownership of our Common Shares
Our operating results and share price are subject to significant volatility
Our net sales and operating results may vary significantly from period to period due to:
(cid:120)
(cid:120)
changes in our customers and/or their demand;
changes in our operating expenses;
(cid:120) management’s ability to execute our business strategies focused on improved operating earnings;
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
organizational and personnel changes;
interruption in operations at our facilities;
product recalls or market withdrawals;
legal and administrative cases (whether civil, such as environmental or product related, or criminal), settlements,
judgments and investigations;
foreign currency fluctuations;
supply shortages or commodity price fluctuations; and
SUNOPTA INC.
22
December 28, 2019 10-K
(cid:120)
general economic conditions.
In addition, our share price may be highly volatile compared to larger public companies. Certain announcements could have a
significant effect on our share price, including announcements regarding:
(cid:120)
fluctuations in financial performance from period to period;
(cid:120) mergers, acquisitions and/or divestitures, either by us or key competitors;
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
changes in key personnel;
strategic partnerships or arrangements;
litigation and governmental inquiries;
changes in governmental regulations and policy;
patents or proprietary rights;
changes in consumer preferences and demand;
new financings; and
general market conditions.
Higher volatility increases the chance of larger than normal price swings which reduces predictability in the price of our
common shares and could impair investment decisions. In addition, price and volume trading volatility in the stock markets
can have a substantial effect on our share price, frequently for reasons other than our operating performance. These broad
market fluctuations could adversely affect the market price of our common shares.
Periods of volatility in the overall market and the market price of a company’s securities, is often followed by securities class
action litigation alleging material misstatements or omissions in disclosures provided to shareholders. Such litigation, if
instituted against us, could result in substantial costs and a diversion of our management’s attention and resources.
Our debt instruments restrict, and our future debt instruments may restrict, our ability to pay dividends to our shareholders,
and we do not currently intend to pay any cash dividends on our common shares in the foreseeable future; therefore, our
shareholders may not be able to receive a return on their common shares until their shares are sold
We have never paid or declared any cash dividends on our common shares. We do not anticipate paying any cash dividends
on our common shares in the foreseeable future because, among other reasons, we currently intend to retain any future earnings
to finance the growth of our business. In addition, the covenants included in our debt instruments, and the covenants to be
included in our future debt instruments may restrict our ability to receive cash from our subsidiaries and pay dividends on our
common shares. The future payment of dividends will be dependent on factors such as these covenant restrictions, cash on
hand, or achieving and maintaining profitability, the financial requirements to fund growth, our general financial condition and
other factors the Board may consider appropriate in the circumstances. Until we pay dividends, which we may never do, our
shareholders will not receive a return on their common shares until their shares are sold.
The future issuance of additional common shares in connection with the exchange of convertible preferred stock, exercise
of stock options, participation in our employee stock purchase plan and issuance of additional securities could dilute the
value of our common shares
We have unlimited common shares authorized but unissued. Our articles of amalgamation authorize us to issue these common
shares, and we may also issue options, rights, warrants and appreciation rights relating to common shares for consideration and
on terms and conditions established by the Board in its sole discretion.
The exchange of outstanding convertible preferred stock, exercise of stock-based awards, participation in our employee stock
purchase plan, and issuance of additional securities in connection with acquisitions or otherwise could result in dilution in the
SUNOPTA INC.
23
December 28, 2019 10-K
value of our common shares and the voting power represented thereby. Furthermore, to the extent common shares are issued
pursuant to the exchange of outstanding convertible preferred stock, exercise of stock-based awards, participation in our
employee stock purchase plan and issuance of additional securities, our share price may decrease due to the additional amount
of common shares available in the market. The subsequent sales of these shares could encourage short sales by our shareholders
and others, which could place further downward pressure on our share price. Moreover, the holders of our stock options may
hedge their positions in our common shares by short selling our common shares, which could further adversely affect our stock
price.
If securities or industry research analysts do not publish or cease publishing research or reports about our business or if
they issue unfavorable commentary or downgrade our common shares, our share price and trading volume could decline
The trading market for our common shares relies in part on the research and reports that securities and industry research analysts
publish about us, our industry, our competitors and our business. We do not have any control over these analysts. Our share
price and trading volumes could decline if one or more securities or industry analysts downgrade our common shares, issue
unfavorable commentary about us, our industry or our business, cease to cover our Company or fail to regularly publish reports
about us, our industry or our business.
Item 1B. Unresolved Staff Comments
None.
SUNOPTA INC.
24
December 28, 2019 10-K
Item 2. Properties
The following table lists the location, description, ownership and segment of our principal properties:
Location
Facility Description
Sales and administrative office
Cocoa processing
Warehouse
Sales and administrative office
Grain processing
Sales and administrative office
Warehouse and office
Grain and coffee processing and sales office
Cocoa storage
Aseptic beverage processing
Warehouse
Aseptic beverage processing
Ingredient processing
Warehouse
Aseptic beverage processing
Warehouse
Grain processing and warehouse
Grain processing, roasting operations and warehouse
Warehouse
Grain processing and warehouse
Sales and administrative office
Frozen fruit processing and warehouse
Frozen fruit processing and warehouse
Frozen fruit processing and warehouse
Frozen fruit processing and warehouse
Frozen fruit processing and warehouse
Fruit ingredient processing and warehouse
Fruit snack processing and warehouse
Fruit snack processing and warehouse
Global Ingredients
Amsterdam, The Netherlands
Middenmeer, The Netherlands
Middenmeer, The Netherlands
Scotts Valley, California
Silistra, Bulgaria
Varna, Bulgaria
Dalian, China
Addis Ababa, Ethiopia
Kenema, Sierra Leone
Plant-Based Foods and Beverages
Modesto, California
Modesto, California
Alexandria, Minnesota
Alexandria, Minnesota
Alexandria, Minnesota
Allentown, Pennsylvania
Allentown, Pennsylvania
Breckenridge, Minnesota
Crookston, Minnesota
Crookston, Minnesota
Grace City, North Dakota
Fruit-Based Foods and Beverages
Placentia, California
Edwardsville, Kansas
Oxnard, California
Oxnard, California
Santa Maria, California
Jacona, Mexico
South Gate, California
Omak, Washington
St. David’s, Ontario
Corporate Services
Mississauga, Ontario
Edina, Minnesota
Executive Offices
Owned/
Leased
Lease Expiry
Date
Leased
Leased
Leased
Leased
Owned
Leased
Leased
Leased
Leased
October 2022
December 2022
December 2022
February 2021
July 2020
November 2024
October 2021
July 2022
Leased May 2024
Leased May 2024
Owned
Owned
Owned
Leased
Leased
Owned
Owned
Leased
Owned
April 2027
November 2025
September 2022
January 2022
Leased
Owned
Owned
Leased
Leased
Owned
June 2020
Leased
Leased May 2027
Leased
October 2020
April 2036
December 2020
Corporate head office
Corporate administrative office
Leased
Leased
June 2021
November 2022
Our executive head office is currently located at 2233 Argentia Drive, Suite 401, Mississauga, Ontario.
Item 3. Legal Proceedings
For a discussion of legal proceedings, see note 23 of the consolidated financial statements at Item 15 of this Form 10-K.
Item 4. Mine Safety Disclosures
Not Applicable.
SUNOPTA INC.
25
December 28, 2019 10-K
PART II
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases Equity
Securities
Our common shares trade in U.S. dollars on The NASDAQ Global Select Market under the symbol “STKL”, and in Canadian
dollars on the TSX under the symbol “SOY”.
As at December 28, 2019, we had approximately 383 shareholders of record. We have never paid cash dividends on our
common stock and do not anticipate paying dividends in the foreseeable future. Our future dividend policy will depend on our
earnings, capital requirements and financial condition, requirements of the financial agreements to which we are then a party
and other factors considered relevant by our Board of Directors. Additionally, the terms of our existing debt instruments
include covenants that restrict our ability to pay dividends to shareholders. The receipt of cash dividends by U.S. shareholders
from a Canadian corporation, such as we are, may be subject to Canadian withholding tax.
Equity Compensation Plan Information
The following table provides information as at December 28, 2019, with respect to our common shares that may be issued
under the Company’s stock incentive and employee share purchase plans:
Number of
Securities to be
Issued Upon
Exercise of
Outstanding
Options, Warrants,
and Rights
(a)
Weighted-Average
Exercise Price of
Outstanding
Options, Warrants
and Rights
(b)
Number of Securities
Remaining Available
for Future Issuance
Under Equity
Compensation Plans
(Excluding Securities
Reflected in Column
(a))
(c)
5,299,016
-
4,195,033
9,494,049
$7.57 (3)
-
$3.15 (3)
$5.87 (3)
3,876,211
814,500
-
4,690,711
Plan Category
Equity compensation plans approved by
securities holders:
2013 Stock Incentive Plan(1)
Employee Stock Purchase Plan
Equity compensation plans not approved by
securities holders:
CEO Plan(2)
Total
(1) Represents common shares of the Company issuable in respect of 1,949,888 stock options, 413,013 restricted stock units (“RSUs”) and 2,936,115
performance share units (“PSUs”) granted to selected employees and directors of the Company.
(2) Represents common shares of the Company issuable in respect of 1,222,243 stock options, 840,438 RSUs and 2,132,352 PSUs granted to the Chief
Executive Officer and Chief Financial Officer of the Company.
(3) Vested RSUs and PSUs entitle the holder to receive one common share per unit without payment of additional consideration. Accordingly, these
units are disregarded for purposes of computing the weighted-average exercise price.
SUNOPTA INC.
26
December 28, 2019 10-K
Shareholder Return Performance Graph
This performance graph shall not be deemed “filed” for purposes of Section 18 of the Exchange Act or incorporated by
reference into any filing of SunOpta under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be
expressly set forth by specific reference in such filing.
The following graph compares the five-year cumulative shareholder return on our common shares to the cumulative total return
of the S&P/TSX Composite and the NASDAQ Industrial Indices for the period which commenced January 3, 2015.
200.00
180.00
160.00
140.00
120.00
100.00
80.00
60.00
40.00
20.00
-
SunOpta Inc.
NASDAQ Industrial
S&P/TSX Composite
2014
2015
2016
2017
2018
2019
SunOpta Inc.
Nasdaq Industrial Index
S&P/TSX Composite Index
2014
100.00
100.00
100.00
2015
2016
2017
2018
57.72
108.24
88.91
59.49
117.31
104.48
65.40
145.52
110.78
32.41
141.40
97.20
2019
21.01
180.67
117.33
Assumes that $100.00 was invested in our common shares and in each index on January 3, 2015.
SUNOPTA INC.
27
December 28, 2019 10-K
Item 6. Selected Financial Data
The following information has been derived from financial statements prepared in accordance with accounting principles
generally accepted in the United States of America (“U.S. GAAP”). The information set forth below is not necessarily indicative
of results of future operations, and should be read in conjunction with the consolidated financial statements and related notes
thereto prepared in accordance with U.S. GAAP contained at Item 15 of this Form 10-K as well as the discussion in Item 7,
“Management’s Discussion and Analysis of Financial Condition and Results of Operations”.
Revenues
Loss from continuing operations
attributable to SunOpta Inc.
Loss from continuing operations
2019
$
2018
$
2017
$
2016
$
2015(1)
$
1,190,022
1,260,852
1,279,593
1,346,731
1,145,134
(758)(3)
(109,205)(4)
(135,320)(5)
(50,618)(6)
(2,996)
attributable to common shareholders(2)
(8,780)(3)
(117,114)(4)
(143,129)(5)
(52,430)(6)
(2,996)
Basic and diluted loss per share from
continuing operations
Total assets
Bank indebtedness
Long-term debt
Operating lease liabilities(7)
Long-term liabilities
(0.10)
923,359
245,536
245,191
69,235
6,297
(1.34)
896,738
280,334
228,863
-
6,365
(1.66)
982,173
234,090
228,033
-
13,652
(0.61)
(0.04)
1,129,558
201,494
231,087
-
20,854
1,219,203
159,773
322,995
-
23,052
(1)
Includes the results of operations of Sunrise Holdings (Delaware), Inc. (“Sunrise”) (acquired October 9, 2015), Niagara Natural Fruit Snack
Company Inc. (assets acquired August 11, 2015) and Citrusource, LLC (acquired March 2, 2015) from the respective dates of acquisition.
(2) Loss from continuing operations attributable to common shareholders includes dividends and accretion on Series A Preferred Stock of $8.0 million,
(3)
(4)
(5)
(6)
$7.9 million, $7.8 million, $1.8 million and $nil in 2019, 2018, 2017, 2016 and 2015, respectively.
Includes a gain on sale of the soy and corn business of $44.0 million.
Includes an impairment charge of $81.2 million related to the remaining goodwill that arose from the acquisition of Sunrise.
Includes an impairment charge of $115.0 million related to the goodwill that arose from the acquisition of Sunrise, as well as a charge of $18.2
million for the impairment of long-lived assets associated with the exit from flexible resealable pouch and nutrition bar product lines and operations,
and consolidation of roasted snack operations, as well as the closure of a juice processing facility located in San Bernardino, California.
Includes a goodwill impairment charge of $17.5 million related to sunflower operations, as well as a charge of $13.3 million for the impairment of
long-lived assets associated with the closure of the San Bernardino juice processing facility and a soy extraction facility located in Heuvelton, New
York.
(7) Effective the beginning of fiscal 2019, we adopted ASC Topic 842, “Leases”, which resulted in the recognition of right-of-use assets and lease
liabilities for leases classified as operating leases. We elected to adopt the standard on a modified retrospective basis without restatement of prior
periods.
SUNOPTA INC.
28
December 28, 2019 10-K
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Forward-Looking Financial Information
This Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) section provides
analysis of our operations and financial position for the fiscal year ended December 28, 2019 and includes information available
to February 27, 2020, unless otherwise indicated herein. It is supplementary information and should be read in conjunction
with the consolidated financial statements included elsewhere in this report.
Certain statements contained in this MD&A may constitute forward-looking statements as defined under securities laws.
Forward-looking statements may relate to our future outlook and anticipated events or results and may include statements
regarding our future financial position, business strategy, budgets, litigation, projected costs, capital expenditures, financial
results, taxes, plans and objectives. In some cases, forward-looking statements can be identified by terms such as “anticipate,”
“estimate,” “target,” “intend,” “project,” “potential,” “predict,” “continue,” “believe,” “expect,” “can,” “could,” “would,”
“should,” “may,” “might,” “plan,” “will,” “budget,” “forecast,” or other similar expressions concerning matters that are not
historical facts, or the negative of such terms are intended to identify forward-looking statements; however, the absence of
these words does not necessarily mean that a statement is not forward-looking. To the extent any forward-looking statements
contain future-oriented financial information or financial outlooks, such information is being provided to enable a reader to
assess our financial condition, material changes in our financial condition, our results of operations, and our liquidity and capital
resources. Readers are cautioned that this information may not be appropriate for any other purpose, including investment
decisions.
Forward-looking statements contained in this MD&A are based on certain factors and assumptions regarding expected growth,
results of operations, performance, and business prospects and opportunities. While we consider these assumptions to be
reasonable, based on information currently available, they may prove to be incorrect. Forward-looking statements are also
subject to certain factors, including risks and uncertainties that could cause actual results to differ materially from what we
currently expect. These factors are more fully described in the “Risk Factors” section at Item 1A of this Form 10-K.
Forward-looking statements contained in this commentary are based on our current estimates, expectations and projections,
which we believe are reasonable as of the date of this report. You should not place undue importance on forward-looking
statements and should not rely upon this information as of any other date. Other than as required under securities laws, we do
not undertake to update any forward-looking information at any particular time. Neither we nor any other person assumes
responsibility for the accuracy and completeness of these forward-looking statements, and we hereby qualify all our forward-
looking statements by these cautionary statements.
Unless otherwise noted herein, all currency amounts in this MD&A are expressed in U.S. dollars. All tabular dollar amounts
are expressed in thousands of U.S. dollars, except per share amounts.
Overview
We are a leading global company focused on the manufacture of plant-based and fruit-based foods and beverage products for
sale to retail, foodservice and branded food customers. In addition, our global ingredient sourcing and production platform
makes us one of the leading suppliers of organic and non-GMO ingredients to the food industry.
Effective the fourth quarter of 2019, we changed our segment reporting to reflect changes to our operating structure. As a
result, we established two new segments – a Plant-Based Foods and Beverages segment and a Fruit-Based Foods and Beverages
segment – based on the synergistic nature of the underlying principal product ingredients. In addition, we realigned the Global
Ingredients segment to combine our international organic ingredients operations and our co-manufactured premium juice
program, based on shared raw material sourcing. With these changes, the following is a summary of the principal activities
and products that comprise each of our three operating segments:
(cid:120) Global Ingredients – We sell organic and non-GMO ingredients sourced from over 60 origins around the world. Our
portfolio includes fruits, vegetables, oils, fats, coffee, nuts, dried fruits, sugars, liquid sweeteners, seeds, grains, rice
and pulses. In addition, utilizing our own production facilities, we process value-added ingredients including cocoa
liquor, butter and powder, sunflower kernel, oil and cakes, sesame seeds, and avocado oil. We also partner with third-
party co-manufacturers to produce consumer-packaged premium juice products (including private label orange juices,
lemonades, and functional waters), utilizing internally-sourced raw materials.
SUNOPTA INC.
29
December 28, 2019 10-K
(cid:120) Plant-Based Foods and Beverages – We offer a full line of plant-based beverages and liquid and dry ingredients
(utilizing almond, soy, coconut, oat, hemp, and other bases), as well as broths, teas and nutritional beverages. In
addition, we package dry- and oil-roasted in-shell sunflower and sunflower kernels, as well as corn-, soy- and legume-
based roasted snacks, and we process and sell raw sunflower inshell and kernel for food and feed applications.
(cid:120) Fruit-Based Foods and Beverages – We offer individually quick frozen (“IQF”) fruit for retail (including strawberries,
blueberries, mango, pineapple, blends, and other berries), IQF and bulk frozen fruit for foodservice (including purées,
fruit cups and smoothies), and custom fruit preparations for industrial use. In addition, we offer fruit snacks, including
bars, twists, ropes and bite-sized varieties.
The segment information presented in this MD&A for fiscal years 2018 and 2017 has been restated to conform with the changes
to our operating structure in fiscal 2019.
Fiscal Year
We operate on a fiscal calendar that results in a given fiscal year consisting of a 52- or 53-week period ending on the Saturday
closest to December 31. Fiscal years 2018, 2017 and 2016 were each 52-week periods ending on December 29, 2018, December
30, 2017, and December 31, 2016, respectively.
Sale of Soy and Corn Business
On February 22, 2019, our subsidiary, SunOpta Grains and Foods Inc., completed the sale of our specialty and organic soy and
corn business to Pipeline Foods, LLC (“Pipeline Foods”) for $66.5 million, net of certain post-closing adjustments. The soy
and corn business engaged in seed and grain conditioning and corn milling and formed part of Global Ingredients. The net
proceeds from this transaction were initially used to repay borrowings and increase availability under our Global Credit Facility
(as described below under the heading “Liquidity and Capital Resources”).
The results of operations of the soy and corn business for period ended February 22, 2019, and years ended December 29, 2018
and December 30, 2017, are summarized in the table below. These results exclude management fees charged by Corporate
Services.
Revenues
Gross profit
Segment operating income (loss)
Earnings (loss) before income taxes
Period ended
February 22, 2019
$
10,346
192
(187)
(187)
Years Ended
December 29, 2018 December 30, 2017
$
112,336
10,449
9,047
8,885
$
104,427
8,310
6,777
6,783
The sale of the soy and corn business simplified our operations, enabling other overhead cost reduction measures to be taken
in 2019 that extended beyond the employees and expenses that transferred to Pipeline Foods. Taking into consideration the
contribution from the soy and corn business, as well as the other associated costs and expenses that were rationalized, the
following table presents a reconciliation of adjusted earnings before interest, taxes, depreciation and amortization (“EBITDA”)
in connection with this transaction from earnings/loss before income taxes of the soy and corn business, which we consider in
this case to be the most directly comparable U.S. GAAP financial measure.
Earnings (loss) before income taxes of soy and corn
business
Depreciation
Interest income
Other expense
Less rationalized costs and expenses
Adjusted EBITDA
Period ended
February 22, 2019
$
Years Ended
December 29, 2018 December 30, 2017
$
$
(187)
129
-
-
(169)
(227)
6,783
847
(97)
91
(3,038)
4,586
8,885
955
(20)
182
(3,579)
6,423
SUNOPTA INC.
30
December 28, 2019 10-K
Adjusted EBITDA is a non-GAAP measure that management uses when assessing the performance of our operations. See
footnote (3) to the “Consolidated Results of Operations for Fiscal Years 2019 and 2018” table below for a discussion on the
use of this non-GAAP measure.
For more information regarding the sale of the soy and corn business, see note 4 to the consolidated financial statements at
Item 15 of this Form 10-K.
Value Creation Plan
In 2016, we established a Value Creation Plan with the objective of maximizing our ability to deliver long-term value to our
shareholders. Since 2016, we have identified and implemented a series of measures under the Value Creation Plan, including
the sale of the soy and corn business (as described above). In 2019, we appointed a new Chief Executive Officer (“CEO”) and
new Chief Financial Officer (“CFO”) to continue to drive the Value Creation Plan. Actions taken in 2019 included a workforce
reduction program and other cost-saving initiatives that are expected to result in approximately $8 million to $10 million of
savings annually beginning in 2020. In addition, we initiated a plan to consolidate certain of our corporate office functions in
Edina, Minnesota, which is expected to be completed in 2020 with the closure of our Placentia, California, office and
downsizing of our Mississauga, Ontario, office. These initiatives are part of our effort to become more efficient and profitable,
by simplifying the business and enhancing decision-making and speed to market.
Prior to 2019, measures taken under the Value Creation Plan included the consolidation of our roasted snack operations and
related disposal of our former roasting facility in Wahpeton, North Dakota, in 2018; the exit from flexible resealable pouch and
nutrition bar product lines and operations initiated in 2017; and the closure of our juice processing facility in San Bernardino,
California, in 2016. In addition, we made a series of organizational changes within our management and executive teams,
including new leadership additions to many corporate, commercial and operational functions. We also added new employees
in the areas of quality, food safety, sales, marketing, operations and engineering, and made capital investments at several of
our manufacturing facilities to enhance food safety and production efficiencies.
Costs incurred and charged to expense under the Value Creation Plan for the years ended December 28, 2019, December 29,
2018 and December 30, 2017 were recorded in the consolidated statement of operations as follows:
Cost of goods sold(1)
Selling, general and administrative expenses(2)
Other expense(3)
December 28, 2019 December 29, 2018 December 30, 2017
$
3,189
22,894
23,829
49,912
$
-
3,556
6,093
9,649
$
100
613
1,661
2,374
(1) Inventory write-downs and facility closure costs recorded in cost of goods sold were allocated to Plant-Based Foods and Beverages.
(2) Consulting/professional fees and temporary labor costs, and employee recruitment, relocation and retention costs recorded in selling, general and
administrative expenses were allocated to Corporate Services.
(3) For the year ended December 28, 2019, costs recorded in other expense were allocated as follows: Global Ingredients – $0.2 million (December 29,
2018 – $nil; December 30, 2017 – $3.9 million); Plant-Based Foods and Beverages – $0.5 million (December 29, 2018 – $1.4 million; December
30, 2017 – $16.8 million); Fruit-Based Foods and Beverages – $1.0 million (December 29, 2018 – $0.1 million; December 30, 2017 – $1.3 million);
and Corporate Services – $4.3 million (December 29, 2018 – $0.2 million; December 30, 2017 – $1.8 million).
We intend to continue to make the necessary strategic business decisions and structural investments that we believe will deliver
sustained profitable growth and deliver long-term value. Consequently, significant additional costs and expenses could arise
in future periods if we determine to initiate further actions under the framework of the Value Creation Plan.
For more information regarding the Value Creation Plan, see note 5 to the consolidated financial statements at Item 15 of this
Form 10-K.
Acquisition of Sanmark
On April 1, 2019, we acquired 100% of the outstanding shares of Sanmark B.V. (“Sanmark”) for $3.3 million, net of cash
acquired, which was financed through existing credit facilities. Sanmark is a sourcing and trading business focused on organic
oils for the food, pharmacy, and cosmetic industries. Sanmark sources raw materials globally and generates most of its sales
in the European and Asia-Pacific markets. The operations of Sanmark have been integrated into our international organic
ingredients operations based in the Netherlands. The results of operations of Sanmark have been included in Global Ingredients
SUNOPTA INC.
31
December 28, 2019 10-K
since the date of acquisition. For more information regarding the acquisition of Sanmark, see note 3 to the consolidated
financial statements at Item 15 of this Form 10-K.
Critical Accounting Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make certain estimates and
assumptions that affect the reported amounts of assets and liabilities, related revenues and expenses, and disclosure of gain and
loss contingencies at the date of the financial statements. The estimates and assumptions made require us to exercise our
judgment and are based on historical experience and various other factors that we believe to be reasonable under the
circumstances. We continually evaluate the information that forms the basis of our estimates and assumptions as our business
and the business environment generally changes. The use of estimates is pervasive throughout our financial statements. The
following are the accounting estimates which we believe to be most significant to our business.
Revenue Recognition
We recognize revenue when we transfer control of promised goods to our customers in an amount that reflects the consideration
to which we expect to be entitled to in exchange for those goods. Control is typically transferred when title and physical
possession of the product has transferred to the customer, which is at the point in time that a product is shipped from our
facilities or delivered to a specified destination, depending on the terms of the contract, and we have a present right to payment.
Consideration is typically determined based on a fixed unit price for the quantity of product transferred. Certain of our revenue
contracts may give rise to an element of variable consideration in the form of rebates or discounts; however, variable
consideration has historically been immaterial in the context of the total consideration due under the contracts. We do not
typically grant customers a general right of return for goods transferred but we will generally accept returns of product for
quality-related issues. The cost of satisfying this promise of quality is accounted for as an assurance-type warranty obligation
rather than variable consideration. Our contracts do not typically include any significant payment terms, as payment is normally
due shortly after the time of transfer.
For sales of raw material ingredients, the duration of our contracts is typically one year or less and may involve multiple
delivery dates over the course of the contract. For consumer products, contracts are typically represented by short-term, binding
purchase orders from customers. The timing of our revenue recognition, customer billings and cash collections, does not result
in significant unbilled receivables (contract assets) or customer advances (contract liabilities) on the consolidated balance sheet.
Contract costs, such as sales commissions, are generally expensed as incurred given the short-term nature of the associated
contracts.
See note 2 of the consolidated financial statements at Item 15 of this Form 10-K for disclosures related to revenue.
Accounts Receivable
Our accounts receivable primarily includes amounts due from our customers. The carrying value of each account is carefully
monitored with a view to assessing the likelihood of collection. An allowance for doubtful accounts is provided for as an
estimate of losses that could result from customers defaulting on their obligations to us. In assessing the amount of reserve
required, a number of factors are considered including the age of the account, the credit-worthiness of the customer, payment
terms, the customer’s historical payment history and general economic conditions. Because the amount of the reserve is an
estimate, the actual amount collected could differ from the carrying value of the amount receivable. Note 7 of the consolidated
financial statements at Item 15 of this Form 10-K provides a summary of the changes in the allowance for doubtful accounts.
Inventory
Inventory is our largest current asset and consists primarily of raw materials and finished goods held for sale. Inventories are
valued at the lower of cost and estimated net realizable value except for certain grain inventories that are carried at market
value. In order to determine the value of inventory at the balance sheet date, we evaluate a number of factors to determine the
adequacy of provisions for inventory. These factors include the age of inventory, the amount of inventory held by type, future
demand for products, and the expected future selling price we expect to realize by selling the inventory. Our estimates are
judgmental in nature and are made at a point in time, using available information, expected business plans, and expected market
conditions. As a result, the actual amount received on sale could differ from our estimated value of inventory. We perform a
review of our inventory by operation and product line on a quarterly basis. Note 8 of the consolidated financial statements at
Item 15 of this Form 10-K provides a summary of the movements in the inventory reserve.
SUNOPTA INC.
32
December 28, 2019 10-K
Leases
Lease assets and liabilities are recognized and measured based on the present value of future lease payments over the lease
term. In measuring lease assets and liabilities, critical estimates and assumptions include the amount and timing of the future
lease payments based on the expected lease term, and the discount rate to apply to those future lease payments. In determining
the expected lease term, we consider the initial noncancelable period of the lease, together with periods covered by renewal
options that we are reasonably certain to exercise. Typically, most of our real estate leases and certain of our equipment leases
include options to extend the leases, with exercise of these options being at our sole discretion. The evaluation of whether the
exercise of a renewal option is reasonably certain is a matter of judgment based on a number of factors, including the length of
the initial lease period, the nature of the underlying asset and importance of the asset to our operations, the addition of significant
leasehold improvements, and the availability of alternative replacement assets, as well as consideration of business, market and
economic factors that may impact our assessment of the useful life of the underlying asset. Generally, we use the initial
noncancelable lease term when determining the lease asset and liability. If there are significant events or changes in
circumstances that cause us to reassess whether we are reasonably certain or not to exercise an option to extend a lease, we will
remeasure the lease asset and liability using revised estimates of the discount rate and remaining lease term as at the
reassessment date. The discount rate used to determine the present value of the future lease payments is the implicit rate in the
lease if readily determinable. When that rate is not readily determinable, we use our incremental borrowing rate, which is the
estimated rate of interest that we would have to pay to borrow on, a collateralized basis over a similar term, an amount equal
to the lease payments in a similar economic environment. We determine our incremental borrowing rate based on the location
of each leased asset, using relevant interest rate yield curves and credit spreads derived from available market data and our
corporate credit rating.
See note 10 of the consolidated financial statements at Item 15 of this Form 10-K for disclosures related to leases.
Goodwill
Goodwill represents the excess in a business combination of the purchase price over the estimated fair value of the identifiable
net assets acquired. Goodwill is not amortized but is instead tested for impairment at least annually, or whenever events or
circumstances change between the annual impairment tests that would indicate the carrying amount of goodwill may be
impaired. We perform the annual test for goodwill impairment in the fourth quarter of each fiscal year. Goodwill is tested for
impairment at the reporting unit level, which is defined as an operating segment or one level below. Goodwill impairment
charges are recognized based on the excess of a reporting unit’s carrying amount over its estimated fair value.
We can elect to qualitatively assess goodwill for impairment if it is more likely than not that the fair value of a reporting unit
exceeds its carrying value. If we elect to quantitatively assess goodwill, or it is not more likely than not that the fair value of a
reporting unit exceeds its carrying value, we estimate the fair values of each of our reporting units. Fair value is determined
using an income approach (discounted cash flow method). We believe an income approach provides the most reliable indication
of fair value as it reflects forecasted revenues and earnings based on business and market conditions that are unique to each
individual reporting unit, which a market approach may not fully incorporate. Because the business is assumed to continue in
perpetuity, the discounted cash flows include a terminal value. Cash flows to perpetuity are forecasted based on projected
revenue growth and our planned business strategies in future periods. Examples of planned strategies would include a plant or
line expansion at an existing facility; a reduction of working capital at a specific location; and price increases or cost reductions
within a reporting unit. The discount rate is based on a reporting unit’s targeted weighted-average cost of capital, which is not
necessarily the same as our weighted-average cost of capital. These assumptions are subject to change and are impacted by
our ability to achieve our forecasts and by economic conditions that may impact future results and result in projections not
being attained. Each year we re-evaluate the assumptions used to reflect changes in the business environment.
For the year ended December 28, 2019, we performed a qualitative assessment of goodwill and determined that the fair values
of our reporting units with goodwill exceeded their carrying values. As a result, we concluded that goodwill was not impaired
in 2019. Based on the results of the quantitative impairment testing performed for the years ended December 29, 2018 and
December 30, 2017, we recognized goodwill impairment charges of $81.2 million and $115.0 million respectively, to fully
write-off the goodwill that arose from our acquisition of Sunrise Holdings (Delaware), Inc. (“Sunrise”) in October 2015. The
operations of Sunrise are included in the Fruit-Based Foods and Beverages segment. The results of our annual impairment
tests for goodwill are described in note 11 of the consolidated financial statements at Item 15 of this Form 10-K.
Intangible Assets
We evaluate amortizable intangible assets acquired through business combinations for impairment if events or changes in
circumstances indicate that the carrying amounts of these assets may not be recoverable. Our evaluation is based on an
SUNOPTA INC.
33
December 28, 2019 10-K
assessment of potential indicators of impairment, such as an adverse change in the business climate that could affect the value
of an asset; the loss of a significant customer; current or forecasted operating or cash flow losses that demonstrate continuing
losses associated with the use of an asset; the introduction of a competing product that results in a significant loss of market
share; and a current expectation that, more likely than not, an intangible asset will be disposed of before the end of its previously
estimated useful life, such as a plan to exit a product line or business in the near term.
Impairment exists when the carrying amount of an amortizable intangible asset is not recoverable through undiscounted future
cash flows and its carrying value exceeds its estimated fair value. A discounted cash flow analysis is typically used to determine
fair value using estimates and assumptions that market participants would apply. Some of the estimates and assumptions
inherent in a discounted cash flow model include the amount and timing of the projected future cash flows, and the discount
rate used to reflect the risks inherent in the future cash flows. A change in any of these estimates and assumptions could produce
a different fair value, which could have a material impact on our results of operations. In addition, an intangible asset’s expected
useful life can increase estimation risk, as longer-lived assets necessarily require longer-term cash flow forecasts, which for
some of our long-lived assets can be in excess of 20 years. In connection with an impairment evaluation, we also reassess the
remaining useful life of the intangible asset and modify it, as appropriate.
Acquisitions
Business acquisitions are accounted for by the acquisition method of accounting. Under this method, the purchase price is
allocated to the assets acquired and the liabilities assumed based on the fair value at the time of the acquisition. Any excess
purchase price over the fair value of identifiable assets acquired and liabilities assumed is recorded as goodwill. We believe
the fair values assigned to the assets acquired and liabilities assumed are based on reasonable assumptions; however, these
assumptions may be incomplete or inaccurate, and unanticipated events and circumstances may occur.
The assumptions and estimates with respect to determining the fair value of customer relationship intangible assets acquired
are among the most significant in our acquisition accounting and generally require the most judgment. Key variables in
determining the fair value of customer relationships are the estimated customer attrition rate and the percentage of revenue
growth attributable to existing customers. Changes to either or both of these variables could have a significant impact on the
customer relationships intangible assets’ values, and changes to the estimated customer attrition rate could have a significant
impact on the estimated useful lives of these assets. The expected customer attrition rate assumed in the estimate of fair value
for the customer relationships intangible assets is generally supported by an analysis of historical attrition of the acquired
business’s customers and consideration of its amortization policy of previously acquired customer relationships, amortization
policies adopted for acquired customer relationships by other companies in similar transactions, and the contractual terms
between the acquired business and its customers. The percentage of revenue growth attributable to existing customers assumed
in the estimate of fair value for the customer relationships intangible assets is typically supported by an analysis of the acquired
business’s historical and forecasted revenue growth rates by customer. Changes in any of the assumptions or estimates used
in determining the fair value of the customer relationship intangible assets could have a significant impact on the amounts
assigned to goodwill in the purchase price allocation. Future net earnings can be affected by changes in these estimates resulting
in an increase or decrease in amortization expense, or impairment of the intangible assets and/or goodwill. Note 12 of the
consolidated financial statements at Item 15 of this Form 10-K outlines annual amortization expense relating to these
intangibles.
Some acquisitions involve contingent consideration to be potentially paid based on the achievement of specified future financial
targets by the acquired business. Acquisition-related contingent consideration is initially recognized as a liability at estimated
fair value and re-measured each reporting period with changes in the estimated fair value recognized in earnings. These
estimates of fair value involve uncertainties as they include assumptions about the likelihood of achieving the specified financial
targets, projections of future financial performance, and assumed discount rates. A change in any of these assumptions could
produce a different fair value, which could impact the amounts assigned to assets and liabilities in the purchase price allocation,
or the amounts recognized in earnings to reflect subsequent changes in the carrying value of the liability.
Contingencies
We make estimates for payments that are contingent on the outcome of uncertain future events. These contingencies include
accrued but unpaid bonuses; tax-related matters; and claims or litigation. In establishing our estimates, we consider historical
experience with similar contingencies and the progress of each contingency, as well as the recommendations of internal and
external advisors and legal counsel. We re-evaluate all contingencies as additional information becomes available; however,
given the inherent uncertainties, the ultimate amount paid could differ from our estimates.
SUNOPTA INC.
34
December 28, 2019 10-K
Income Taxes
We are liable for income taxes in the U.S., Canada, and other jurisdictions where we operate. Our effective tax rate differs
from the statutory tax rate and will vary from year to year primarily as a result of numerous permanent differences, investment
and other tax credits, the provision for income taxes at different rates in foreign and other provincial jurisdictions, enacted
statutory tax rate increases or reductions in the year, the benefit of cross-jurisdictional financing structures, changes due to
foreign exchange, changes in valuation allowance based on our recoverability assessments of deferred tax assets, and favorable
or unfavorable resolution of various tax examinations.
In making an estimate of our income tax liability, we first assess which items of income and expense are taxable in a particular
jurisdiction. This process involves a determination of the amount of taxes currently payable as well as the assessment of the
effect of temporary timing differences resulting from different treatment of items for accounting and tax purposes. These
differences in the timing of the recognition of income or the deductibility of expenses result in deferred income tax balances
that are recorded as assets or liabilities as the case may be on our balance sheet. We also estimate the amount of valuation
allowance to maintain relating to loss carry forwards and other balances that can be used to reduce future taxes payable. This
judgment is based on forecasted results in the jurisdiction and certain tax planning strategies and, as a result, actual results may
differ from forecasts. We assess the likelihood of the ultimate realization of these tax assets by looking at the relative size of
the tax assets in relation to the profitability of the businesses and the jurisdiction to which they can be applied, the number of
years based on management’s estimate it will take to use the tax assets and any other special circumstances. If different
judgments had been used, our income tax liability could have been different from the amount recorded. In addition, the taxing
authorities of those jurisdictions upon audit may not agree with our assessment. Note 19 of the consolidated financial
statements at Item 15 of this Form 10-K provides an analysis of the changes in the valuation allowance and the components of
our deferred tax assets.
While we believe we have adequately provided for all tax positions, amounts asserted by taxing authorities could differ from
our accrued position. Accordingly, additional provisions on federal, provincial, state and foreign tax-related matters could be
recorded in the future as revised estimates are made or the underlying matters are settled or otherwise resolved.
SUNOPTA INC.
35
December 28, 2019 10-K
Consolidated Results of Operations for Fiscal Years 2019 and 2018
Revenues
Global Ingredients
Plant-Based Foods and Beverages
Fruit-Based Foods and Beverages
Total revenues
Gross Profit
Global Ingredients
Plant-Based Foods and Beverages
Fruit-Based Foods and Beverages
Total gross profit
Segment operating income (loss)(1)
Global Ingredients
Plant-Based Foods and Beverages
Fruit-Based Foods and Beverages
Corporate Services
Total segment operating income (loss)
Other expense (income), net
Goodwill impairment
Earnings (loss) before the following
Interest expense, net
Provision for (recovery of) income taxes
Net loss(2),(3)
Earnings attributable to non-controlling interests
Loss attributable to SunOpta Inc.
Dividends and accretion on Series A Preferred Stock
December 28,
2019
$
December 29,
2018
$
478,772
361,398
349,852
1,190,022
581,307
314,076
365,469
1,260,852
49,942
58,812
6,499
115,253
15,965
29,476
(26,873)
(21,322)
(2,754)
(40,048)
-
37,294
34,677
3,221
(604)
154
(758)
(8,022)
61,249
40,477
21,744
123,470
23,266
10,766
(16,029)
(14,071)
3,932
2,825
81,222
(80,115)
34,406
(5,378)
(109,143)
62
(109,205)
(7,909)
Change
$
(102,535)
47,322
(15,617)
(70,830)
(11,307)
18,335
(15,245)
(8,217)
(7,301)
18,710
(10,844)
(7,251)
(6,686)
(42,873)
(81,222)
117,409
271
8,599
108,539
92
108,447
(113)
Change
%
-17.6%
15.1%
-4.3%
-5.6%
-18.5%
45.3%
-70.1%
-6.7%
-31.4%
173.8%
-67.7%
-51.5%
-170.0%
-1517.6%
-100.0%
146.6%
0.8%
159.9%
99.4%
148.4%
99.3%
-1.4%
Loss attributable to common shareholders(4)
(8,780)
(117,114)
108,334
92.5%
(1) When assessing the financial performance of our operating segments, we use an internal measure of operating income/loss that excludes other
income/expense items and goodwill impairments determined in accordance with U.S. GAAP. This measure is the basis on which management, including
the CEO, assesses the underlying performance of our operating segments.
We believe that disclosing this non-GAAP measure assists investors in comparing financial performance across reporting periods on a consistent basis
by excluding items that are not indicative of our operating performance. However, the non-GAAP measure of operating income should not be considered
in isolation or as a substitute for performance measures calculated in accordance with U.S. GAAP. The following table presents a reconciliation of
segment operating income/loss to earnings/loss before the following, which we consider to be the most directly comparable U.S. GAAP financial measure.
SUNOPTA INC.
36
December 28, 2019 10-K
December 28, 2019
Segment operating income (loss)
Other income (expense), net
Earnings (loss) before the following
December 29, 2018
Segment operating income (loss)
Other income (expense), net
Goodwill impairment
Earnings (loss) before the following
Global
Ingredients
$
Plant-Based
Foods and
Beverages
$
Fruit-Based
Foods and
Beverages
$
15,965
43,399
59,364
23,266
2,326
-
25,592
29,476
(518)
28,958
10,766
(2,151)
-
8,615
(26,873)
(1,028)
(27,901)
(16,029)
(388)
(81,222)
(97,639)
Corporate
Services
$
(21,322)
(1,805)
(23,127)
(14,071)
(2,612)
-
(16,683)
Consolidated
$
(2,754)
40,048
37,294
3,932
(2,825)
(81,222)
(80,115)
We believe that investors’ understanding of our financial performance is enhanced by disclosing the specific items that we exclude from segment
operating income/loss. However, any measure of operating income/loss excluding any or all of these items is not, and should not be viewed as, a substitute
for operating income/loss prepared under U.S. GAAP. These items are presented solely to allow investors to more fully understand how we assess
financial performance.
(2) When assessing our financial performance, we use an internal measure of earnings attributable to common shareholders determined in accordance with
U.S. GAAP that excludes specific items recognized in other income/expense, impairment losses on goodwill and long-lived assets, and other unusual
items that are identified and evaluated on an individual basis, which due to their nature or size, we would not expect to occur as part of our normal
business on a regular basis. We believe that the identification of these excluded items enhances the analysis of our financial performance of our business
when comparing those operating results between periods, as we do not consider these items to be reflective of normal business operations.
The following table presents a reconciliation of adjusted earnings/loss from net earnings/loss, which we consider to be the most directly comparable U.S.
GAAP financial measure. In addition, in recognition of the sale of the soy and corn business (as described above under the heading “Sale of Soy and
Corn Business”), and our exit from flexible resealable pouch and nutrition bar product lines and operations (as described above under the heading “Value
Creation Plan”), we have prepared this table in a columnar format to present the effect of the disposal of these operations on our consolidated results for
the current and comparative periods. We believe this presentation assists investors in assessing the results of the operations we have disposed of and the
effect of those operations on our financial performance.
SUNOPTA INC.
37
December 28, 2019 10-K
For the years ended
December 28, 2019
Net earnings (loss)
Earnings attributable to non-controlling interests
Dividends and accretion of Series A Preferred Stock
Earnings (loss) attributable to common shareholders
Adjusted for:
Gain on sale of soy and corn business(a)
Costs related to Value Creation Plan(b)
Plant expansion costs(c)
Contract manufacturer transition costs(d)
Product withdrawal and recall costs(e)
Other(f)
Net income tax effect(g)
Adjusted loss
December 29, 2018
Net earnings (loss)
Earnings attributable to non-controlling interests
Dividends and accretion of Series A Preferred Stock
Earnings (loss) attributable to common shareholders
Adjusted for:
Goodwill impairment(h)
Inventory write-downs(i)
Equipment start-up costs(j)
New product commercialization costs(k)
Costs related to Value Creation Plan(l)
Reserve for notes receivable(m)
Product withdrawal and recall costs(n)
Other(o)
Fair value adjustment on contingent consideration(p)
Recovery of product withdrawal costs(q)
Reversal of stock-based compensation(r)
Net income tax effect(g)
Adjusted earnings (loss)
Excluding
disposed operations
Per Diluted
Share
$
$
Disposed operations
Per Diluted
Share
$
$
Consolidated
Per Diluted
Share
$
$
(32,273)
(154)
(8,022)
(40,449)
-
9,649
609
448
260
(2,533)
(67)
31,669
-
-
(0.46)
31,669
0.36
(44,027)
-
-
-
-
-
12,064
(0.10)
(604)
(154)
(8,022)
(8,780)
(44,027)
9,649
609
448
260
(2,533)
11,997
(32,083)
(0.37)
(294)
(0.00)
(32,377)
(0.37)
(1.37)
(111,477)
(62)
(7,909)
(119,448)
81,222
3,101
2,913
2,729
1,696
2,232
1,456
296
(2,821)
(1,200)
(182)
681
2,334
-
-
2,334
-
-
-
-
678
-
-
-
-
-
-
(176)
(109,143)
(62)
(7,909)
0.03
(117,114)
(1.34)
81,222
3,101
2,913
2,729
2,374
2,232
1,456
296
(2,821)
(1,200)
(182)
505
(27,325)
(0.31)
2,836
0.03
(24,489)
(0.28)
(a) Reflects the gain on sale of the soy and corn business, net of transaction costs and post-closing adjustments, which was recorded in other
income.
(b) Reflects employee retention and relocation costs of $2.2 million, and professional fees of $1.4 million recorded in SG&A expenses; and
employee termination costs of $8.6 million (net of the reversal of $4.1 million of previously recognized stock-based compensation related to
forfeited awards previously granted to terminated employees), CEO and CFO recruitment costs of $1.3 million, and facility closure costs of
$0.3 million, all recorded in other expense.
(c) Reflects costs related to the expansion of our Allentown, Pennsylvania, plant-based beverage facility and start-up of our new organic avocado
oil facility in Ethiopia, which were recorded in cost of goods sold.
(d) Reflects costs to transition premium juice production activities to new contract manufacturers, which were recorded in cost of goods sold and
other expense.
(e) Reflects product withdrawal and recall costs that were not eligible for reimbursement under insurance policies or exceeded the limits of those
policies, including costs related to the recall of certain sunflower kernel products initiated in 2016, which were recorded in other expense.
(f) Other includes gains on the settlement of certain legal matters and a project cancellation, partially offset by losses on disposal of assets,
insurance deductibles, and business development costs, which were recorded in other income/expense.
(g) Reflects the tax effect of the preceding adjustments to earnings and reflects an overall estimated annual effective tax rate of approximately
27% for 2019 (2018 – 27%) on adjusted earnings/loss before tax.
(h) Reflects the impairment of goodwill that arose from the acquisition of Sunrise in 2015.
(i) Reflects the write-down of certain frozen fruit inventory items in the fourth quarter of 2018, due to a change in expected use of aged stocks,
and reduced sales pricing and high production costs, which was recorded in cost of goods sold.
(j) Reflects costs related to the start-up of new roasting equipment for grains, seeds and legumes at our Crookston, Minnesota, facility, as well
as the start-up of a second processing line at our cocoa facility in the Netherlands, which were recorded in cost of goods sold.
(k) Reflects costs for development, production trials and start-up costs, incremental freight charges, and employee training related to the
commercialization of new consumer products, which were recorded in cost of goods sold ($2.3 million) and SG&A expenses ($0.4 million).
SUNOPTA INC.
38
December 28, 2019 10-K
(l) Reflects the write-down of inventories of $0.1 million recorded in cost of goods sold; professional and consulting fees, and employee
recruitment and relocation costs of $0.6 million recorded in SG&A expenses; and asset impairment, facility closure and employee termination
costs of $1.7 million recorded in other expense, all related to the Value Creation Plan.
(m) Reflects a bad debt reserve for notes receivable associated with a previously sold business, which was recorded in other expense.
(n) Reflects product withdrawal and recall costs that were not eligible for reimbursement under insurance policies or exceeded the limits of those
policies, including costs related to the sunflower recall, which were recorded in other expense.
(o) Other included the accretion of contingent consideration obligations, gain/loss on the sale of assets, severance costs unrelated to the Value
Creation Plan, and settlement of a legal matter, which were recorded in other expense/income.
(p) Reflects a fair value adjustment to reduce the contingent consideration obligation related to a prior business acquisition, based on the results
for the business in fiscal 2018, which was recorded in other income.
(q) Reflects the recovery from a third-party supplier of $1.2 million of costs incurred relating to the withdrawal of certain consumer-packaged
products due to quality-related issues, which was recorded in cost of goods sold. Costs incurred related to this withdrawal were recognized
in cost of goods sold in 2016.
(r) Reflects the reversal to SG&A expenses of previously recognized stock-based compensation related to performance share units granted to
certain employees as the performance conditions were not achieved.
We believe that investors’ understanding of our financial performance is enhanced by disclosing the specific items that we exclude to compute adjusted
earnings/loss. However, adjusted earnings/loss is not, and should not be viewed as, a substitute for earnings prepared under U.S. GAAP. Adjusted
earnings/loss is presented solely to allow investors to more fully understand how we assess our financial performance.
(3) We use a measure of adjusted EBITDA when assessing the performance of our operations, which we believe is useful to investors’ understanding of our
operating profitability because it excludes non-operating expenses, such as interest and income taxes, and non-cash expenses, such as depreciation,
amortization, stock-based compensation and asset impairment charges, as well as other unusual items that affect the comparability of operating
performance. We also use this measure to review and assess our progress under the Value Creation Plan and to assess operating performance in
connection with our employee incentive programs. In addition, we are subject to certain restrictions on incurring additional indebtedness based on
availability and metrics that include in their calculation a measure of EBITDA. We define adjusted EBITDA as segment operating income/loss plus
depreciation, amortization and non-cash stock-based compensation, and excluding other unusual items as identified in the determination of adjusted
earnings (refer above to footnote (2)). The following table presents a reconciliation of segment operating income/loss and adjusted EBITDA from net
earnings/loss, which we consider to be the most directly comparable U.S. GAAP financial measure. In addition, as described above under footnote (2),
we have prepared this table in a columnar format to present the effect of the disposals of the soy and corn business, and flexible resealable pouch and
nutrition bar operations on our consolidated results for the periods presented. We believe this presentation assists investors in assessing the results of the
operations we have disposed of and the effect of those operations on our financial performance.
For the years ended
December 28, 2019
Net earnings (loss)
Provision for (recovery of) income taxes
Interest expense, net
Other expense (income), net
Total segment operating loss
Depreciation and amortization
Stock-based compensation(a)
Costs related to Value Creation Plan(b)
Plant expansion costs(c)
Contract manufacturer transition costs(d)
Adjusted EBITDA
December 29, 2018
Net earnings (loss)
Provision for (recovery of) income taxes
Interest expense, net
Other expense, net
Goodwill impairment
Total segment operating income (loss)
Depreciation and amortization
Stock-based compensation
Inventory write-downs(e)
Equipment start-up costs(f)
New product commercialization costs(g)
Costs related to Value Creation Plan(b)
Recovery of product withdrawal costs(h)
Adjusted EBITDA
Excluding
disposed operations Disposed operations
$
$
Consolidated
$
(32,273)
(8,731)
34,677
3,979
(2,348)
33,823
11,616
3,556
609
289
47,545
(111,477)
(6,269)
34,503
2,056
81,222
35
31,941
7,939
3,101
2,913
2,729
713
(1,200)
48,171
31,669
11,952
-
(44,027)
(406)
129
-
-
-
-
(277)
2,334
891
(97)
769
-
3,897
847
-
-
-
-
-
-
4,744
(604)
3,221
34,677
(40,048)
(2,754)
33,952
11,616
3,556
609
289
47,268
(109,143)
(5,378)
34,406
2,825
81,222
3,932
32,788
7,939
3,101
2,913
2,729
713
(1,200)
52,915
(a) Stock-based compensation of $11.6 million was recorded in SG&A expenses, and the reversal of $4.1 million of previously recognized stock-
based compensation related to forfeited awards previously granted to terminated employees was recognized in other income.
(b) For 2019, reflects employee retention and relocation costs of $2.2 million, and professional fees of $1.4 million recorded in SG&A expenses.
For 2018, reflects the write-down of remaining flexible resealable pouch and nutrition bar inventories of $0.1 million recorded in cost of
goods sold; and professional and consulting fees, and employee recruitment and relocation costs of $0.6 million recorded in SG&A expenses.
SUNOPTA INC.
39
December 28, 2019 10-K
(c) Reflects costs related to the expansion of our Allentown, Pennsylvania, plant-based beverage facility and start-up of our new organic avocado
oil facility in Ethiopia, which were recorded in cost of goods sold.
(d) Reflects costs to transition premium juice production activities to new contract manufacturers, which were recorded in cost of goods sold.
(e) Reflects the write-down of certain frozen fruit inventory items in the fourth quarter of 2018, due to a change in expected use of aged stocks,
and reduced sales pricing and high production costs, which was recorded in cost of goods sold.
(f) Reflects costs related to the start-up of new roasting equipment for grains, seeds and legumes at our Crookston, Minnesota, facility, as well
as the start-up of a second processing line at our cocoa facility in the Netherlands, which were recorded in cost of goods sold.
(g) Reflects costs for development, production trials and start-up costs, incremental freight charges, and employee training related to the
commercialization of new consumer products, which were recorded in cost of goods sold ($2.3 million) and SG&A expenses ($0.4 million).
(h) Reflects the recovery from a third-party supplier of $1.2 million of costs incurred relating to the withdrawal of certain consumer-packaged
products due to quality-related issues, which was recorded in cost of goods sold. Costs incurred related to this withdrawal were recognized
in cost of goods sold in 2016.
Although we use adjusted EBITDA as a measure to assess the performance of our business and for the other purposes set forth above, this measure has
limitations as an analytical tool, and should not be considered in isolation, or as a substitute for an analysis of our results of operations as reported in
accordance with U.S. GAAP. Some of these limitations are:
(cid:120)
(cid:120)
(cid:120)
(cid:120)
adjusted EBITDA does not reflect the interest expense, or the cash requirements necessary to service interest payments on our indebtedness;
adjusted EBITDA does not include the recovery/payment of taxes, which is a necessary element of our operations;
although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the
future, and adjusted EBITDA does not reflect any cash requirements for such replacements; and
adjusted EBITDA does not include non-cash stock-based compensation, which is an important component of our total compensation program
for employees and directors.
Because of these limitations, adjusted EBITDA should not be considered as a measure of discretionary cash available to us to invest in the growth of our
business. Management compensates for these limitations by not viewing adjusted EBITDA in isolation, and specifically by using other U.S. GAAP and
non-GAAP measures, such as revenues, gross profit, segment operating income, earnings and adjusted earnings to measure our operating performance.
Adjusted EBITDA is not a measurement of financial performance under U.S. GAAP and should not be considered as an alternative to our results of
operations or cash flows from operations determined in accordance with U.S. GAAP, and our calculation of adjusted EBITDA may not be comparable
to the calculation of a similarly titled measure reported by other companies.
(4) In order to evaluate our results of operations, we use certain non-GAAP measures that we believe enhance an investor’s ability to derive meaningful
period-over-period comparisons and trends from our results of operations. In particular, we evaluate our revenues on a basis that excludes the effects of
fluctuations in commodity pricing and foreign exchange rates. In addition, we exclude specific items from our reported results that due to their nature
or size, we do not expect to occur as part of our normal business on a regular basis. These items are identified above under footnote (2), and in the
discussion of our results of operations below. These non-GAAP measures are presented solely to allow investors to more fully assess our results of
operations and should not be considered in isolation of, or as substitutes for, an analysis of our results as reported under U.S. GAAP.
Revenues for the year ended December 28, 2019 decreased by 5.6% to $1,190.0 million from $1,260.9 million for the year
ended December 29, 2018. Excluding the impact on revenues of the sale of the soy and corn business, the exit from flexible
resealable pouch and nutrition bar product lines, and the acquisition of Sanmark (a net decrease in revenues of $91.0 million),
a profit-neutral change to a co-manufacturing agreement with a customer (a decrease in revenues of $9.8 million), and changes
in foreign exchange rates (a decrease in revenues of $9.6 million) and commodity-related pricing (a decrease in revenues of
$6.5 million), revenues increased by 4.0% in 2019, compared with 2018. The increase in revenues on an adjusted basis reflected
the expansion of plant-based beverage and broth offerings, growth in plant-based ingredient extraction volumes, and increased
trading volumes of internationally-sourced organic ingredients, partially offset by declines in sales volumes for frozen fruit, net
of increased pricing, and reduced demand for fruit ingredients.
Gross profit decreased $8.2 million, or 6.7%, to $115.3 million for the year ended December 28, 2019, compared with $123.5
million for the year ended December 29, 2018. As a percentage of revenues, gross profit for the year ended December 28,
2019 was 9.7% compared to 9.8% for the year ended December 29, 2018, a decrease of 0.1%. The gross margin percentage
for 2019 would have been 9.8% excluding plant expansion and contract manufacturing transition costs of $0.9 million. For
2018, the gross profit percentage would have been 10.8%, excluding equipment start-up and product introduction costs ($5.3
million), a non-cash foreign exchange loss on U.S. dollar-denominated raw material purchase contracts within our international
organic ingredients operations ($4.9 million), and inventory write-downs for certain frozen fruit inventory items ($3.1 million),
partially offset by the recovery of $1.2 million of previously-incurred product withdrawal costs from a third-party supplier.
The decline in the gross profit percentage on an adjusted basis was mainly due to lower profitability within the Fruit-Based
Foods and Beverages segment, largely due to the impact of a shortfall of frozen strawberry supply in 2019 due to poor weather
conditions in both central Mexico and California, which resulted in higher fruit purchase prices and reduced production volumes
and related inefficiencies for our frozen fruit operations. The negative impact to gross profit from the strawberry shortfall was
estimated to be approximately $17.7 million in 2019. Also contributing to the decline in the gross profit percentage was reduced
pricing spreads for certain organic ingredients and manufacturing inefficiencies within the Global Ingredients segment. These
factors were offset by the favorable impact within the Plant-Based Foods and Beverages segment of higher sales and production
SUNOPTA INC.
40
December 28, 2019 10-K
volumes of plant-based beverages, broths and plant-based ingredients, together with improved plant utilization and
productivity-driven cost savings, and additional aseptic processing capacity that came on-line in the third quarter of 2019.
For the year ended December 28, 2019, we realized a total segment operating loss of $2.8 million, compared with total segment
operating income of $3.9 million for the year ended December 29, 2018. The decrease in total segment operating income
reflected lower overall gross profit, as described above, together with a similar level of SG&A expenses, partially offset by a
favorable foreign exchange impact of $1.6 million mainly within our international organic ingredients operations. SG&A
expenses reflected increased stock-based compensation costs related to the adoption of an equity-based bonus plan in 2019
($3.7 million), together with higher third-party professional fees and employee recruitment, relocation and retention costs
associated with the Value Creation Plan ($2.9 million), mostly offset by the elimination of expenses associated with the sale of
the soy and corn business, together with workforce reductions and other cost-saving initiatives taken in 2019.
Further details on revenue, gross profit and segment operating income/loss variances are provided below under “Segmented
Operations Information”.
Other income for the year ended December 28, 2019 of $40.0 million reflected a pre-tax gain on sale of the soy and corn
business of $44.0 million, the reversal of $4.1 million of previously recognized stock-based compensation related to forfeited
awards previously granted to terminated employees, and legal settlement and project cancellation gains of $3.1 million. These
other income amounts were offset mainly by employee termination and recruitment costs of $9.9 million associated with the
Value Creation Plan, including costs related to our CEO and CFO transitions, sale of the soy and corn business, and planned
corporate office restructuring. Other expense for the year ended December 29, 2018 of $2.8 million reflected a bad debt reserve
for notes receivable associated with a previously sold business ($2.2 million), facility closure costs and asset impairment
charges related to the closure of our nutrition bar facility and the sale of our former roasted snack facility ($1.3 million) and
employee termination costs ($0.4 million), all associated with the Value Creation Plan, as well as product withdrawal and recall
costs ($1.5 million). These expenses were partially offset by a $2.8 million reduction to the remaining contingent consideration
obligation that arose from a prior business acquisition.
In 2018, we recognized a non-cash impairment charge of $81.2 million to write-off the remaining goodwill that arose from our
acquisition of Sunrise in October 2015. This charge was recorded in the Fruit-Based Foods and Beverages segment.
Net interest expense increased by $0.3 million to $34.7 million for the year ended December 28, 2019, compared with $34.4
million for the year ended December 29, 2018. Interest expense included the amortization of debt issuance costs of $2.7 million
and $2.5 million in 2019 and 2018, respectively.
We recognized a provision of income tax of $3.2 million for the year ended December 28, 2019, compared with a recovery of
income taxes of $5.4 million for the year ended December 29, 2018. Excluding the impact of stock-based compensation,
goodwill impairment and other non-deductible amounts from pre-tax earnings, the effective tax rate was 31.3% in 2019,
compared with 27.5% in 2018.
On a consolidated basis, we realized a loss attributable to common shareholders of $8.8 million (diluted loss per share of $0.10)
for the year ended December 28, 2019, compared with a loss attributable to common shareholders of $117.1 million (diluted
loss per share of $1.34) for the year ended December 29, 2018.
For the year ended December 28, 2019, adjusted loss was $32.7 million, or $0.37 per diluted share, on a consolidated basis,
compared with adjusted loss of $24.5 million, or $0.28 per diluted share, on a consolidated basis for the year ended December
29, 2018. Excluding the results of the disposed soy and corn, flexible resealable pouch and nutrition bar operations, adjusted
loss was $32.1 million, or $0.37 per diluted share, for the year ended December 28, 2019, compared with adjusted loss of $27.3
million, or $0.31 per diluted share, for the year ended December 29, 2018. Adjusted EBITDA for the year ended December
28, 2019 was $47.3 million on a consolidated basis, compared with $52.9 million on a consolidated basis for the year ended
December 29, 2018. Excluding disposed operations, adjusted EBITDA for the year ended December 28, 2019 was $47.5
million, compared with $48.2 million for the year ended December 29, 2018. Adjusted earnings and adjusted EBITDA are
non-GAAP financial measures. See footnotes (2) and (3) to the table above for a reconciliation of adjusted loss and adjusted
EBITDA from net earnings/loss, which we consider to be the most directly comparable U.S. GAAP financial measure.
SUNOPTA INC.
41
December 28, 2019 10-K
Segmented Operations Information
Global Ingredients
December 28, 2019 December 29, 2018
Change % Change
Revenues
Gross profit
Gross profit %
Operating income
Operating income %
$
$
478,772 $
49,942
10.4%
15,965 $
3.3%
581,307 $
61,249
10.5%
23,266 $
4.0%
(102,535)
(11,307)
(7,301)
-17.6%
-18.5%
-0.1%
-31.4%
-0.7%
Global Ingredients contributed $478.8 million in revenues for the year ended December 28, 2019, compared to $581.3 million
for the year ended December 29, 2018, a decrease of $102.5 million, or 17.6%. Excluding the impact on revenues of the sale
of the soy and corn business and acquisition of Sanmark (a net decrease in revenues of $87.9 million) and commodity-related
pricing and foreign exchange rate movements (a decrease in revenues of $23.3 million), Global Ingredients revenues increased
approximately 1.8%. The table below explains the decrease in reported revenues:
Global Ingredients Revenue Changes
Revenues for the year ended December 29, 2018
Impact of the sale of the soy and corn business
Decreased commodity pricing for internationally-sourced organic ingredients
Unfavorable foreign exchange impact on euro-denominated sales due to a stronger U.S.
dollar period-over-period
Increased volumes of internationally-sourced organic ingredients including oils (which
included incremental revenues of Sanmark from the date of acquisition), coffee, sugars
and cocoa, and premium juice products, offset by lower volumes of organic nuts, grains,
and fruits and vegetables
Revenues for the year ended December 28, 2019
$581,307
(94,081)
(13,652)
(9,645)
14,843
$478,772
Gross profit in Global Ingredients decreased by $11.3 million to $49.9 million for the year ended December 28, 2019, compared
to $61.2 million for the year ended December 29, 2018, and the gross profit percentage decreased by 0.1% to 10.4%. Excluding
the impact on gross profit of the sale of the soy and corn business, the gross profit percentage would have been 10.6% and
11.1% in 2019 and 2018, respectively. The decrease in gross profit percentage excluding the soy and corn business reflected
reduced pricing spreads and manufacturing inefficiencies within our international organic ingredients operations, partially
offset by a favorable foreign exchange result. The table below explains the decrease in gross profit:
SUNOPTA INC.
42
December 28, 2019 10-K
Global Ingredients Gross Profit Changes
Gross profit for the year ended December 29, 2018
Impact of the sale of the soy and corn business
Lower pricing spread on fruits and vegetables, cocoa and animal feed, together with
lower cocoa commodity hedging gains ($0.7 million) within our international organic
ingredients operations, partially offset by increased volumes for certain organic
ingredients and higher pricing spread on coffee
Manufacturing inefficiencies related to the ramp-up of the second cocoa processing line,
together with lower yields for organic sunflower oil and sesame seed production due to
the quality of the raw material inputs, and start-up costs related to the new organic
avocado oil facility
Decrease in foreign exchange losses on U.S. dollar-denominated raw material purchase
contracts within our international organic ingredients operations
Gross profit for the year ended December 28, 2019
$61,249
(8,118)
(5,557)
(2,490)
4,858
$49,942
Operating income in Global Ingredients decreased by $7.3 million, or 31.4%, to $16.0 million for the year ended December
28, 2019, compared to $23.3 million for the year ended December 29, 2018. The table below explains the decrease in operating
income:
Global Ingredients Operating Income Changes
Operating income for the year ended December 29, 2018
Decrease in gross profit, as explained above
Higher employee-related compensation and facility costs within our international
organic ingredients operations, partially offset by SG&A reductions from the sale of the
soy and corn business and favorable foreign exchange impact on euro-denominated
SG&A expenses
Decrease in corporate cost allocations due to the sale of the soy and corn business
Net foreign exchange gains on the revaluation of U.S. dollar-denominated receivable
and payable balances, partially offset by $0.4 million decrease in marked-to-market
gains related to forward currency contracts
Operating income for the year ended December 28, 2019
$23,266
(11,307)
(849)
3,765
1,090
$15,965
Looking forward, we believe Global Ingredients is positioned to take advantage of opportunities in the growing organic and
non-GMO food categories. Having completed the sale of our soy and corn business, we intend to focus our efforts on improving
the profitability of our international organic ingredients operations. In 2020, we intend to invest in ingredient categories where
we have strong positions, including cocoa, oil and coffee, while rationalizing certain underperforming categories. In addition,
we intend to focus on addressing inefficiencies experienced at our cocoa and sunflower processing facilities in order to improve
the margin profile for these ingredients, while continuing the ramp-up of our new organic avocado oil facility. The statements
in this paragraph are forward-looking statements. See “Forward-Looking Statements” above. Several factors could adversely
impact our ability to meet these forward-looking expectations, including increased supply pressure in the commodity-based
markets in which we operate, increased competition, volume decreases or loss of customers, or our inability to secure quality
inputs or achieve our product mix or operational goals, along with the other factors described above under “Forward-Looking
Statements.”
SUNOPTA INC.
43
December 28, 2019 10-K
Plant-Based Foods and Beverages
December 28, 2019 December 29, 2018
Change % Change
Revenues
Gross profit
Gross profit %
Operating income
Operating income %
$
$
361,398 $
58,812
16.3%
29,476 $
8.2%
314,076 $
40,477
12.9%
10,766 $
3.4%
47,322
18,335
18,710
15.1%
45.3%
3.4%
173.8%
4.8%
Plant-Based Foods and Beverages contributed $361.4 million in revenues for the year ended December 28, 2019, compared to
$314.1 million for the year ended December 29, 2018, an increase of $47.3 million, or 15.1%. Excluding the impact on revenues
of a profit-neutral change to a co-manufacturing agreement with a customer (a decrease in revenues of $9.8 million), sales of
flexible resealable pouch and nutrition bar products (a decrease in revenues of $3.1 million), and changes in sunflower
commodity-related pricing (an increase in revenues of $3.6 million), Plant-Based Foods and Beverages revenues increased
approximately 18.2%. The table below explains the increase in reported revenues:
Plant-Based Foods and Beverages Revenue Changes
Revenues for the year ended December 29, 2018
Higher sales volumes of plant-based beverages and everyday broth offerings, including
output from additional aseptic processing capacity that came on-line in the third quarter
of 2019, as well as increased demand for plant-based ingredients
Increased commodity pricing for domestically-sourced sunflower
Lower revenues due a profit-neutral change to a co-manufacturing agreement with a
customer
Impact of the exit from flexible resealable pouch and nutrition bars product lines
Lower volumes of sunflower inshell and kernel, partially offset by higher volumes of
retail birdfeed and roasted snacks and ingredients
Revenues for the year ended December 28, 2019
$314,076
59,477
3,589
(9,828)
(3,103)
(2,813)
$361,398
Gross profit in Plant-Based Foods and Beverages increased by $18.3 million to $58.8 million for the year ended December 28,
2019, compared to $40.5 million for the year ended December 29, 2018, and the gross profit percentage increased by 3.4% to
16.3%. The increase in the gross profit percentage reflected strong production volumes, improved plant utilization and
productivity-driven cost savings within our plant-based beverage and ingredient extraction operations. The table below
explains the increase in gross profit:
Plant-Based Foods and Beverages Gross Profit Changes
Gross profit for the year ended December 29, 2018
Higher sales volumes, plant utilization and productivity improvements within our plant-
based beverage and ingredient extraction operations
Improved margin performance for roasted snacks and ingredients, partially offset by
lower sales and production volumes of sunflower inshell and kernel
Gross profit for the year ended December 28, 2019
$40,477
18,266
69
$58,812
Operating income in Plant-Based Foods and Beverages increased by $18.7 million to $29.5 million for the year ended
December 28, 2019, compared to $10.8 million for the year ended December 29, 2018. The table below explains the increase
in operating income:
SUNOPTA INC.
44
December 28, 2019 10-K
Plant-Based Foods and Beverages Operating Income Changes
Operating income for the year ended December 29, 2018
Increase in gross profit, as explained above
Impact of workforce reductions and other cost savings initiatives
Increase in corporate cost allocations due to the realignment of Corporate Services
following the sale of the soy and corn business
Operating income for the year ended December 28, 2019
$10,766
18,335
3,219
(2,844)
$29,476
Looking forward we believe the markets targeted by our Plant-Based Foods and Beverages segment have long-term growth
potential. Building on the results achieved in 2019, we expect continued growth in revenues and gross profit from our plant-
based beverage and ingredient operations in 2020. Growth in 2020 should benefit from a full-year output from two new aseptic
processing lines that were commissioned at our Allentown, Pennsylvania, plant-based beverage facility in the third quarter of
2019. In addition, we plan to execute several major capital projects in 2020 to further increase our aseptic processing capacity
and expand our ingredient extraction capabilities. We expect continued challenges in our domestic sunflower and roasted
snacks business in 2020, due in part to a wet 2019 harvest season that resulted in reduced sunflower yields and lower quality
product. Due to these challenges, we intend to assess plant operating costs and seek to optimize SG&A expenses, and take
pricing actions to offset commodity cost increases. The statements in this paragraph are forward-looking statements. See
“Forward-Looking Statements” above. Several factors could adversely impact our ability to meet these forward-looking
expectations, including unfavorable shifts in consumer preferences, increased competition, volume decreases or loss of
customers, inability to obtain financing to support planned capital projects, unexpected delays in executing on our capital
projects, inefficiencies in our manufacturing processes, lack of consumer product acceptance, or our inability to successfully
implement cost savings initiatives indicated above, along with the other factors described above under “Forward-Looking
Statements.”
Fruit-Based Foods and Beverages
December 28, 2019 December 29, 2018
Change % Change
Revenues
Gross profit
Gross profit %
Operating loss
Operating loss %
$
$
349,852 $
6,499
1.9%
(26,873) $
-7.7%
365,469 $
21,744
5.9%
(16,029) $
-4.4%
(15,617)
(15,245)
(10,844)
-4.3%
-70.1%
-4.0%
-67.7%
-3.3%
Fruit-Based Foods and Beverages contributed $349.9 million in revenues for the year ended December 28, 2019, compared to
$365.5 million for the year ended December 29, 2018, a decrease of $15.6 million, or 4.3%. Excluding the impact on revenues
of changes in raw fruit commodity-related pricing (an increase in revenues of $3.6 million), Fruit-Based Foods and Beverages
revenues decreased approximately 5.3%. The table below explains the decrease in reported revenues:
Fruit-Based Foods and Beverages Revenue Changes
Revenues for the year ended December 29, 2018
Reduced volumes of frozen fruit mainly into the foodservice channel, together with a
modest decline in demand for fruit ingredients from yogurt producers, partially offset by
increased sales pricing for frozen fruit
Higher sales volumes of fruit snack products
Revenues for the year ended December 28, 2019
$365,469
(16,187)
570
$349,852
Gross profit in Fruit-Based Foods and Beverages decreased by $15.2 million to $6.5 million for the year ended December 28,
2019, compared to $21.7 million for the year ended December 29, 2018, and the gross profit percentage decreased by 4.0% to
1.9%. The decrease in the gross profit percentage primarily reflected the impact of higher commodity pricing for frozen fruit
due to the shortage of strawberries, together with unfavorable production variances within our frozen fruit operations due to
SUNOPTA INC.
45
December 28, 2019 10-K
lower plant utilization and rework of bulk inventories to meet customer demand, together with lower volumes and plant
utilization for fruit ingredients. The weather-related impact to gross profit from frozen fruit was estimated to be approximately
$17.7 million in 2019, or approximately a negative 5% impact on the gross profit percentage. These factors were partially
offset by strong production volumes and productivity-driven cost savings within our fruit snacks operations. The table below
explains the decrease in gross profit:
Fruit-Based Foods and Beverages Gross Profit Changes
Gross profit for the year ended December 29, 2018
Impact of the strawberry shortage due to higher commodity pricing and costs associated
with reduced plant utilization and rework of bulk inventories (approximately $17.7
million), and lower volumes and plant utilization for fruit ingredients, together with the
impact of a claim recovery from a supplier in 2018 for $1.2 million, partially offset by
higher sales pricing for frozen fruit
Higher sales volumes, plant utilization and productivity improvements within our fruit
snack operations
Gross profit for the year ended December 28, 2019
$21,744
(15,843)
598
$6,499
Operating loss in Fruit-Based Foods and Beverages increased by $10.8 million to $26.9 million for the year ended December
28, 2019, compared to of $16.0 million for the year ended December 29, 2018. The table below explains the increase in
operating loss:
Fruit-Based Foods and Beverages Operating Loss Changes
Operating loss for the year ended December 29, 2018
Decrease in gross profit, as explained above
Increase in corporate cost allocations due to the realignment of Corporate Services
resources following the sale of the soy and corn business
Impact of headcount reductions due in part to the centralization of transactional and
other support functions related to the former Sunrise business, and other cost savings
initiatives, together with favorable foreign exchange on international operations
Operating loss for the year ended December 28, 2019
$(16,029)
(15,245)
(674)
5,075
$(26,873)
Revenues and margins for frozen fruit were in-line with our expectations for the second half of 2019, after considering the
impacts of higher cost and limited supply from the 2019 strawberry harvest. While this supply disruption is expected to
continue to negatively impact revenues and margins until the 2020 crop cycle is completed, we saw a return to positive gross
margins in the fourth quarter of 2019. We expect sequential margin improvement in 2020, as we realize the full effect of
pricing actions taken in 2019, together with expected labor cost savings in 2020 from new plant automation initiatives. Within
our fruit snacks and fruit ingredient businesses, we expect flat to modest revenue growth in 2020, with a consistent margin
profile to 2019. From a strategic perspective, we are focused on building a single synergistic fruit operation combining our
existing frozen fruit, fruit ingredient and fruit snacks businesses, while diversifying our fruit sourcing globally to reduce the
weather-related risks on fruit supply. The statements in this paragraph are forward-looking statements. See “Forward-Looking
Statements” above. Several factors could adversely impact our ability to meet these forward-looking expectations, including
unfavorable shifts in consumer preferences, increased competition, realization of sales pricing initiatives, availability and field
pricing for fruit, availability and pricing of other raw material supplies, volume decreases or loss of customers, unexpected
delays in our fruit optimization plan, inefficiencies in our manufacturing processes, lack of consumer product acceptance, or
our inability to successfully implement the particular goals and strategies indicated above, along with the other factors described
above under “Forward-Looking Statements.”
Corporate Services
December 28, 2019 December 29, 2018
Change % Change
Operating loss
$
(21,322) $
(14,071) $
(7,251)
-51.5%
SUNOPTA INC.
46
December 28, 2019 10-K
Operating loss at Corporate Services increased by $7.3 million to $21.3 million for the year ended December 28, 2019,
compared to a loss of $14.1 million for the year ended December 29, 2018. The table below explains the increase in operating
loss:
Corporate Services Operating Loss Changes
Operating loss for the year ended December 29, 2018
Increased stock-based compensation costs related to the initiation of an equity-based
annual bonus plan for most employees in 2019
Higher non-structural third-party professional fees and employee recruitment, relocation
and retention costs associated with the Value Creation Plan
Higher employee-related variable compensation, and salary increases, partially offset by
reductions in travel and other discretionary spending, and favorable foreign exchange
impact on Canadian dollar-denominated SG&A expenses
Decrease in corporate cost allocations to SunOpta operating segments
Operating loss for the year ended December 28, 2019
$(14,071)
(3,678)
(2,943)
(383)
(247)
$(21,322)
Corporate cost allocations mainly consist of salaries of corporate personnel who directly support the operating segments, as
well as costs related to the enterprise resource management system. These expenses are allocated to the operating segments
based on (1) specific identification of allocable costs that represent a service provided to each segment and (2) a proportionate
distribution of costs based on a weighting of factors such as revenue contribution and the number of people employed within
each segment.
SUNOPTA INC.
47
December 28, 2019 10-K
Consolidated Results of Operations for Fiscal Years 2018 and 2017
Revenues
Global Ingredients
Plant-Based Foods and Beverages
Fruit-Based Foods and Beverages
Total revenues
Gross Profit
Global Ingredients
Plant-Based Foods and Beverages
Fruit-Based Foods and Beverages
Total gross profit
Segment operating income (loss)(1)
Global Ingredients
Plant-Based Foods and Beverages
Fruit-Based Foods and Beverages
Corporate Services
Total segment operating income
Other expense, net
Goodwill impairment
Loss before the following
Interest expense, net
Recovery of income taxes
Net loss(2),(3)
Earnings attributable to non-controlling interests
Loss attributable to SunOpta Inc.
Dividends and accretion on Series A Preferred Stock
December 29,
2018
$
December 30,
2017
$
581,307
314,076
365,469
1,260,852
556,166
342,714
380,713
1,279,593
61,249
40,477
21,744
123,470
23,266
10,766
(16,029)
(14,071)
3,932
2,825
81,222
(80,115)
34,406
(5,378)
(109,143)
62
(109,205)
(7,909)
70,918
23,092
51,077
145,087
25,589
(7,094)
13,570
(31,298)
767
23,660
115,000
(137,893)
32,504
(35,829)
(134,568)
752
(135,320)
(7,809)
Change
$
25,141
(28,638)
(15,244)
(18,741)
(9,669)
17,385
(29,333)
(21,617)
(2,323)
17,860
(29,599)
17,227
3,165
(20,835)
(33,778)
57,778
1,902
30,451
25,425
(690)
26,115
(100)
Change
%
4.5%
-8.4%
-4.0%
-1.5%
-13.6%
75.3%
-57.4%
-14.9%
-9.1%
251.8%
-218.1%
55.0%
412.6%
-88.1%
-29.4%
41.9%
5.9%
85.0%
18.9%
-91.8%
19.3%
-1.3%
Loss attributable to common shareholders(4)
(117,114)
(143,129)
26,015
18.2%
(1) The following table presents a reconciliation of segment operating income/loss to earnings/loss before the following, which we consider to be the most
directly comparable U.S. GAAP financial measure (refer to footnote (1) to the “Consolidated Results of Operations for Fiscal Years 2019 and 2018”
table regarding the use of this non-GAAP measure).
SUNOPTA INC.
48
December 28, 2019 10-K
December 29, 2018
Segment operating income (loss)
Other income (expense), net
Goodwill impairment
Earnings (loss) before the following
December 30, 2017
Segment operating income (loss)
Other expense, net
Goodwill impairment
Earnings (loss) before the following
Global
Ingredients
$
Plant-Based
Foods and
Beverages
$
Fruit-Based
Foods and
Beverages
$
23,266
2,326
-
25,592
25,589
(4,315)
-
21,274
10,766
(2,151)
-
8,615
(7,094)
(16,765)
-
(23,859)
(16,029)
(388)
(81,222)
(97,639)
13,570
(1,650)
(115,000)
(103,080)
Corporate
Services
$
(14,071)
(2,612)
-
(16,683)
(31,298)
(930)
-
(32,228)
Consolidated
$
3,932
(2,825)
(81,222)
(80,115)
767
(23,660)
(115,000)
(137,893)
(2) The following table presents a reconciliation of adjusted earnings/loss from net earnings/loss, which we consider to be the most directly comparable U.S.
GAAP financial measure (refer to footnote (2) to the “Consolidated Results of Operations for Fiscal Years 2019 and 2018” table regarding the use of this
non-GAAP measure). In addition, in recognition of the sale of the soy and corn business (as described above under the heading “Sale of Soy and Corn
Business”), and our exit from flexible resealable pouch and nutrition bar product lines and operations (as described above under “Value Creation Plan”),
we have prepared this table in a columnar format to present the effect of these operations on our consolidated results for the periods presented. We
believe this presentation assists investors in assessing the results of the operations we have disposed of and the effect of those operations on our financial
performance.
SUNOPTA INC.
49
December 28, 2019 10-K
For the years ended
December 29, 2018
Net earnings (loss)
Earnings attributable to non-controlling interests
Dividends and accretion of Series A Preferred Stock
Loss attributable to common shareholders
Adjusted for:
Goodwill impairment(a)
Inventory write-downs(b)
Equipment start-up costs(c)
New product commercialization costs(d)
Costs related to the Value Creation Plan(e)
Reserve for notes receivable(f)
Product withdrawal and recall costs(g)
Other(h)
Fair value adjustment on contingent consideration(i)
Recovery of product withdrawal costs(j)
Reversal of stock-based compensation(k)
Net income tax effect(l)
Adjusted earnings (loss)
December 30, 2017
Net loss
Earnings attributable to non-controlling interests
Dividends and accretion of Series A Preferred Stock
Loss attributable to common shareholders
Adjusted for:
Goodwill impairment(a)
Costs related to the Value Creation Plan(m)
Product withdrawal and recall costs(n)
Recovery of legal settlement(o)
Reversal of stock-based compensation(k)
Other(h)
Net income tax effect(l)
Change in unrecognized tax benefits(p)
Impact of change in enacted U.S. corporate tax rates(q)
Adjusted loss
Excluding
disposed operations
Per Diluted
Share
$
$
Disposed operations
Per Diluted
Share
$
$
Consolidated
Per Diluted
Share
$
$
(1.37)
(111,477)
(62)
(7,909)
(119,448)
81,222
3,101
2,913
2,729
1,696
2,232
1,456
296
(2,821)
(1,200)
(182)
681
2,334
-
-
2,334
-
-
-
-
678
-
-
-
-
-
-
(176)
(109,143)
(62)
(7,909)
0.03
(117,114)
(1.34)
81,222
3,101
2,913
2,729
2,374
2,232
1,456
296
(2,821)
(1,200)
(182)
505
(27,325)
(0.31)
2,836
0.03
(24,489)
(0.28)
(122,944)
(752)
(7,809)
(131,505)
115,000
32,160
1,142
(1,024)
(546)
442
(18,332)
(452)
(8,437)
(11,552)
(11,624)
-
-
(134,568)
(752)
(7,809)
(1.52)
(11,624)
(0.13)
(143,129)
(1.66)
-
17,752
-
-
-
-
(6,923)
-
-
115,000
49,912
1,142
(1,024)
(546)
442
(25,255)
(452)
(8,437)
(0.13)
(795)
(0.01)
(12,347)
(0.14)
(a) Reflects the impairment of goodwill that arose from the acquisition of Sunrise in 2015.
(b) Reflects the write-down of certain frozen fruit inventory items in the fourth quarter of 2018, due to a change in expected use of aged stocks,
and reduced sales pricing and high production costs, which was recorded in cost of goods sold.
(c) Reflects costs related to the start-up of new roasting equipment for grains, seeds and legumes at our Crookston, Minnesota, facility, as well
as the start-up of a second processing line at our cocoa facility in the Netherlands, which were recorded in cost of goods sold.
(d) Reflects costs for development, production trials and start-up costs, incremental freight charges, and employee training related to the
commercialization of new consumer products, which were recorded in cost of goods sold ($2.3 million) and SG&A expenses ($0.4 million).
(e) Reflects the write-down of inventories of $0.1 million recorded in cost of goods sold; professional and consulting fees, and employee
recruitment and relocation costs of $0.6 million recorded in SG&A expenses; and asset impairment, facility closure and employee termination
costs of $1.7 million recorded in other expense, all related to the Value Creation Plan.
(f) Reflects a bad debt reserve for notes receivable associated with a previously sold business, which was recorded in other expense.
(g) Reflects product withdrawal and recall costs that were not eligible for reimbursement under insurance policies or exceeded the limits of those
policies, including costs related to the recall of certain sunflower kernel products initiated in 2016, which were recorded in other expense.
(h) Other included the accretion of contingent consideration obligations, gain/loss on the sale of assets, severance costs unrelated to the Value
Creation Plan, and settlement of a legal matter, which were recorded in other expense/income.
(i) Reflects a fair value adjustment to reduce the contingent consideration obligation related to a prior business acquisition, based on the results
for the business in fiscal 2018, which was recorded in other income.
(j) Reflects the recovery from a third-party supplier of $1.2 million of costs incurred relating to the withdrawal of certain consumer-packaged
products due to quality-related issues, which was recorded in cost of goods sold. Costs incurred related to this withdrawal were recognized
in cost of goods sold in 2016.
(k) Reflects the reversal to SG&A expenses of previously recognized stock-based compensation related to performance share units granted to
certain employees as the performance conditions were not achieved.
SUNOPTA INC.
50
December 28, 2019 10-K
(l) Reflects the tax effect of the preceding adjustments to earnings and reflects an overall estimated annual effective tax rate of approximately
27% for 2018 (2017 – 30%) on adjusted earnings before tax.
(m) Reflects inventory write-downs and facility closure costs of $3.2 million recorded in cost of goods sold; consulting fees, temporary labor,
employee recruitment, relocation and retention costs, and bad debt reserves of $22.9 million recorded in SG&A expenses; and asset
impairment charges and employee termination costs of $23.8 million recorded in other expense.
(n) Reflects costs related to the sunflower recall, including a $0.7 million adjustment for the estimated lost gross profit in the first quarter of 2017
caused by the sunflower recall, which reflected a shortfall in revenues against prior year volumes of approximately $3.3 million, less associated
cost of goods sold of approximately $2.6 million; and $0.4 million of product withdrawal costs not eligible for reimbursement under our
insurance policies, which were recorded in other expense.
(o) Reflects a recovery on the early extinguishment of a rebate obligation that arose from the prior settlement in 2016 of a flexible resealable
pouch product recall dispute with a customer, which was recorded in other income.
(p) Reflects the realization of previously unrecognized tax benefits, due to the expiration of the statute of limitations.
(q) Reflects the remeasurement of deferred tax balances to reflect new U.S. corporate tax rates enacted in December 2017.
(3) The following table presents a reconciliation of segment operating income/loss and adjusted EBITDA, which we consider to be the most directly
comparable U.S. GAAP financial measure (refer to footnote (2) to the “Consolidated Results of Operations for Fiscal Years 2019 and 2018” table
regarding the use of this non-GAAP measure). In addition, as described above in footnote (2), we have prepared this table in a columnar format to
present the effect of the disposals of the soy and corn business, and flexible resealable pouch and nutrition bar operations on our consolidated results for
the periods presented. We believe this presentation assists investors in assessing the results of the operations we have disposed of and the effect of those
operations on our financial performance.
For the years ended
December 29, 2018
Net earnings (loss)
Provision for (recovery of) income taxes
Interest expense (income), net
Other expense, net
Goodwill impairment
Total segment operating income
Depreciation and amortization
Stock-based compensation
Inventory write-downs(a)
Equipment start-up costs(b)
New product commercialization costs(c)
Costs related to Value Creation Plan(d)
Recovery of product withdrawal costs(e)
Adjusted EBITDA
December 30, 2017
Net loss
Recovery of income taxes
Interest expense, net
Other expense, net
Goodwill impairment
Total segment operating income (loss)
Depreciation and amortization
Stock-based compensation(f)
Costs related to Value Creation Plan(d)
Product withdrawal and recall costs(g)
Adjusted EBITDA
Excluding
disposed operations Disposed operations
$
$
Consolidated
$
(111,477)
(6,269)
34,503
2,056
81,222
35
31,941
7,939
3,101
2,913
2,729
713
(1,200)
48,171
(122,944)
(28,397)
32,524
8,665
115,000
4,848
31,039
6,395
23,144
729
66,155
2,334
891
(97)
769
-
3,897
847
-
-
-
-
-
-
4,744
(11,624)
(7,432)
(20)
14,995
-
(4,081)
1,785
-
2,939
-
643
(109,143)
(5,378)
34,406
2,825
81,222
3,932
32,788
7,939
3,101
2,913
2,729
713
(1,200)
52,915
(134,568)
(35,829)
32,504
23,660
115,000
767
32,824
6,395
26,083
729
66,798
(a) Reflects the write-down of certain frozen fruit inventory items in the fourth quarter of 2018, due to a change in expected use of aged stocks,
and reduced sales pricing and high production costs, which was recorded in cost of goods sold.
(b) Reflects costs related to the start-up of new roasting equipment for grains, seeds and legumes at our Crookston, Minnesota, facility, as well
as the start-up of a second processing line at our cocoa facility in the Netherlands, which were recorded in cost of goods sold.
(c) Reflects costs for development, production trials and start-up costs, incremental freight charges, and employee training related to the
commercialization of new consumer products, which were recorded in cost of goods sold ($2.3 million) and SG&A expenses ($0.4 million).
(d) For 2018, reflects the write-down of inventories of $0.1 million recorded in cost of goods sold; and professional and consulting fees, and
employee recruitment and relocation costs of $0.6 million recorded in SG&A expenses. For 2017, reflects inventory write-downs and facility
closure costs of $3.2 million recorded in cost of goods sold, and consulting fees, temporary labor, employee recruitment, relocation and
retention costs of $22.9 million recorded in SG&A expenses.
(e) Reflects the recovery from a third-party supplier of $1.2 million of costs incurred relating to the withdrawal of certain consumer-packaged
products due to quality-related issues, which was recorded in cost of goods sold. Costs incurred related to this withdrawal were recognized
in cost of goods sold in 2016.
(f) For 2017, stock-based compensation of $6.4 million was recorded in SG&A expenses, and the reversal of $0.7 million of previously
recognized stock-based compensation related to forfeited awards previously granted to terminated employees was recognized in other expense.
(g) Reflects the estimated lost gross profit of $0.7 million caused by the recall of certain sunflower kernel initiated in 2016, which reflected the
shortfall in revenues in the first quarter of 2017 against first quarter 2016 volumes of approximately $3.3 million, less associated cost of goods
sold of approximately $2.6 million.
SUNOPTA INC.
51
December 28, 2019 10-K
(4) Refer to footnote (4) to the “Consolidated Results of Operations for Fiscal Years 2019 and 2018” table regarding the use of certain other non-GAAP
measures in the discussion of our results of operations below.
Revenues for the year ended December 29, 2018 decreased by 1.5% to $1,260.9 million from $1,279.6 million for the year
ended December 30, 2017. Excluding the impact on revenues for the year ended December 29, 2018, of sales of flexible
resealable pouch and nutrition bar products (a decrease in revenues of $50.0 million), changes in commodity-related pricing (a
decrease in revenues of $23.0 million) and foreign exchange rates (an increase in revenues of $9.7 million), revenues increased
by 3.6% in 2018, compared with 2017. The increase in revenues on an adjusted basis reflected higher demand for organic
ingredients, and higher volumes of plant-based beverages and new broth offerings, as well as fruit snack products. These
increases were offset by the impact of lower pricing for frozen fruit and volumes of fruit ingredient products, and lower volumes
and pricing for domestically-sourced grains and seeds.
Gross profit decreased $21.6 million, or 14.9%, to $123.5 million for the year ended December 29, 2018, compared with $145.1
million for the year ended December 30, 2017. As a percentage of revenues, gross profit for the year ended December 29,
2018 was 9.8% compared to 11.3% for the year ended December 30, 2017, a decrease of 1.5%. The gross margin percentage
for 2018 would have been 10.8% excluding equipment start-up and product introduction costs ($5.3 million), a non-cash foreign
exchange loss on U.S. dollar-denominated raw material purchase contracts within our international organic ingredients
operations ($4.9 million), and inventory write-downs for certain frozen fruit inventory items ($3.1 million), partially offset by
the recovery of $1.2 million of previously-incurred product withdrawal costs from a third-party supplier. For 2017, the gross
profit percentage would have been 11.2%, excluding a non-cash foreign exchange gain on U.S. dollar-denominated raw
material purchase contracts ($5.2 million), partially offset by the write-down of flexible resealable pouch and nutrition bar
inventories ($2.6 million), lost margin caused by the recall of certain sunflower kernel products initiated in 2016 ($0.7 million),
and facility closure costs ($0.6 million). The decline in the gross profit percentage on an adjusted basis mainly reflected the
impact of lower sales pricing for frozen fruit within the Fruit-Based Foods and Beverages segment. Also contributing to the
decline in the gross profit percentage was higher costs for premium juice products within the Global Ingredient segment,
together with the loss of higher-margin milled corn volumes and reduced pricing spread on organic feed. These factors were
offset by the favorable impact of improved plant utilization for plant-based beverages and productivity-driven cost savings
within the Plant-Based Foods and Beverages segment, as well as operational savings following the discontinuance of flexible
resealable pouch and nutrition bar production.
Total segment operating income for the year ended December 29, 2018 increased by $3.1 million, or 412.6%, to $3.9 million,
compared with $0.8 million for the year ended December 30, 2017. The increase in segment operating income reflected a
$19.3 million decrease in SG&A expenses and a favorable year-over-year foreign exchange impact of $5.4 million (including
a $4.8 million favorable result related to forward currency contracts within our international organic ingredient operations,
which partially offset the foreign exchange movement within gross profit). The decrease in SG&A expenses mainly reflected
a reduction in consulting fees and temporary labor costs ($16.1 million), and employee recruitment, relocation and retention
costs ($5.8 million) associated with the Value Creation Plan, partially offset by higher employee-related compensation costs in
2018, compared with 2017.
Further details on revenue, gross profit and segment operating income/loss variances are provided below under “Segmented
Operations Information”.
Other expense for the year ended December 29, 2018 of $2.8 million mainly reflected a bad debt reserve for notes receivable
associated with a previously sold business ($2.2 million), facility closure costs and asset impairment charges related to the
closure of our nutrition bar facility and the sale of our former roasted snack facility ($1.3 million) and employee termination
costs ($0.4 million), all associated with the Value Creation Plan, as well as product withdrawal and recall costs ($1.5 million).
These expenses were partially offset by a $2.8 million reduction to the remaining contingent consideration obligation that arose
from a prior business acquisition. Other expense for the year ended December 30, 2017 of $23.7 million reflected the
impairment of long-lived assets related to the exits from our flexible resealable pouch and nutrition bar product lines and
operations, and consolidation of our roasted snack operations, as well as the closure of our juice processing facility ($18.2
million), and employee termination costs ($5.6 million) associated with the Value Creation Plan, partially offset by a $1.0
million recovery on the early extinguishment of a rebate obligation that arose from the prior settlement of a recall dispute with
a customer related to flexible resealable pouch products.
In 2018 and 2017, we recognized non-cash impairment charges of $81.2 million and $115.0 million, respectively, to fully write-
off the goodwill that arose from our acquisition of Sunrise in October 2015, which is included in our Fruit-Based Foods and
Beverages segment.
Interest expense increased by $1.9 million to $34.4 million for the year ended December 29, 2018, compared with $32.5 million
SUNOPTA INC.
52
December 28, 2019 10-K
for the year ended December 30, 2017. Interest expense included the amortization of debt issuance costs of $2.5 million and
$2.8 million in 2018 and 2017, respectively. The year-over-year increase in cash interest expense primarily reflected higher
borrowings under our line of credit facilities to fund increased working capital requirements and settle costs incurred under the
Value Creation Plan, together with an increase in weighted-average interest rates.
We recognized a recovery of income tax of $5.4 million for the year ended December 29, 2018, compared with a recovery of
income tax of $35.8 million for the year ended December 30, 2017 (which included a $8.4 million recovery related to the
remeasurement of deferred tax balances to reflect the corporate tax rates enacted in the U.S. in December 2017, and the
realization of $0.5 million of previously unrecognized tax benefits). Excluding the impact of goodwill impairment and other
non-deductible amounts from pre-tax losses, the effective tax rates for 2018 and 2017 would have been 27.5% and 48.6%,
respectively. The effective tax rate in 2018 reflected the impact of the reduction in the U.S. federal corporate tax rate from
35% to 21%, and the effective tax rate for 2017 reflected the effect of a mix of pre-tax losses in the U.S. (related to costs
associated with the Value Creation Plan) and pre-tax earnings in certain other jurisdictions.
On a consolidated basis, we realized a loss attributable to common shareholders of $117.1 million (diluted loss per share of
$1.34) for the year ended December 29, 2018, compared with a loss attributable to common shareholders of $143.1 million
(diluted loss per share of $1.66) for the year ended December 30, 2017.
For the year ended December 29, 2018, adjusted loss was $24.5 million, or $0.28 per diluted share, on a consolidated basis,
compared with an adjusted loss of $12.3 million, or $0.14 per diluted share, on a consolidated basis for the year ended December
30, 2017. Excluding disposed operations, adjusted loss was $27.3 million, or $0.31 per diluted share, for the year ended
December 29, 2018, compared with an adjusted loss of $11.6 million, or $0.13 per diluted share, for the year ended December
30, 2017. Adjusted EBITDA for the year ended December 29, 2018 was $52.9 million on a consolidated basis, compared with
$66.8 million on a consolidated basis for the year ended December 30, 2017. Excluding disposed operations, adjusted EBITDA
for the year ended December 29, 2018 was $48.2 million, compared with $66.2 million for the year ended December 30, 2017.
Adjusted earnings and adjusted EBITDA are non-GAAP financial measures. See footnotes (2) and (3) to the table above for a
reconciliation of adjusted earnings/loss and adjusted EBITDA from loss from continuing operations, which we consider to be
the most directly comparable U.S. GAAP financial measure.
SUNOPTA INC.
53
December 28, 2019 10-K
Segmented Operations Information
Global Ingredients
December 29, 2018 December 30, 2017
Change % Change
Revenues
Gross profit
Gross profit %
Operating income
Operating income %
$
$
581,307 $
61,249
10.5%
23,266 $
4.0%
556,166 $
70,918
12.8%
25,589 $
4.6%
25,141
(9,669)
(2,323)
4.5%
-13.6%
-2.3%
-9.1%
-0.6%
Global Ingredients contributed $581.3 million in revenues for the year ended December 29, 2018, compared to $556.2 million
for the year ended December 30, 2017, an increase of $25.1 million, or 4.5%. Excluding the impact on revenues of changes
including commodity-related pricing and foreign exchange rate movements (an increase in revenues of $0.4 million), Global
Ingredients revenues increased approximately 4.4%. The table below explains the increase in reported revenue:
Global Ingredients Revenue Changes
Revenues for the year ended December 30, 2017
Increased volumes of internationally-sourced organic ingredients including cocoa, oils,
fruits and vegetables, and coffee, partially offset by lower volumes of animal feed and
seeds, and premium juice products
Favorable foreign exchange impact on euro-denominated sales due to a weaker U.S.
dollar period-over-period
Increased commodity pricing for domestically-sourced corn, partially offset by lower
pricing for feed and soy
Decreased commodity pricing for internationally-sourced organic ingredients
Decreased domestically-sourced volumes of specialty soy (due to tighter supply in 2018
and exit from certain varieties in 2017) and milled corn, partially offset by higher
volumes of specialty corn and organic feed
Revenues for the year ended December 29, 2018
$556,166
36,506
9,730
3,904
(13,186)
(11,813)
$581,307
Gross profit in Global Ingredients decreased by $9.7 million to $61.2 million for the year ended December 29, 2018 compared
to $70.9 million for the year ended December 30, 2017, and the gross profit percentage decreased by 2.3% to 10.5%. The
decrease in gross profit percentage was primarily due to the unfavorable non-cash foreign exchange impact on U.S. dollar-
denominated raw material purchase contracts within our international organic ingredients operations. In addition, the decrease
in gross profit percentage reflected higher processing and supply chain costs for premium juice products, together with the loss
of higher margin milled corn volumes and reduced pricing spread on organic feed. These factors were partially offset by a
favorable cocoa hedging result within our international organic ingredients operations, as well as improved pricing spreads on
organic cocoa and certain other organic ingredients. The table below explains the decrease in gross profit:
SUNOPTA INC.
54
December 28, 2019 10-K
Global Ingredients Gross Profit Changes
Gross profit for the year ended December 30, 2017
Unfavorable foreign exchange impact in 2018 on U.S. dollar-denominated raw material
purchase contracts within our international organic ingredients operations, compared
with a favorable foreign exchange impact in 2017 (partially offset below in operating
income by a $4.8 million favorable reduction in losses on forward currency contracts)
Higher processing and supply chain costs for premium juice products
Lower volumes of higher margin milled corn, and reduced pricing spread for animal
feed
Higher volumes and pricing spreads for certain internationally-sourced organic
ingredients, including cocoa, fruits and vegetables, coffee and oils, partially offset by
seeds, animal feed and grains, as well as start-up costs of $0.2 million related to the
expansion of our cocoa facility in the Netherlands
Favorable cocoa commodity hedging result within our international organic ingredient
operations
Gross profit for the year ended December 29, 2018
$70,918
(10,030)
(2,997)
(2,148)
5,054
452
$61,249
Operating income in Global Ingredients decreased by $2.3 million, or 9.1%, to $23.3 million for the year ended December 29,
2018, compared to $25.6 million for the year ended December 30, 2017. The table below explains the decrease in operating
income:
Global Ingredients Operating Income Changes
Operating income for the year ended December 30, 2017
Decrease in gross profit, as explained above
Higher employee-related compensation costs and unfavorable foreign exchange impact
on euro-denominated SG&A expenses, partially offset by lower professional fees
Decrease in foreign exchange losses within our international organic ingredient
operations, which included a $4.8 million reduction in marked-to-market losses related
to forward currency contracts
Decrease in corporate cost allocations
Operating income for the year ended December 29, 2018
$25,589
(9,669)
(1,042)
5,561
2,827
$23,266
Plant-Based Foods and Beverages
December 29, 2018 December 30, 2017
Change % Change
Revenues
Gross profit
Gross profit %
Operating income (loss)
Operating income (loss) %
$
$
314,076 $
40,477
12.9%
10,766 $
3.4%
342,714 $
23,092
6.7%
(7,094) $
-2.1%
(28,638)
17,385
17,860
-8.4%
75.3%
6.2%
251.8%
5.5%
Plant-Based Foods and Beverages contributed $314.1 million in revenues for the year ended December 29, 2018, compared to
$342.7 million for the year ended December 30, 2017, a $28.6 million, or 8.4% decrease. Excluding the impact on revenues
of sales of flexible resealable pouch and nutrition bar products (a decrease in revenues of $50.0 million) and changes in
sunflower commodity-related pricing (a decrease in revenues of $2.9 million), Plant-Based Foods and Beverages revenues
increased approximately 8.4%. The table below explains the decrease in reported revenues:
SUNOPTA INC.
55
December 28, 2019 10-K
Plant-Based Foods and Beverages Revenue Changes
Revenues for the year ended December 30, 2017
Impact of the exit from flexible resealable pouch and nutrition bars product lines
Soft domestic sunflower market due to global competition, partially offset by higher
roasted snack volumes
Decreased commodity pricing for domestically-sourced sunflower
Higher volumes of plant-based beverages into the foodservice and retail channels, and
the introduction of new broth offerings
Revenues for the year ended December 29, 2018
$342,714
(50,039)
(3,231)
(2,855)
27,487
$314,076
Gross profit in Plant-Based Foods and Beverages increased by $17.4 million to $40.5 million for the year ended December 29,
2018 compared to $23.1 million for the year ended December 30, 2017, and the gross profit percentage increased by 6.2% to
12.9%. The increase in gross profit percentage was primarily due to the favorable impact of higher sales volumes of plant-
based beverages and broth offerings, together with improved plant utilization and productivity-driven cost savings. In addition,
the increase in gross profit percentage reflected operational savings following the discontinuance of flexible resealable pouch
and nutrition bar production in the fourth quarter of 2017. These factors were offset by costs related to the commercialization
of new beverage products and start-up costs related to new roasting equipment for grains, seeds and legumes at our Crookston,
Minnesota, facility, as well as reduced sunflower pricing and operating inefficiencies within our sunflower operations due to
lower production volumes. The table below explains the increase in gross profit:
Plant-Based Foods and Beverages Gross Profit Changes
Gross profit for the year ended December 30, 2017
Higher sales volumes, plant utilization and productivity improvements for plant-based
beverages and broth offerings, partially offset by new product commercialization costs
of $2.4 million
Operational savings following the discontinuance of flexible resealable pouch and
nutrition bar production in the fourth quarter of 2017
Start-up costs of $2.7 million and commercial delays related to new roasting equipment,
and lower volumes and pricing for sunflower inshell and kernel
Gross profit for the year ended December 29, 2018
$23,092
12,879
8,228
(3,722)
$40,477
Operating income in Plant-Based Foods and Beverages increased by $17.9 million to $10.8 million for the year ended
December 29, 2018, compared to an operating loss of $7.1 million for the year ended December 30, 2017. The table below
explains the increase in operating income:
Plant-Based Foods and Beverages Operating Income Changes
Operating loss for the year ended December 30, 2017
Increase in gross profit, as explained above
Decrease in corporate cost allocations
Higher employee-related compensation costs and marketing expenses, partially offset
by lower consulting costs
Operating income for the year ended December 29, 2018
$(7,094)
17,385
4,661
(4,186)
$10,766
SUNOPTA INC.
56
December 28, 2019 10-K
Fruit-Based Foods and Beverages
December 29, 2018 December 30, 2017
Change % Change
Revenues
Gross profit
Gross profit %
Operating income (loss)
Operating income (loss) %
$
$
365,469 $
21,744
5.9%
(16,029) $
-4.4%
380,713 $
51,077
13.4%
13,570 $
3.6%
(15,244)
(29,333)
(29,599)
-4.0%
-57.4%
-7.5%
-218.1%
-8.0%
Fruit-Based Foods and Beverages contributed $365.5 million in revenues for the year ended December 29, 2018, compared to
$380.7 million for the year ended December 30, 2017, a $15.2 million, or 4.0% decrease. Excluding the impact on revenues
of changes in raw fruit commodity-related pricing (a decrease in revenues of $10.8 million), Fruit-Based Foods and Beverages
revenues decreased approximately 1.2%. The table below explains the decrease in reported revenues:
Fruit-Based Foods and Beverages Revenue Changes
Revenues for the year ended December 30, 2017
Lower pricing (related to strategic pricing reductions to gain distribution) more than
offsetting higher volumes of frozen fruit, and lower volumes of fruit ingredients due to
declines in consumer preferences for certain yogurt items
Decreased commodity pricing for raw fruit
Higher volumes of fruit snack products
Revenues for the year ended December 29, 2018
$380,713
(12,289)
(10,836)
7,881
$365,469
Gross profit in Fruit-Based Foods and Beverages decreased by $29.3 million to $21.7 million for the year ended December 29,
2018 compared to $51.1 million for the year ended December 30, 2017, and the gross profit percentage decreased by 7.5% to
5.9%. For the year ended December 29, 2018, the gross profit percentage primarily reflected lower sales pricing, unfavorable
product mix and inventory write-downs for certain frozen fruit items, and lower sales and unfavorable plant utilization for fruit
ingredients, partially offset by the favorable impact of increased sales volumes of higher-margin fruit snack products, together
with improved plant utilization and productivity-driven cost savings. The table below explains the decrease in gross profit:
Fruit-Based Foods and Beverages Gross Profit Changes
Gross profit for the year ended December 30, 2017
$51,077
Lower sales pricing, unfavorable product mix, and inventory write-downs of $3.1
million in the fourth quarter of 2018 for certain frozen fruit items, and lower volumes
and unfavorable plant utilization for fruit ingredients, partially offset by productivity-
driven cost savings and the recovery of previously-incurred product withdrawal costs of
$1.2 million
Higher sales volumes, plant utilization and productivity improvements within our fruit
snack operations
Gross profit for the year ended December 29, 2018
(33,212)
3,879
$21,744
Operating income in Fruit-Based Foods and Beverages decreased by $29.6 million to an operating loss of $16.0 million for the
year ended December 29, 2018, compared to operating income of $13.6 million for the year ended December 30, 2017. The
table below explains the decrease in operating income:
SUNOPTA INC.
57
December 28, 2019 10-K
Fruit-Based Foods and Beverages Operating Income Changes
Operating income for the year ended December 30, 2017
Decrease in gross profit, as explained above
Higher employee-related compensation costs and unfavorable foreign exchange on
international operations
Decrease in corporate cost allocations
Operating loss for the year ended December 29, 2018
$13,570
(29,333)
(687)
421
$(16,029)
Corporate Services
December 29, 2018 December 30, 2017
Change % Change
Operating loss
$
(14,071) $
(31,298) $
17,227
55.0%
Operating loss at Corporate Services decreased by $17.2 million to $14.1 million for the year ended December 29, 2018, from
a loss of $31.3 million for the year ended December 30, 2017. The table below explains the decrease in operating loss:
Corporate Services Operating Loss Changes
Operating loss for the year ended December 30, 2017
Lower non-structural third-party consulting costs and employee recruitment, relocation
and retention costs associated with the Value Creation Plan
Lower employee-related compensation costs, professional fees and travel expenses, as
well as favorable foreign exchange impacts on foreign currency transactions and
Canadian dollar-denominated SG&A expenses, partially offset by increased product
development costs and depreciation expense
Decrease in corporate cost allocations to SunOpta operating segments
Increased stock-based compensation costs as a result of a change in our long-term
incentive plan in the second quarter of 2017
Operating loss for the year ended December 29, 2018
$(31,298)
21,897
4,781
(7,909)
(1,542)
$(14,071)
Corporate cost allocations mainly consist of salaries of corporate personnel who directly support the operating segments, as
well as costs related to the enterprise resource management system. These expenses are allocated to the operating segments
based on (1) specific identification of allocable costs that represent a service provided to each segment and (2) a proportionate
distribution of costs based on a weighting of factors such as revenue contribution and number of people employed within each
segment.
Liquidity and Capital Resources
We have the following sources from which we can fund our operating cash requirements:
(cid:120) Existing cash and cash equivalents;
(cid:120) Available operating lines of credit;
(cid:120) Cash flows generated from operating activities, including working capital efficiency efforts;
(cid:120) Cash flows generated from the exercise, if any, of stock options during the year;
(cid:120) Potential additional long-term financing, including the offer and sale of debt and/or equity securities; and
(cid:120) Potential sales of businesses or assets.
SUNOPTA INC.
58
December 28, 2019 10-K
On February 11, 2016, we entered a five-year credit agreement for a senior secured asset-based revolving credit facility in the
maximum aggregate principal amount of $350 million, subject to borrowing base capacity (the “Global Credit Facility”). On
January 28, 2020, we entered into a restatement agreement, amending and restating the existing credit agreement to, among
other things, extend the maturity date of the Global Credit Facility to March 31, 2022. The Global Credit Facility supports the
working capital and general corporate needs of our global operations, in addition to funding strategic initiatives. Subject to
customary borrowing conditions and the agreement of any such lenders to provide such increased commitments, we may
request to increase the total lending commitments under this facility to a maximum aggregate principal amount not to exceed
$450 million. The applicable margin in the Global Credit Facility ranges from 0.25% to 0.75% with respect to base rate and
prime rate borrowings and from 1.25% to 1.75% for eurocurrency rate and bankers’ acceptance rate borrowings. In addition,
under the restatement agreement, the margin is increased by an additional 0.50% while our total leverage ratio exceeds a
specific threshold. Based on outstanding borrowings under the Global Credit Facility (as described below), the 50 basis-point
increase in the margin rate will increase interest expense and reduce cash flows by approximately $1.2 million on an annualized
basis.
On September 19, 2017 and October 22, 2018, the Global Credit Facility was amended to add an additional $20 million U.S.
asset-based credit subfacility (the “U.S. Subfacility”), which was fully drawn as of October 22, 2018. Commencing on March
31, 2019, quarterly amortization payments on the aggregate principal amount of the U.S. Subfacility are equal to $3.33 million,
and these payments may be funded through borrowings under the revolving facilities of the Global Credit Facility. Borrowings
repaid under the U.S. Subfacility may not be borrowed again. As at December 28, 2019, $10.0 million remained drawn on the
U.S. Subfacility. The applicable margin for the U.S. Subfacility is set quarterly based on average borrowing availability for
the preceding fiscal quarter ranges from 2.00% to 2.50% with respect to base rate and prime rate borrowings and from 3.00%
to 3.50% for eurocurrency rate and bankers’ acceptance rate borrowings.
As at December 28, 2019, we had outstanding borrowings of $241.7 million (December 29, 2018 – $276.8 million) and
available borrowing capacity of approximately $43 million (December 29, 2018 – $55 million) under the Global Credit Facility.
For more information on the Global Credit Facility, see note 14(1) to the consolidated financial statements at Item 15 of this
Form 10-K.
As at December 28, 2019, we had borrowings of $3.9 million (€3.5 million) outstanding under a $6.7 million (€6.0 million)
revolving credit facility used to fund the activities of our Bulgarian sunflower processing operations. This annual facility
matures on April 30, 2020, and our intention is to renew the facility for another year at that time. For more information on the
Bulgarian credit facility, see note 14(2) to the consolidated financial statements at Item 15 of this Form 10-K.
On October 20, 2016, SunOpta Foods issued $231.0 million of 9.5% Senior Secured Second Lien Notes due October 9, 2022
(the “Notes”). As at December 28, 2019, the outstanding principal amount of the Notes was $223.5 million, reflecting the
redemption of $7.5 million principal amount of the Notes by SunOpta Foods in October 2017. For more information on the
Notes, see note 14(3) to the consolidated financial statements at Item 15 of this Form 10-K.
On October 7, 2016, SunOpta Foods issued 85,000 shares of Series A Preferred Stock (the “Preferred Stock”) for $85.0 million.
The Preferred Stock has a stated value and initial liquidation preference of $1,000 per share. Cumulative preferred dividends
accrue daily on the Preferred Stock at an annualized rate of 8.0% of the liquidation preference prior to October 5, 2025, which
presently equates to quarterly dividend payments of $1.7 million, and 12.5% of the liquidation preference thereafter (subject
to an increase of 1.0% per quarter, up to a maximum rate of 5.0% per quarter on the occurrence of certain events of non-
compliance). Prior to October 5, 2025, SunOpta Foods may pay dividends in cash or elect, in lieu of paying cash, to add the
amount that would have been paid to the liquidation preference. After October 4, 2025, any failure to pay dividends in cash
will be an event of non-compliance. For more information on the Notes, see note 15 to the consolidated financial statements
at Item 15 of this Form 10-K.
In order to finance significant acquisitions, if any, that may arise in the future, we may need additional sources of cash that we
could attempt to obtain through a combination of additional bank or subordinated financing, a private or public offering of debt
or equity securities, or the issuance of common stock as consideration in an acquisition. There can be no assurance that these
types of financing would be available at all or, if so, on terms that are acceptable to us.
In the event that we require additional liquidity due to market conditions, unexpected actions by our lenders, changes to our
growth strategy, reduced earnings, or other factors, our ability to obtain any additional financing on favorable terms, if at all,
could be limited. In order to reduce our indebtedness and improve our position to obtain additional financing, we may explore
the sale of selected businesses or assets from time to time.
SUNOPTA INC.
59
December 28, 2019 10-K
Cash Flows
Fiscal 2019 Compared to Fiscal 2018
Net cash and cash equivalents decreased $1.8 million to $1.5 million as at December 28, 2019, compared with $3.3 million at
December 29, 2018.
Cash provided by operating activities was $9.8 million for the year ended December 28, 2019, compared with cash used of
$11.1 million for the year ended December 29, 2018, an increase in cash provided of $20.9 million. The increase in cash
provided reflected reduced working capital levels, including lower inventories of organic ingredients, which generated $29.3
million of cash year-over-year, partially offset by a year-over-year increase in net cash payments of $6.5 million for costs
incurred under the Value Creation Plan.
Excluding net proceeds from the sale of the soy and corn business of $63.3 million, cash used in investing activities was $36.1
million for the year ended December 28, 2019, compared with cash used of $28.8 million for the year ended December 29,
2018, an increase in cash used of $7.3 million. The increase in cash used reflected cash paid of $3.3 million to acquire Sanmark
in 2019 and proceeds received of $2.7 million from the sale of businesses and assets in 2018. Capital expenditures were $32.8
million in 2019, compared with $31.6 million in 2018, mainly related to the expansion of our plant-based beverage capacity,
the addition of new automation at our frozen fruit and cocoa processing facilities, and completion of our new organic avocado
oil facility.
Cash used in financing activities was $38.8 million for the year ended December 28, 2019, compared with cash provided of
$40.0 million for the year ended December 29, 2018, an increase in cash used of $78.8 million. Net borrowings under our line
of credit facilities decreased $32.8 million in 2019, compared with an increase of $50.3 million in 2018. This decrease in
borrowings reflected the initial application of the net proceeds from the sale of the soy and corn business to repay borrowings
under our line of credit facilities, together with the reduction in working capital.
Fiscal 2018 Compared to Fiscal 2017
Net cash and cash equivalents increased $0.0 million to $3.3 million as at December 29, 2018, compared with $3.2 million at
December 30, 2017.
Cash used in operating activities was $11.1 million for the year ended December 29, 2018, compared with cash provided of
$31.5 million for the year ended December 30, 2017, an increase in cash used of $42.6 million. The increase in cash used
reflected lower year-over-year operating results and higher inventory purchases in 2018 to support the commercialization of
new consumer product offerings, the expansion of our cocoa processing operations, and volume growth across other categories
of organic ingredients. In addition, cash generated in 2017 reflected the immediate benefit from working capital-efficiency
efforts as part of the Value Creation Plan to reduce inventories, maximize purchasing terms and accelerate accounts receivable
collections. All of these factors were partially offset by a year-over-year reduction in net cash payments under the Value
Creation Plan of $34.7 million.
Cash used in investing activities was $28.8 million for the year ended December 29, 2018, compared with cash used of $40.1
million for the year ended December 30, 2017, a decrease in cash used of $11.3 million. The decrease in cash used mainly
reflected a decrease in capital expenditures related to the early buyout of $11.9 million of equipment leases in 2017 associated
with the closure of our juice processing facility and exit from flexible resealable pouch operations.
Cash provided by financing activities was $40.0 million for the year ended December 29, 2018, compared with cash provided
of $10.6 million for the year ended December 30, 2017, an increase in cash provided of $29.4 million. Net borrowings under
our line of credit facilities increased $50.3 million in 2018, compared with an increase of $22.2 million in 2017, a year-over-
year increase in net borrowings of $28.1 million. This increase in borrowings reflected an increase in working capital
requirements ($39.0 million), partially offset by a decrease in capital spending of $9.5 million and repayments of long-term
debt of $8.1 million (mainly related to a $7.5 million principal repayment on the Notes in 2017).
Off – Balance Sheet Arrangements
There are currently no off-balance sheet arrangements that have or are reasonably likely to have a current or future material
effect on our financial condition, results of operations, liquidity, capital expenditures or capital resources.
SUNOPTA INC.
60
December 28, 2019 10-K
Contractual Obligations
The table below sets out our contractual obligations as at December 28, 2019:
Bank indebtedness(1)
Long-term debt
Interest on bank indebtedness and long-term debt(2)
Purchase commitments
Operating leases
Long-term liabilities
Commodity and foreign exchange contracts
Total
$
245,536
253,270
71,017
221,256
106,012
6,297
(211)
2020
$
245,536
3,796
30,290
221,256
17,695
6,297
(211)
903,177
524,659
Payments due by Period
2023-2024
2021-2022
$
$
Thereafter
$
-
237,276
39,741
-
28,476
-
-
305,493
-
6,280
728
-
15,964
-
-
22,972
-
5,918
258
-
43,877
-
-
50,053
(1)
Includes borrowings of $235.5 million under the revolving facilities of the Global Credit Facility that have terms of six months or less. Outstanding
borrowings under these revolving facilities are repayable in full on March 31, 2022. Also includes borrowings of $10.0 million under the U.S.
Subfacility that are repayable in quarterly instalments of $3.3 million on December 31, 2019, March 31, 2020 and June 30, 2020.
(2)
Interest on bank indebtedness is calculated based on scheduled repayments over the periods as indicated, using existing interest rates at December
28, 2019, as disclosed in note 14 to the consolidated financial statements included in Item 15 of this Form 10-K.
Item 7A. Quantitative and Qualitative Disclosures About Market Risk
Interest rate risk
Variable and fixed rate borrowings carry different types of interest rate risk. Variable rate debt gives less predictability to
earnings and cash flows as interest rates change, while the fair value of fixed rate debt is affected by changes in interest rates.
As at December 28, 2019, we had $245.5 million of variable rate debt, mainly comprised of the Global Credit Facility, and
$245.2 million principal amount of fixed rate debt, mainly comprised of the Notes. A 100 basis-point change in interest rates
would have a pre-tax effect of approximately $2.5 million on our earnings and cash flows, based on current outstanding
borrowings of variable rate debt, and the fair value of the fixed-rate Notes would increase or decrease by approximately $6.0
million.
Foreign currency risk
All of our U.S. subsidiaries use the U.S. dollar as their functional currency, and the U.S. dollar is also our reporting currency.
In addition, the functional currency of our Canadian and Mexican operations is the U.S. dollar. The functional currency of our
operations located in Europe are principally the euro. For these operations, gains or losses on translation of net assets to U.S.
dollars on consolidation are recorded in accumulated other comprehensive loss within shareholders’ equity. We are exposed
to foreign exchange rate fluctuations as the financial results of our European subsidiaries are translated into U.S. dollars on
consolidation. A 10% change in the exchange rates for the euro, relative to the U.S. dollar, would affect the carrying value of
our net assets by approximately $7.4 million, with a corresponding impact to accumulated other comprehensive loss.
Our operations based in the U.S. have limited exposure to other currencies since almost all sales and purchases are made in
U.S. dollars. The European operations are exposed to various currencies as they purchase product from a wide variety of
countries in several currencies and primarily sell into the European market. It is our intention to hold excess funds in the
currency in which the funds are likely to be used, which will from time to time potentially expose us to exchange rate
fluctuations when converted into U.S. dollars. In addition, we enter into forward foreign exchange contracts to reduce exposure
to fluctuations in foreign currency exchange rates. These contracts mature within one year. As at December 28, 2019, we had
open forward foreign exchange contracts with a total notional amount of approximately $19 million, which were marked-to-
market resulting in an unrealized loss of $0.1 million. Assuming an unfavorable 10% change in year-end exchange rates, the
unrealized loss would increase by approximately $1.7 million.
SUNOPTA INC.
61
December 28, 2019 10-K
Commodity risk
We enter into commodity futures contracts to hedge our organic cocoa and coffee positions in an effort to minimize price
fluctuations. As at December 28, 2019, we had net open contracts to sell 3,210 metric tons (“MT”) of cocoa and 306 MT of
coffee, which were marked-to-market resulting in an unrealized gain of $0.3 million. Assuming a 10% increase in the
commodity prices for cocoa and coffee, the unrealized gain would decrease by approximately $0.9 million.
Item 8. Financial Statements and Supplementary Data
The consolidated financial statements required by this item are set forth immediately following the signature page to this Form
10-K beginning on page F1 and are incorporated herein by reference.
Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure
None.
SUNOPTA INC.
62
December 28, 2019 10-K
Item 9A - Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Our management has established disclosure controls and procedures designed to ensure that information required to be
disclosed by the Company in the reports that it files or submits under the Securities Exchange Act of 1934, as amended (the
“Exchange Act”) is recorded, processed, summarized and reported within time periods specified in the Securities and Exchange
Commission’s rules and forms. Such disclosure controls and procedures include, without limitation, controls and procedures
designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the
Exchange Act is accumulated and communicated to its management to allow timely decisions regarding required disclosure.
Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial
Officer, we conducted an evaluation of our disclosure controls and procedures (as such term is defined under Rule 13a-15(e)
promulgated under the Exchange Act) as of the end of the period covered by this annual report. Based on this evaluation, our
Chief Executive Officer and our Chief Financial Officer concluded that our disclosure controls and procedures were effective
as of December 28, 2019.
Management’s Annual Report on Internal Control Over Financial Reporting
Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined
in Rule 13a-15(f) under the Exchange Act.
Our internal control framework and processes are designed to provide reasonable assurance to management and our Board of
Directors regarding the reliability of financial reporting and the preparation of our consolidated financial statements for external
purposes in accordance with accounting principles generally accepted in the United States of America.
All internal control systems, no matter how well designed, have inherent limitations. Because of these inherent limitations,
internal control over financial reporting may not prevent or detect misstatements. Therefore, even those systems determined to
be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. Projections
of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of
changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Management assessed the effectiveness of our internal control over financial reporting as of December 28, 2019. In making
this assessment, management used the criteria set forth by the Committee on Sponsoring Organizations of the Treadway
Commission in Internal Control—Integrated Framework (2013).
Based on its assessment, our management concluded that our internal control over financial reporting was effective as of
December 28, 2019, based on those criteria.
The effectiveness of our internal control over financial reporting as of December 28, 2019 has been audited by Ernst & Young
LLP, Independent Registered Public Accounting Firm, that also audited our consolidated financial statements for the year
ended December 28, 2019, as stated in their reports which appear herein.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting during the quarter ended December 28, 2019 that
materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
SUNOPTA INC.
63
December 28, 2019 10-K
Report of Independent Registered Public Accounting Firm
To the Shareholders and the Board of Directors of SunOpta Inc.
Opinion on Internal Control over Financial Reporting
We have audited SunOpta Inc.’s internal control over financial reporting as of December 28, 2019, based on criteria established
in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway
Commission (2013 framework) (the COSO criteria). In our opinion, SunOpta Inc. (the Company) maintained, in all material
respects, effective internal control over financial reporting as of December 28, 2019, based on the COSO criteria.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States)
(PCAOB), the 2019 consolidated financial statements of the Company and our report dated February 27, 2020 expressed an
unqualified opinion thereon.
Basis for Opinion
The Company’s management is responsible for maintaining effective internal control over financial reporting and for its
assessment of the effectiveness of internal control over financial reporting included in the accompanying Management’s Annual
Report on Internal Controls Over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal
control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required
to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and
regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the
audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all
material respects.
Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material
weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk,
and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a
reasonable basis for our opinion.
Definition and Limitations of Internal Control Over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally
accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures
that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and
dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit
preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and
expenditures of the company are being made only in accordance with authorizations of management and directors of the
company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or
disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also,
projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate
because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
/s/ Ernst & Young LLP
Chartered Professional Accountants
Licensed Public Accountants
Toronto, Canada
February 27, 2020
Item 9B. Other Information
None.
SUNOPTA INC.
64
December 28, 2019 10-K
Item 10. Directors, Executive Officers and Corporate Governance
PART III
The information required under this item is incorporated herein by reference to our Definitive Proxy Statement for the Annual
Meeting of Shareholders to be filed with the Securities and Exchange Commission not later than 120 days after December 28,
2019 (the “2020 Proxy Statement”).
Item 11. Executive Compensation
The information required under this item is incorporated herein by reference from the 2020 Proxy Statement.
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
The information required under this item is incorporated herein by reference from the 2020 Proxy Statement.
Item 13. Certain Relationships and Related Transactions, and Director Independence
The information required under this item is incorporated herein by reference from the 2020 Proxy Statement.
Item 14. Principal Accounting Fees and Services
The information required under this item is incorporated herein by reference from the 2020 Proxy Statement.
Item 15. Exhibits and Financial Statement Schedules
The following documents are being filed as part of this annual report.
PART IV
1. Financial Statements. See “Index to Consolidated Financial Statements” set forth on page F1.
2. Financial Statement Schedules. All schedules for which provision is made in the applicable accounting requirements of
the Securities and Exchange Commission are not required or the required information has been included within the
financial statements or the notes thereto.
3. Exhibits. The list of exhibits in the Exhibit Index included in this annual report is incorporated herein by reference.
Exhibits
Description
EXHIBIT INDEX
2.1
3.1
3.2
Asset Purchase Agreement, dated as of February 22, 2019, by and between Pipeline Foods, LLC and
SunOpta Grains and Foods Inc. (incorporated by reference to Exhibit 2.1 to the Company’s Current Report
on Form 8-K filed on February 26, 2019).
Amalgamation of Stake Technology Ltd. and 3754481 Canada Ltd. (formerly George F. Pettinos (Canada)
Limited) (incorporated by reference to Exhibit 3.1 to the Company’s Annual Report on Form 10-KSB for
the year ended December 31, 2000).
Certificate of Amendment, dated October 31, 2003, to change the Company’s name from Stake
Technology Ltd. to SunOpta Inc. (incorporated by reference to Exhibit 3i(b) to the Company’s Annual
Report on Form 10-K for the year ended December 31, 2003).
SUNOPTA INC.
65
December 28, 2019 10-K
Exhibits
Description
3.3
3.4
3.5
3.6
3.7
3.8
3.9
Articles of Amalgamation of SunOpta Inc. and Sunrich Valley Inc., Integrated Drying Systems Inc., Kettle
Valley Dried Fruits Ltd., Pro Organics Marketing Inc., Pro Organics Marketing (East) Inc., 4157648
Canada Inc. and 4198000 Canada Ltd., dated January 1, 2004 (incorporated by reference to Exhibit 3i(c)
to the Company’s Annual Report on Form 10-K for the year ended December 31, 2003).
Articles of Amalgamation of SunOpta Inc. and 6319734 Canada Inc., 4157656 Canada Inc. and Kofman-
Barenholtz Foods Limited, dated January 1, 2005 (incorporated by reference to Exhibit 3i(d) to the
Company’s Annual Report on Form 10-K for the year ended December 31, 2004).
Articles of Amalgamation of SunOpta Inc. and 4307623 Canada Inc., dated January 1, 2006 (incorporated
by reference to Exhibit 3i(e) to the Company’s Annual Report on Form 10-K for the year ended December
31, 2005).
Articles of Amalgamation of SunOpta Inc., 4208862 SunOpta Food Ingredients Canada Ltd., 4406150
Canada Inc. and 4406168 Canada Inc., dated January 1, 2007 (incorporated by reference to Exhibit 3i(f)
to the Company’s Annual Report on Form 10-K for the year ended December 31, 2007).
Articles of Amalgamation of SunOpta Inc. and 4460596 Canada Inc., dated January 1, 2008 (incorporated
by reference to Exhibit 3i(g) to the Company’s Annual Report on Form 10-K for the year ended December
31, 2007).
Amended and Restated By-law No. 14, dated May 27, 2010 (incorporated by reference to Exhibit 4.4 to
the Company’s Registration Statement on Form S-3 filed on July 3, 2014).
Certificate of Amendment, dated July 10, 2013, to authorize the directors to fix the number of directors to
be elected by the shareholders and to appoint one or more directors (incorporated by reference to Exhibit
4.3 to the Company’s Registration Statement on Form S-3 filed on July 3, 2014).
3.10
By-Law Number 15 of SunOpta Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Current
Report on Form 8-K filed on November 13, 2015).
4.1
4.2
4.3
4.4
4.5
4.6
Form of Certificate representing Common Shares, no par value (incorporated by reference to Exhibit 4.9
to the Company’s Registration Statement on Form S-8 filed on September 2, 2011).
Shareholder Rights Plan Agreement, dated November 10, 2015, between SunOpta Inc. and American
Stock Transfer & Trust Company, LLC, as rights agent (incorporated by reference to Exhibit 4.1 to the
Company’s Current Report on Form 8-K filed on November 13, 2015).
Amended and Restated Shareholder Rights Plan Agreement, dated November 10, 2015, amended and
restated as of April 18, 2016, between SunOpta Inc. and American Stock Transfer & Trust Company,
LLC, as rights agent (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form
8-K filed on April 20, 2016).
Amended and Restated Certificate of Incorporation of SunOpta Foods Inc., setting forth the terms of its
Series A Preferred Stock, which is exchangeable for Common Shares of SunOpta Inc. (incorporated by
reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on October 12, 2016).
Articles of Amendment of SunOpta Inc., setting forth the terms of its Special Shares, Series 1
(incorporated by reference to Exhibit 4.2 to the Company’s Current Report on Form 8-K filed on October
12, 2016).
Indenture, dated as of October 20, 2016, among SunOpta Foods, the guarantors named therein and U.S.
Bank National Association, as trustee and notes collateral agent (incorporated by reference to Exhibit 4.1
to the Company’s Current Report on Form 8-K filed on October 26, 2016).
SUNOPTA INC.
66
December 28, 2019 10-K
Exhibits
Description
4.7
4.8
4.9
4.10
4.11*
10.1†
10.2†
10.3†
10.4†
10.5
10.6†
10.7†
10.8†
10.9†
Form of 9.5% Senior Secured Second Lien Notes due 2022 (incorporated by reference to Exhibit 4.2 to
the Company’s Current Report on Form 8-K filed on October 26, 2016).
Second Lien U.S. Security Agreement, dated as of October 20, 2016, among the grantors referred therein
and U.S. Bank National Association, as notes collateral agent (incorporated by reference to Exhibit 4.3 to
the Company’s Current Report on Form 8-K filed on October 26, 2016).
Second Lien Canadian Security Agreement, dated as of October 20, 2016, among the grantors referred
therein and U.S. Bank National Association, as notes collateral agent (incorporated by reference to Exhibit
4.4 to the Company’s Current Report on Form 8-K filed on October 26, 2016).
Amended and Restated Intercreditor Agreement, dated as of October 20, 2016, among Bank of America,
N.A. as first lien collateral agent, the Notes Collateral Agent and the grantors referred therein
(incorporated by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on October
26, 2016).
Description of Registrant’s Securities Registered Under Section 12 of the Securities Exchange Act of
1934.
Employee Stock Purchase Plan amended March 4, 2013 (incorporated by reference to Exhibit 10.1 to the
Company’s Annual Report on Form 10-K for the year ended December 29, 2012).
Retiring Allowance Agreement, dated March 8, 2011, between the Company and Jeremy Kendall which
terminates and supersedes the Employment Agreement dated October 1, 2001 between the Company and
Mr. Jeremy Kendall, as amended (incorporated by reference to Exhibit 10.3 to the Company’s Annual
Report on Form 10-K for the year ended December 31, 2010).
SunOpta Inc. 2002 Stock Option Plan, Amended and Restated May 2011 (incorporated by reference to
Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on May 24, 2011).
Letter Agreement, dated October 10, 2011, by and between SunOpta Inc. and Robert McKeracher
(incorporated by reference to Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q for the
quarter ended October 1, 2011).
Stock Deferral Plan for Non-Employee Directors dated August 12, 2014 (incorporated by reference to
Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q for the quarter ended July 5, 2014).
Letter Agreement re Terms of Employment, dated October 10, 2011, by and between SunOpta Inc. and
John Ruelle (incorporated by reference to Exhibit 10.13 to the Company’s Annual Report on Form 10-K
for the year ended January 3, 2015).
Letter Agreement re Amendment of Terms of Employment, dated April 5, 2013, by and between SunOpta
Inc. and John Ruelle (incorporated by reference to Exhibit 10.14 to the Company’s Annual Report on
Form 10-K for the year ended January 3, 2015).
Letter Agreement re Amendment of Terms of Employment, dated December 30, 2014, by and between
SunOpta Inc. and John Ruelle (incorporated by reference to Exhibit 10.15 to the Company’s Annual
Report on Form 10-K for the year ended January 3, 2015).
Employment Agreement, dated April 2012, by and between The Organic Corporation B.V. and G.J.M.
Versteegh (incorporated by reference to Exhibit 10.16 to the Company’s Annual Report on Form 10-K
for the year ended January 3, 2015).
10.10†
Separation Agreement, dated July 6, 2015, between SunOpta Inc. and Steven Bromley (incorporated by
reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on July 7, 2015).
SUNOPTA INC.
67
December 28, 2019 10-K
Exhibits
Description
10.11
10.12+
10.13+
10.14
10.15
10.16†
10.17†
10.18†
10.19†
10.20†
10.21†
10.22†
Commitment Letter, dated July 30, 2015, among SunOpta Inc., SunOpta Foods Inc., Bank of Montreal
and BMO Capital Markets Corp. (incorporated by reference to Exhibit 10.1 to the Company’s Current
Report on Form 8-K filed on August 3, 2015).
Second Lien Loan Agreement, dated October 9, 2015, among SunOpta Inc., as Holdings, SunOpta Foods
Inc., as the Borrower, Certain Subsidiaries of SunOpta Inc., as Subsidiary Guarantors and Loan Parties,
the Several Lenders from Time to Time Parties Hereto, Bank of Montreal, as Administrative Agent and
Collateral Agent, BMO Capital Markets Corp. and Co(cid:2362)peratieve Centrale Raiffeisen-Boerenleenbank
B.A., “Rabobank Nederland”, New York Branch, as Joint Lead Arrangers and Joint Bookrunners
(incorporated by reference to Exhibit 10.5 to the Company’s Quarterly Report on Form 10-Q for the
quarter ended October 3, 2015).
Credit Agreement, dated as of February 11, 2016, among SunOpta Inc., SunOpta Foods Inc., The Organic
Corporation B.V., the other borrowers and guarantors party thereto, the lenders party thereto, Bank of
America, N.A., as U.S. Administrative Agent, Bank of America, N.A. (acting through its Canada Branch),
as Canadian Administrative Agent, Bank of America, N.A. (acting through its London Branch), as Dutch
Administrative Agent, and Bank of America, N.A., as Collateral Agent (incorporated by reference to
Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on February 17, 2016).
Support Agreement dated February 11, 2016, among SunOpta Inc., Wedge Acquisition Inc. and Wedge
Acquisition Holdings Inc. (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on
Form 8-K filed on February 18, 2016).
Second Amending Agreement, dated October 9, 2015, amending the Seventh Amended and Restated
Credit Agreement, among SunOpta Inc. and SunOpta Foods, as Borrowers, Each of the Financial
Institutions and Other Entities from Time to Time Parties Thereto, as Lenders, Certain Affiliates of the
Borrowers, as Obligors, and Bank of Montreal, as Agent (incorporated by reference to Exhibit 10.19 to
the Company’s Annual Report on Form 10-K for the year ended January 2, 2016).
Amended 2013 Stock Incentive Plan (incorporated by reference to Exhibit C to the Company’s Definitive
Proxy Statement on Schedule 14A filed on March 31, 2016).
Form of Incentive Stock Option Award Agreement under Amended 2013 Stock Incentive Plan
(incorporated by reference to Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q for the
quarter ended July 2, 2016).
Form of Restricted Stock Unit Award Agreement (Non-Employee Directors) under Amended 2013 Stock
Incentive Plan (incorporated by reference to Exhibit 10.3 to the Company’s Quarterly Report on Form 10-
Q for the quarter ended July 2, 2016).
Form of 2016 Performance Share Unit Award Agreement under 2013 Amended Stock Incentive Plan
(incorporated by reference to Exhibit 10.4 to the Company’s Quarterly Report on Form 10-Q for the
quarter ended July 2, 2016).
Employment Agreement, dated August 18, 2016, by and between SunOpta Inc. and Jill E. Barnett
(incorporated by reference to Exhibit 10.6 to the Company’s Quarterly Report on Form 10-Q for the
quarter ended October 1, 2016).
Employment Agreement, dated August 18, 2016, by and between SunOpta Inc. and James P. Gratzek
(incorporated by reference to Exhibit 10.7 to the Company’s Quarterly Report on Form 10-Q for the
quarter ended October 1, 2016).
Employment Agreement Amendment, dated August 19, 2016, by and between The Organic Corporation
B.V. and G.J.M. Versteegh (incorporated by reference to Exhibit 10.9 to the Company’s Quarterly Report
on Form 10-Q for the quarter ended October 1, 2016).
SUNOPTA INC.
68
December 28, 2019 10-K
Exhibits
Description
10.23
10.24
10.25
10.26
10.27
10.28
10.29†
10.30†
10.31†
10.32†
10.33†
10.34†
First Amendment, dated as of October 7, 2016, to the Credit Agreement, dated as of February 11, 2016,
among SunOpta Inc., SunOpta Foods Inc., The Organic Corporation B.V., each of the other borrowers
and guarantors party thereto from time to time, the lenders party thereto from time to time, Bank of
America, N.A., as U.S. Administrative Agent, Bank of America, N.A. (acting through its Canada Branch),
as Canadian Administrative Agent, Bank of America, N.A. (acting through its London Branch), as Dutch
Administrative Agent under the Dutch, and Bank of America, N.A, as Collateral Agent (incorporated by
reference to Exhibit 10.11 to the Company’s Quarterly Report on Form 10-Q for the quarter ended October
1, 2016).
First Amendment, dated as of October 7, 2016, to the Second Lien Loan Agreement, dated as of October
9, 2015, among SunOpta Inc., SunOpta Foods Inc., certain subsidiaries of SunOpta Inc., the several banks
and other financial institutions or entities from time to time party thereto, and Bank of Montreal, as
Administrative Agent and Collateral Agent (incorporated by reference to Exhibit 10.12 to the Company’s
Quarterly Report on Form 10-Q for the quarter ended October 1, 2016).
Subscription Agreement, dated October 7, 2016, between SunOpta Inc., SunOpta Foods Inc. and Oaktree
Organics, L.P. and Oaktree Huntington Investment Fund II, L.P. (incorporated by reference to Exhibit
10.1 to the Company’s Current Report on Form 8-K filed on October 12, 2016).
Investor Rights Agreement, dated October 7, 2016, between SunOpta Inc., SunOpta Foods Inc. and
Oaktree Organics, L.P. and Oaktree Huntington Investment Fund II, L.P. (incorporated by reference to
Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on October 12, 2016).
Exchange and Support Agreement, dated October 7, 2016, between SunOpta Inc., SunOpta Foods Inc.,
Oaktree Organics, L.P. and Oaktree Huntington Investment Fund II, L.P. and any person that becomes a
Holder of Preferred Stock, from time to time (incorporated by reference to Exhibit 10.3 to the Company’s
Current Report on Form 8-K filed on October 12, 2016).
Voting Trust Agreement, dated October 7, 2016, between SunOpta Inc., SunOpta Foods Inc., the trustee
named therein, Oaktree Organics, L.P. and Oaktree Huntington Investment Fund II, L.P. and any other
Holder of Preferred Stock, from time to time (incorporated by reference to Exhibit 10.4 to the Company’s
Current Report on Form 8-K filed on October 12, 2016).
Letter Agreement, dated November 8, 2016, between Hendrik Jacobs and SunOpta Inc. (incorporated by
reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on November 15, 2016).
Letter Agreement, dated November 8, 2016, between Robert McKeracher and SunOpta Inc. (incorporated
by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on November 15, 2016).
Letter Agreement, dated November 8, 2016, between John Ruelle and SunOpta Inc. (incorporated by
reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed on November 15, 2016).
Letter Agreement, dated November 8, 2016, between Gerard Versteegh and SunOpta Inc. (incorporated
by reference to Exhibit 10.4 to the Company’s Current Report on Form 8-K filed on November 15, 2016).
Executive employment Agreement, effective February 6, 2017, between SunOpta Inc. and David J. Colo
(incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on
February 7, 2017).
Restricted Stock Award Agreement, dated effective February 6, 2017, between SunOpta Inc. and David
J. Colo (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on
February 7, 2017).
SUNOPTA INC.
69
December 28, 2019 10-K
Exhibits
Description
10.35†
10.36
10.37
10.38
10.39†
10.40†
10.41†
10.42†
10.43†
10.44†
10.45†
10.46†
10.47†
Performance Share Unit Award Agreement, dated effective February 6, 2017, between SunOpta Inc. and
David J. Colo (incorporated by reference to Exhibit 10.4 to the Company’s Current Report on Form 8-K
filed on February 7, 2017).
Second Amendment and Joinder, dated September 19, 2017, to the Credit Agreement, dated as of February
11, 2016, among SunOpta Inc., SunOpta Foods Inc., The Organic Corporation B.V., the other borrowers
and guarantors party thereto, the lenders party thereto, Bank of America, N.A., as U.S. Administrative
Agent, Bank of America, N.A. (acting through its Canada Branch), as Canadian Administrative Agent,
Bank of America, N.A. (acting through its London Branch), as Dutch Administrative Agent, and Bank of
America, N.A., as Collateral Agent (incorporated by reference to Exhibit 10.1 to the Company’s Current
Report on Form 8-K filed on September 22, 2017).
Consent to Purchase Shares, dated May 6, 2017, among SunOpta Inc., Oaktree Organics, L.P., and Oaktree
Huntington Investment Fund II, L.P. (incorporated by reference to Exhibit 10.1 to the Company’s Current
Report on Form 8-K (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form
8-K filed on May 8, 2017).
Amendment Agreement, dated May 6, 2017, between SunOpta Inc., Oaktree Organics, L.P., Oaktree
Huntington Investment Fund II, L.P., SunOpta Foods Inc. and OCM SunOpta Trustee, LLC. (incorporated
by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on May 8, 2017).
Restricted Stock Unit Award Agreement, dated effective March 9, 2017, between SunOpta Inc. and David
J. Colo (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on
March 13, 2017, as amended).
Employment Agreement, dated March 13, 2017, by and between SunOpta Inc. and Robert Duchscher
(incorporated by reference to Exhibit 10.5 to the Company’s Quarterly Report on Form 10-Q for the
quarterly period ended April 1, 2017).
Employment Agreement, dated April 1, 2017, by and between SunOpta Inc. and Jeffrey Gough
(incorporated by reference to Exhibit 10.6 to the Company’s Quarterly Report on Form 10-Q for the
quarterly period ended April 1, 2017).
Amended 2013 Stock Incentive Plan (incorporated by reference to Exhibit A to the Company’s Definitive
Proxy Statement on Schedule 14A filed on April 13, 2017).
Form of 2017 Incentive Stock Option Award Agreement under Amended 2013 Stock Incentive Plan
(incorporated by reference to Exhibit 10.10 to the Company’s Quarterly Report on Form 10-Q for the
quarterly period ended July 1, 2017).
Form of 2017 Restricted Stock Unit Award Agreement under Amended 2013 Stock Incentive Plan
(incorporated by reference to Exhibit 10.11 to the Company’s Quarterly Report on Form 10-Q for the
quarterly period ended July 1, 2017).
Form of 2017 Performance Share Unit Award Agreement under Amended 2013 Stock Incentive Plan
(incorporated by reference to Exhibit 10.12 to the Company’s Quarterly Report on Form 10-Q for the
quarterly period ended July 1, 2017).
Employment Agreement, effective January 23, 2017, by and between SunOpta Inc. and Patrick McCoy
(incorporated by reference to Exhibit 10.49 to the Company’s Annual Report on Form 10-K for the year
ended December 30, 2017, filed on March 1, 2018).
Employment Agreement, effective February 21, 2017, by and between SunOpta Inc. and Michael J. Buick
(incorporated by reference to Exhibit 10.50 to the Company’s Annual Report on Form 10-K for the year
ended December 30, 2017, filed on March 1, 2018).
SUNOPTA INC.
70
December 28, 2019 10-K
Exhibits
Description
10.48†
10.49†
10.50†
10.51†
10.52
10.53†
10.54†
10.55†
10.56†
10.57†
10.58†
10.59†
Employment Agreement, effective March 6, 2017, by and between SunOpta Inc. and Robert S. Grant
(incorporated by reference to Exhibit 10.51 to the Company’s Annual Report on Form 10-K for the year
ended December 30, 2017, filed on March 1, 2018).
Employment Agreement, effective April 10, 2017, by and between SunOpta Inc. and Christopher
Whitehair (incorporated by reference to Exhibit 10.52 to the Company’s Annual Report on Form 10-K for
the year ended December 30, 2017, filed on March 1, 2018).
Employment Agreement, effective November 1, 2017, by and between SunOpta Inc. and George Miketa
(incorporated by reference to Exhibit 10.53 to the Company’s Annual Report on Form 10-K for the year
ended December 30, 2017, filed on March 1, 2018).
Letter Agreement, dated March 28, 2018, between Robert McKeracher and SunOpta Inc. (incorporated
by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on March 30, 2018).
Third Amendment and Joinder, dated as of October 22, 2018, to the Credit Agreement, dated as of
February 11, 2016 (as amended by the First Amendment dated as of October 7, 2016 and as further
amended by the Second Amendment and Joinder dated as of September 19, 2017), among SunOpta Inc.,
SunOpta Foods Inc., The Organic Corporation B.V., the other borrowers and guarantors party thereto, the
lenders party thereto, Bank of America, N.A., as U.S. Administrative Agent, Bank of America, N.A.
(acting through its Canada Branch), as Canadian Administrative Agent, Bank of America, N.A. (acting
through its London Branch), as Dutch Administrative Agent, and Bank of America, N.A., as Collateral
Agent (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on
October 25, 2018).
SunOpta Inc. 2018 Short-Term Incentive Plan (incorporated by reference to Exhibit 10.55 to the
Company’s Annual Report on Form 10-K for the year ended December 29, 2018).
Letter Agreement and Final Release, effective March 5, 2019, between SunOpta Inc. and David Colo
(incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on March
11, 2019).
Separation Agreement and Full and Final Release, dated March 15, 2019, by and between SunOpta Inc.
and John Ruelle (incorporated by reference to Exhibit 10.2 to the Company’s Quarterly Report on Form
10-Q filed on May 9, 2019).
Employment Agreement, effective March 29, 2019, between SunOpta Inc. and Joseph D. Ennen
(incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on April
2, 2019).
Restricted Stock Award Agreement, dated effective April 1, 2019, between SunOpta Inc. and Joseph D.
Ennen (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on
April 2, 2019).
Stock Option Award Agreement, dated effective April 1, 2019, between SunOpta Inc. and Joseph D.
Ennen (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed on
April 2, 2019).
Performance Share Unit Award Agreement, dated effective April 1, 2019, between SunOpta Inc. and
Joseph D. Ennen (incorporated by reference to Exhibit 10.4 to the Company’s Current Report on Form 8-
K filed on April 2, 2019).
10.60†
Amended 2013 Stock Incentive Plan (incorporated by reference to Exhibit A to the Company’s Definitive
Proxy Statement on Schedule 14A filed on April 19, 2019).
SUNOPTA INC.
71
December 28, 2019 10-K
Exhibits
Description
10.61†
10.62†
10.63†
10.64†
10.65†
10.66†
10.67†
10.68†
10.69+
Employment Agreement, dated August 30, 2019, between SunOpta Inc. and Scott E. Huckins
(incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on
September 5, 2019).
Restricted Stock Award Agreement, dated effective September 3, 2019, between SunOpta Inc. and Scott
Huckins (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed
on September 5, 2019).
Stock Option Award Agreement, dated effective September 3, 2019, between SunOpta Inc. and Scott
Huckins (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed
on September 5, 2019).
Performance Share Unit Award Agreement, dated effective September 3, 2019, between SunOpta Inc. and
Scott Huckins (incorporated by reference to Exhibit 10.4 to the Company’s Current Report on Form 8-K
filed on September 5, 2019).
Separation Agreement and Full and Final Release, dated September 20, 2019, by and between SunOpta
Inc. and Robert Grant (incorporated by reference to Exhibit 10.12 to the Company’s Quarterly Report on
Form 10-Q filed on November 6, 2019).
Separation Agreement and Full and Final Release, dated September 30, 2019, by and between SunOpta
Inc. and Jeffrey Gough (incorporated by reference to Exhibit 10.13 to the Company’s Quarterly Report on
Form 10-Q filed on November 6, 2019).
Separation Agreement and Full and Final Release, dated September 30, 2019, by and between SunOpta
Inc. and James Gratzek (incorporated by reference to Exhibit 10.14 to the Company’s Quarterly Report
on Form 10-Q filed on November 6, 2019).
Letter Agreement and Final Release, effective November 5, 2019, between SunOpta Inc. and Robert
McKeracher (incorporated by reference to Exhibit 10.15 to the Company’s Quarterly Report on Form 10-
Q filed on November 6, 2019).
Restatement Agreement, dated as of January 28, 2020, amending and restating the Credit Agreement,
dated as of February 11, 2016 (as amended by the First Amendment dated as of October 7, 2016, Second
Amendment and Joinder dated as of September 19, 2017 and as further amended by the Third Amendment
and Joinder dated as of October 22, 2018), among SunOpta Inc., SunOpta Foods Inc., The Organic
Corporation B.V., the other borrowers and guarantors party thereto, the lenders party thereto, Bank of
America, N.A., as U.S. Administrative Agent, Bank of America, N.A. (acting through its Canada Branch),
as Canadian Administrative Agent, Bank of America, N.A. (acting through its London Branch), as Dutch
Administrative Agent, and Bank of America, N.A., as Collateral Agent (incorporated by reference to
Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on January 30, 2020).
10.70†*
Separation Agreement and Full and Final Release, dated November 1, 2019, by and between SunOpta Inc.
and George Miketa.
21*
List of subsidiaries.
23.1*
Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm.
23.2*
Consent of Deloitte LLP, Independent Registered Public Accounting Firm.
31.1*
Certification by Joseph D. Ennen, Chief Executive Officer, pursuant to Rule 13a – 14(a) under the
Securities Exchange Act of 1934, as amended.
SUNOPTA INC.
72
December 28, 2019 10-K
Exhibits
Description
31.2*
32*
Certification by Scott Huckins, Chief Financial Officer, pursuant to Rule 13a – 14(a) under the Securities
Exchange Act of 1934, as amended.
Certifications by Joseph D. Ennen, Chief Executive Officer, and Scott Huckins, Chief Financial Officer,
pursuant to 18 U.S.C. Section 1350.
101.INS* XBRL Instance Document
101.SCH* XBRL Taxonomy Extension Schema Document
101.CAL* XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF* XBRL Taxonomy Extension Definition Linkbase Document
101.LAB* XBRL Taxonomy Extension Label Linkbase Document
101.PRE* XBRL Taxonomy Extension Presentation Linkbase Document
104*
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
+ Exhibits and schedules to this exhibit have been omitted pursuant to Item 601(b)(2) of Regulation S-K. SunOpta will
furnish copies of the omitted exhibits and schedules to the Securities and Exchange Commission upon its request.
† Indicates management contract or compensatory plan or arrangement.
* Filed herewith.
SUNOPTA INC.
73
December 28, 2019 10-K
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this
report to be signed on its behalf by the undersigned, thereunto duly authorized.
SIGNATURES
SUNOPTA INC.
/s/ Scott Huckins
Scott Huckins
Chief Financial Officer
Date: February 27, 2020
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons
on behalf of the registrant and in the capacities and on the dates indicated.
Signature
/s/ Joseph D. Ennen
Joseph D. Ennen
/s/ Scott Huckins
Scott Huckins
/s/ Dean Hollis
Dean Hollis
/s/ Albert Bolles
Albert Bolles
/s/ Derek Briffett
Derek Briffett
/s/ Michael Detlefsen
Michael Detlefsen
/s/ Rebecca Fisher
Rebecca Fisher
/s/ Katrina Houde
Katrina Houde
/s/ Leslie Starr Keating
Leslie Starr Keating
/s/ Brendan Springstubb
Brendan Springstubb
Item 16. Form 10-K Summary
Title
Chief Executive Officer and Director
(Principal Executive Officer)
Chief Financial Officer
(Principal Financial and Accounting Officer)
Chair of the Board and Director
Director
Director
Director
Director
Director
Director
Director
Date
February 27, 2020
February 27, 2020
February 27, 2020
February 27, 2020
February 27, 2020
February 27, 2020
February 27, 2020
February 27, 2020
February 27, 2020
February 27, 2020
The Company has chosen not to include an optional summary of the information required by this Form 10-K. For a reference
to information in the Form 10-K, investors should refer to the Table of Contents to this Form 10-K.
SUNOPTA INC.
74
December 28, 2019 10-K
SunOpta Inc.
Index to Consolidated Financial Statements
Reports of Independent Registered Public Accounting Firms
Consolidated Statements of Operations
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
Consolidated Statements of Comprehensive Loss
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
Consolidated Balance Sheets
As at December 28, 2019 and December 29, 2018
Consolidated Statements of Shareholders’ Equity
As at and for the years ended December 28, 2019, December 29, 2018 and December 30, 2017
Consolidated Statements of Cash Flows
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
Notes to Consolidated Financial Statements
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
Page
F2-F3
F4
F5
F6
F7
F8
F9
SUNOPTA INC.
-F1-
December 28, 2019 10-K
Report of Independent Registered Public Accounting Firm
To the Shareholders and the Board of Directors of SunOpta Inc.
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of SunOpta Inc. (the Company) as of December 28, 2019 and
December 29, 2018, consolidated statements of operations, comprehensive loss, shareholders’ equity and cash flows for each
of the two years in the period ended December 28, 2019 and the related notes (collectively referred to as the “consolidated
financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial
position of the Company at December 28, 2019 and December 29, 2018, and the results of its operations and its cash flows for
each of the two years in the period ended December 28, 2019, in conformity with U.S. generally accepted accounting principles.
We also audited the adjustments described in Note 24 Segmented Information that were applied to restate the 2017 consolidated
financial statements. In our opinion, such adjustments are appropriate and have been properly applied. However, we were not
engaged to audit, review or apply any procedures to the 2017 consolidated financial statements of the Company other than with
respect to the adjustments and, accordingly, we do not express an opinion or any other form of assurance on the 2017
consolidated financial statements taken as a whole.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States)
(PCAOB), the Company's internal control over financial reporting as of December 28, 2019, based on criteria established in
Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission
(2013 framework) and our report dated February 27, 2020 expressed an unqualified opinion thereon.
Adoption of ASU No. 2016-02
As discussed in Note 10 to the consolidated financial statements, the Company changed its method of accounting for leases in
2019 due to the adoption of ASU No. 2016-012, Leases (ASC 842).
Basis for Opinion
These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on
the Company’s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are
required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable
rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform
the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due
to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial
statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included
examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included
evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall
presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
/s/ Ernst & Young LLP
Chartered Professional Accountants
Licensed Public Accountants
We have served as the Company’s auditor since 2018.
Toronto, Canada
February 27, 2020
SUNOPTA INC.
-F2-
December 28, 2019 10-K
Report of Independent Registered Public Accounting Firm
To the Shareholders and the Board of Directors of SunOpta Inc.
Opinion on the Financial Statements
We have audited, before the effects of the retrospective adjustments for the change in reportable segments discussed in Note
24 to the 2019 consolidated financial statements, the consolidated statements of operations, comprehensive loss, shareholders’
equity, and cash flows of SunOpta Inc. and subsidiaries (the “Company”), for the year ended December 30, 2017, and the
related notes (collectively referred to as the “financial statements”) (the 2017 financial statements before the effects of the
retrospective adjustments discussed in Note 24 to the 2019 financial statements are not presented herein). In our opinion, the
2017 financial statements, before the effects of the retrospective adjustments for the change in reportable segments discussed
in Note 24 to the 2019 financial statements, present fairly, in all material respects, the results of the Company’s operations and
its cash flows for the year ended December 30, 2017, in conformity with accounting principles generally accepted in the United
States of America.
We were not engaged to audit, review, or apply any procedures to the retrospective adjustments for the change in reportable
segments discussed in Note 24 to the financial statements, and accordingly, we do not express an opinion or any other form of
assurance about whether such retrospective adjustments are appropriate and have been properly applied. Those retrospective
adjustments were audited by other auditors.
Basis for Opinion
These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on
the Company’s financial statements based on our audit. We are a public accounting firm registered with the Public Company
Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in
accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange
Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the
audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to
error or fraud. Our audit included performing procedures to assess the risks of material misstatement of the financial statements,
whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on
a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the
accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the
financial statements. We believe that our audit provides a reasonable basis for our opinion.
/s/ Deloitte LLP
Chartered Professional Accountants
Licensed Public Accountants
Toronto, Canada
February 28, 2018 (February 26, 2019 as to Note 23 to the 2018 financial statements (not presented herein))
We began serving as the Company’s auditor in 2008. In 2018, we became the predecessor auditor.
SUNOPTA INC.
-F3-
December 28, 2019 10-K
SunOpta Inc.
Consolidated Statements of Operations
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
(All dollar amounts expressed in thousands of U.S. dollars, except per share amounts)
December 28, 2019 December 29, 2018 December 30, 2017
$
$
$
Revenues (note 2)
Cost of goods sold
Gross profit
Selling, general and administrative expenses
Intangible asset amortization (note 12)
Other expense (income), net (note 18)
Goodwill impairment (note 11)
Foreign exchange loss (gain)
Earnings (loss) before the following
Interest expense, net (note 14)
Earnings (loss) before income taxes
Provision for (recovery of) income taxes (note 19)
Net loss
Earnings attributable to non-controlling interests
Loss attributable to SunOpta Inc.
Dividends and accretion on Series A Preferred Stock (note 15)
Loss attributable to common shareholders
Loss per share (note 20)
Basic
Diluted
Weighted-average common shares outstanding (000s) (note 20)
Basic
Diluted
1,190,022
1,260,852
1,279,593
1,074,769
1,137,382
1,134,506
115,253
108,340
10,971
(40,048)
-
(1,304)
37,294
34,677
2,617
3,221
(604)
154
(758)
(8,022)
(8,780)
(0.10)
(0.10)
87,787
87,787
123,470
108,248
11,038
2,825
81,222
252
145,087
127,507
11,195
23,660
115,000
5,618
(80,115)
(137,893)
34,406
32,504
(114,521)
(170,397)
(5,378)
(35,829)
(109,143)
(134,568)
62
752
(109,205)
(135,320)
(7,909)
(7,809)
(117,114)
(143,129)
(1.34)
(1.34)
87,082
87,082
(1.66)
(1.66)
86,355
86,355
(See accompanying notes to consolidated financial statements)
SUNOPTA INC.
-F4-
December 28, 2019 10-K
SunOpta Inc.
Consolidated Statements of Comprehensive Loss
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
(All dollar amounts expressed in thousands of U.S. dollars)
December 28, 2019 December 29, 2018 December 30, 2017
$
$
$
Net loss
(604)
(109,143)
(134,568)
Other comprehensive earnings (loss), net of income taxes
Changes related to cash flow hedges (note 6)
Unrealized gains, net
Reclassification of gains to earnings
Net changes related to cash flow hedges
Currency translation adjustment
Other comprehensive earnings (loss), net of income taxes
Comprehensive loss
Comprehensive earnings attributable to non-controlling interests
-
-
-
(1,614)
(1,614)
(2,218)
144
384
(79)
305
(2,559)
(2,254)
1,263
(1,568)
(305)
6,184
5,879
(111,397)
(128,689)
207
713
Comprehensive loss attributable to SunOpta Inc.
(2,362)
(111,604)
(129,402)
(See accompanying notes to consolidated financial statements)
SUNOPTA INC.
-F5-
December 28, 2019 10-K
SunOpta Inc.
Consolidated Balance Sheets
As at December 28, 2019 and December 29, 2018
(All dollar amounts expressed in thousands of U.S. dollars)
ASSETS
Current assets
Cash and cash equivalents
Accounts receivable (note 7)
Inventories (note 8)
Prepaid expenses and other current assets
Current income taxes recoverable
Total current assets
Property, plant and equipment (note 9)
Operating lease right-of-use assets (note 10)
Goodwill (note 11)
Intangible assets (note 12)
Deferred income taxes (note 19)
Other assets
Total assets
LIABILITIES
Current liabilities
Bank indebtedness (note 14)
Accounts payable and accrued liabilities (note 13)
Customer and other deposits
Income taxes payable
Other current liabilities
Current portion of long-term debt (note 14)
Current portion of operating lease liabilities (note 10)
Current portion of long-term liabilities
Total current liabilities
Long-term debt (note 14)
Operating lease liabilities (note 10)
Long-term liabilities
Deferred income taxes (note 19)
Total liabilities
Series A Preferred Stock (note 15)
December 28, 2019
$
December 29, 2018
$
1,498
121,445
323,546
35,985
7,480
489,954
184,550
68,433
28,422
150,009
-
1,991
923,359
245,536
133,529
37
1,272
802
2,987
17,215
4,286
405,664
242,204
52,020
2,011
9,027
710,926
82,524
318,456
35,767
(214,931)
(11,271)
128,021
1,888
129,909
923,359
3,280
132,131
361,957
29,024
7,029
533,421
171,032
-
27,959
160,975
182
3,169
896,738
280,334
155,371
1,445
2,208
862
1,840
-
4,286
446,346
227,023
-
2,079
8,149
683,597
81,302
314,357
31,796
(206,151)
(9,667)
130,335
1,504
131,839
896,738
EQUITY
SunOpta Inc. shareholders’ equity
Common shares, no par value, unlimited shares authorized,
88,089,733 shares issued (December 29, 2018 - 87,423,280) (note 16)
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Non-controlling interests
Total equity
Total equity and liabilities
Commitments and contingencies (note 23)
(See accompanying notes to consolidated financial statements)
SUNOPTA INC.
-F6-
December 28, 2019 10-K
SunOpta Inc.
Consolidated Statements of Shareholders’ Equity
As at and for the years ended December 28, 2019, December 29, 2018 and December 30, 2017
(All dollar amounts expressed in thousands of U.S. dollars)
Additional
paid-in
capital
$
Retained
earnings
(accumu-
lated deficit)
$
Accumulated
other com-
prehensive
loss
$
Non-
controlling
interests
$
Total
$
Common shares
$
000s
Balance at December 31, 2016
85,744
300,426
25,522
53,838
(13,104)
2,731
369,413
Employee share purchase plan
Stock incentive plan
Stock-based compensation
Dividends on Series A Preferred Stock (note 15)
Accretion on Series A Preferred Stock (note 15)
Net loss
Currency translation adjustment
Cash flow hedges, net of income taxes
of $130 (note 6)
Acquisition of non-controlling interests
61
952
-
-
-
-
-
-
-
409
8,064
-
-
-
-
-
-
-
-
(3,439)
5,709
-
-
-
-
-
214
-
-
-
(6,800)
(1,009)
(135,320)
-
-
-
-
-
-
-
6,223
-
-
-
-
-
752
(39)
409
4,625
5,709
(6,800)
(1,009)
(134,568)
6,184
-
-
(305)
(82)
-
(1,869)
(305)
(1,737)
Balance at December 30, 2017
86,757
308,899
28,006
(89,291)
(7,268)
1,575
241,921
Employee share purchase plan
Stock incentive plan
Withholding taxes on stock-based awards
Stock-based compensation
Dividends on Series A Preferred Stock (note 15)
Accretion on Series A Preferred Stock (note 15)
Net loss
Currency translation adjustment
Cash flow hedges, net of income taxes
of $130 (note 6)
Dividends paid by subsidiary to non-
controlling interest
Cumulative effect of adoption of new revenue
accounting standard
112
554
-
-
-
-
-
-
-
-
-
630
4,828
-
-
-
-
-
-
-
-
-
-
(3,517)
(632)
7,939
-
-
-
-
-
-
-
-
(6,800)
(1,109)
(109,205)
-
-
-
-
-
-
254
-
-
-
-
-
-
-
(2,704)
305
-
-
-
-
-
-
62
145
-
630
1,311
(632)
7,939
(6,800)
(1,109)
(109,143)
(2,559)
305
-
-
(278)
(278)
-
254
Balance at December 29, 2018
87,423
314,357
31,796
(206,151)
(9,667)
1,504
131,839
Employee share purchase plan
Stock incentive plan
Withholding taxes on stock-based awards
Stock-based compensation
Dividends on Series A Preferred Stock (note 15)
Accretion on Series A Preferred Stock (note 15)
Net loss
Currency translation adjustment
Capital contribution to majority-owned
subsidiary
Dividend paid by subsidiary to non-
controlling interest
185
482
-
-
-
-
-
-
-
-
475
3,624
-
-
-
-
-
-
-
-
-
(3,120)
(394)
7,485
-
-
-
-
-
-
-
-
-
-
(6,800)
(1,222)
(758)
-
-
-
-
-
-
-
-
-
-
(1,604)
-
-
-
-
-
-
-
-
154
(10)
271
(31)
475
504
(394)
7,485
(6,800)
(1,222)
(604)
(1,614)
271
(31)
Balance at December 28, 2019
88,090
318,456
35,767
(214,931)
(11,271)
1,888
129,909
(See accompanying notes to consolidated financial statements)
SUNOPTA INC.
-F7-
December 28, 2019 10-K
SunOpta Inc.
Consolidated Statements of Cash Flows
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
(All dollar amounts expressed in thousands of U.S. dollars)
December 28, 2019 December 29, 2018 December 30, 2017
$
$
$
CASH PROVIDED BY (USED IN)
Operating activities
Net loss
Items not affecting cash:
Depreciation and amortization
Amortization of debt issuance costs (note 14)
Deferred income taxes (note 19)
Stock-based compensation (note 17)
Unrealized loss (gain) on derivative instruments (note 6)
Gain on sale of business (note 4)
Goodwill impairment (note 11)
Impairment of long-lived assets (note 18)
Fair value of contingent consideration (note 18)
Reserve for notes receivable (note 18)
Other
Changes in non-cash working capital, net of businesses acquired
or sold (note 21)
Net cash flows from operating activities
Investing activities
Net proceeds from sale of businesses (note 4)
Purchases of property, plant and equipment
Acquisition of business, net of cash acquired (note 3)
Proceeds from sale of assets
Acquisition of non-controlling interests
Other
Net cash flows from investing activities
Financing activities
Increase (decrease) under line of credit facilities (note 14)
Borrowings under long-term debt (note 14)
Repayment of long-term debt (note 14)
Payment of cash dividends on Series A Preferred Stock (note 15)
Payment of contingent consideration
Proceeds from the exercise of stock options and employee
share purchases (note 17)
Dividends paid by subsidiary to non-controlling interest
Payment of debt issuance costs
Other
Net cash flows from financing activities
Foreign exchange gain (loss) on cash held in a foreign currency
Increase (decrease) in cash and cash equivalents during the year
Cash and cash equivalents - beginning of the year
Cash and cash equivalents - end of the year
Non-cash investing and financing activities (notes 10 and 21)
(604)
(109,143)
(134,568)
33,952
2,721
1,060
7,485
(410)
(44,027)
-
-
-
-
(263)
9,895
9,809
63,324
(32,764)
(3,341)
-
-
-
27,219
(32,795)
3,230
(2,746)
(6,800)
-
585
(31)
(412)
206
(38,763)
(47)
(1,782)
3,280
1,498
32,788
2,536
(7,390)
7,939
465
-
81,222
409
(2,635)
2,232
(197)
(19,367)
(11,141)
1,236
(31,603)
-
1,437
-
159
(28,771)
50,275
2,029
(1,810)
(6,800)
(4,399)
1,309
(278)
-
(292)
40,034
(70)
52
3,228
3,280
32,824
2,825
(27,899)
5,709
(631)
-
115,000
18,193
371
-
9
19,630
31,463
307
(41,139)
-
2,385
(1,737)
62
(40,122)
22,170
5,176
(9,959)
(6,691)
(4,330)
5,034
-
(442)
(390)
10,568
68
1,977
1,251
3,228
(See accompanying notes to consolidated financial statements)
SUNOPTA INC.
-F8-
December 28, 2019 10-K
SunOpta Inc.
Notes to Consolidated Financial Statements
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts)
____________________________________________________________________________________________________
1. Significant Accounting Policies
Basis of Presentation
These consolidated financial statements include the accounts of SunOpta Inc. and those of its wholly-owned and majority-
owned subsidiaries (collectively, the “Company” or “SunOpta”) and have been prepared by the Company in United States
(“U.S.”) dollars and in accordance with accounting principles generally accepted in the United States of America (“U.S.
GAAP”). All intercompany accounts and transactions have been eliminated on consolidation.
As described in note 24, in the fourth quarter of 2019, the Company changed its segment reporting to reflect changes to its
operating structure. All segment information presented in these consolidated financial statements for the current and
comparative fiscal years has been restated to reflect the new segment reporting structure.
Fiscal Year
The fiscal year of the Company consists of a 52- or 53-week period ending on the Saturday closest to December 31. Fiscal years
2019, 2018 and 2017 were each 52-week periods ending on December 28, 2019, December 29, 2018 and December 30, 2017,
respectively. Fiscal year 2020 will be a 53-week period ending on January 2, 2021, with quarterly periods ending on March 28,
June 27, and September 26, 2020.
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make certain estimates and
assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Areas involving
significant estimates and assumptions include: allowances for doubtful accounts; inventory reserves; income tax liabilities and
assets, and related valuation allowances; provisions for loss contingencies related to claims and litigation; allocation of the
purchase price of acquired businesses; fair value of contingent consideration liabilities; useful lives of property, plant and
equipment and intangible assets; expected lease terms and discount rates in measuring lease assets and liabilities; expected
future cash flows used in evaluating long-lived assets for impairment; and reporting unit fair values in testing goodwill for
impairment. The estimates and assumptions made require judgment on the part of management and are based on the Company’s
historical experience and various other factors that are believed to be reasonable in the circumstances. Management continually
evaluates the information that forms the basis of its estimates and assumptions as the business of the Company and the general
business environment changes.
Business Acquisitions
Acquired businesses are accounted for using the acquisition method of accounting, which requires that assets acquired and
liabilities assumed be recorded at fair value, with limited exceptions. Any excess of the purchase price over the fair value of the
net assets acquired is recorded as goodwill. Acquisition-related transaction costs are accounted for as an expense in the period
in which the costs are incurred. Contingent consideration is measured at fair value and recognized as part of the consideration
transferred in exchange for the acquired businesses. Contingent consideration liabilities are remeasured to fair value at each
reporting date with the changes in fair value recognized in other expense/income on the consolidated statements of operations.
Financial Instruments
The Company’s financial instruments recognized in the consolidated balance sheets and included in working capital consist of
cash and cash equivalents, accounts receivable, derivative instruments, accounts payable and accrued liabilities, and customer
and other deposits. Cash and cash equivalents and derivative instruments are measured at fair value each reporting period. The
fair values of the remaining financial instruments approximate their carrying values due to their short-term maturities.
The Company’s financial instruments exposed to credit risk include cash equivalents, accounts receivable and derivative
instruments. The Company places its cash and cash equivalents with institutions of high creditworthiness. To limit the credit
risk associated with derivative instruments, the Company contracts with counterparties that are highly-rated financial
SUNOPTA INC.
-F9-
December 28, 2019 10-K
SunOpta Inc.
Notes to Consolidated Financial Statements
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts)
____________________________________________________________________________________________________
institutions. The Company’s trade accounts receivable are not subject to a high concentration of credit risk. The Company
routinely assesses the financial strength of its customers and believes that its accounts receivable credit risk exposure is limited.
The Company maintains an allowance for doubtful accounts based on the expected collectability of the accounts receivable.
Fair Value
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction
between market participants at the measurement date (that is, an exit price). Fair value measurements are estimated based on
inputs categorized as follows:
(cid:120) Level 1 inputs include quoted prices (unadjusted) for identical assets or liabilities in active markets that are observable.
(cid:120) Level 2 inputs include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or
similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the
asset or liability; and inputs that are derived principally from or corroborated by observable market data by correlation
or other means.
(cid:120) Level 3 includes unobservable inputs that reflect the Company’s own assumptions about what factors market
participants would use in pricing the asset or liability.
When measuring fair value, the Company maximizes the use of observable inputs and minimizes the use of unobservable
inputs.
Foreign Currency Translation
The assets and liabilities of the Company’s operations having a functional currency other than the U.S. dollar are translated
into U.S. dollars at the exchange rate prevailing at the balance sheet date, and at the average rate for the reporting period for
revenue and expense items. The cumulative currency translation adjustment is recorded as a component of accumulated other
comprehensive income in shareholders’ equity. Foreign currency gains and losses related to the remeasurement of the
Company’s Mexican operation into its U.S. dollar functional currency are recognized in earnings.
Exchange gains and losses on transactions occurring in a currency other than an operation’s functional currency are recognized
in earnings.
Cash and Cash Equivalents
Cash and cash equivalents consist of cash and short-term deposits with an original maturity of 90 days or less.
Accounts Receivable
Accounts receivable includes trade receivables that are recorded at the invoiced amount and do not bear interest. The allowance
for doubtful accounts is an estimate of the amount of probable credit losses in existing accounts receivable. Account balances
are charged off against the allowance when the Company determines the receivable will not be recovered. As at December 28,
2019 and December 29, 2018, no customer’s balance represented 10% or more of the Company’s consolidated trade receivables
balance.
Inventories
Inventories (excluding commodity grains) are valued at the lower of cost and net realizable value. Shipping and handling costs
are included in cost of goods sold on the consolidated statements of operations.
As at December 29, 2018, inventories of commodity grains owned by the Company’s former soy and corn business (see note
4) were valued based on quoted market prices.
SUNOPTA INC.
-F10-
December 28, 2019 10-K
SunOpta Inc.
Notes to Consolidated Financial Statements
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts)
____________________________________________________________________________________________________
Property, Plant and Equipment
Property, plant and equipment are stated at cost, less accumulated depreciation. Depreciation is provided using the straight-
line basis at rates reflecting the estimated useful lives of the assets.
Buildings
Machinery and equipment
Enterprise software
Office furniture and equipment
Vehicles
Goodwill
20 - 40 years
5 - 20 years
3 - 5 years
3 - 7 years
3 - 7 years
Goodwill represents the excess in a business combination of the purchase price over the estimated fair value of the identifiable
net assets acquired. Goodwill is not amortized but is instead tested for impairment at least annually, or whenever events or
circumstances change between the annual impairment tests that would indicate the carrying amount of goodwill may be
impaired. The Company performs its annual test for goodwill impairment in the fourth quarter of each fiscal year. The
Company can elect to qualitatively assess goodwill for impairment if it is more likely than not that the fair value of a reporting
unit exceeds its carrying value. If the Company elects to quantitatively assess goodwill, or it is not more likely than not that
the fair value of a reporting unit exceeds its carrying value, the Company estimates the fair value of each of its reporting units.
Goodwill impairment charges are recognized based on the excess of a reporting unit’s carrying amount over its fair value. The
fair values of the reporting units are determined using an income approach (discounted cash flow method). The results of the
Company annual impairment tests for goodwill are described in note 11.
Intangible Assets
The Company’s finite-lived intangible assets consist of customer relationships, patents and trademarks, and other intangible
assets. These intangible assets are amortized on a straight-line basis over their estimated useful lives as follows:
Customer relationships
Patents and trademarks
Other
Impairment of Long-Lived Assets
10 - 25 years
15 years
5 - 15 years
The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the
carrying amounts of the assets may not be recoverable through undiscounted future cash flows. If impairment exists based on
expected future undiscounted cash flows, a loss is recognized in earnings. The amount of the impairment loss is the excess of
the carrying amount of the impaired asset over the fair value of the asset, typically determined using a discounted cash flow
analysis (income approach).
Derivative Instruments
The Company is exposed to fluctuations in commodity prices and foreign currency exchange. The Company utilizes certain
derivative financial instruments to enhance its ability to manage these risks, including exchange-traded commodity futures and
forward foreign exchange contracts. Derivative instruments are entered into for periods consistent with related underlying
exposures and do not constitute positions independent of those exposures. The Company does not enter into contracts for
speculative purposes.
All derivative instruments are recognized on the consolidated balance sheets at fair value. Changes in the fair value of
derivative instruments are recorded in earnings or other comprehensive earnings, based on whether the instrument is designated
as part of a hedge transaction. Gains or losses on derivative instruments reported in accumulated other comprehensive income
are reclassified to earnings in the period in which earnings are affected by the underlying hedged item. The ineffective portion
December 28, 2019 10-K
SUNOPTA INC.
-F11-
SunOpta Inc.
Notes to Consolidated Financial Statements
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts)
____________________________________________________________________________________________________
of all hedges is recognized in earnings in the current period. As at December 28, 2019, the Company utilized the following
derivative instruments to manage commodity and foreign currency risks:
(cid:120) Exchange-traded commodity futures contracts to economically hedge its exposure to price fluctuations on cocoa and
coffee transactions to the extent considered practicable for minimizing risk from market price fluctuations. Futures
contracts used for economical hedging purposes are purchased and sold through regulated commodity exchanges in
the U.S. However, inventories may not be completely hedged, due in part to the Company’s assessment of its exposure
from expected price fluctuations. All futures contracts are marked-to-market, with gains and losses on these contracts
included in cost of goods sold on the consolidated statements of operations.
(cid:120) Forward foreign exchange contracts to minimize exchange rate fluctuations relating to foreign currency denominated
purchase and sale contracts and accounts payable and receivable. Forward foreign exchange contracts designated as
hedges are marked-to-market with the effective portion of the gain or loss recognized in other comprehensive earnings
and subsequently recognized in earnings in the same period the hedged item affects earnings. Gains and losses on
forward exchange contracts not specifically designated as hedging instruments are included in foreign exchange
gain/loss on the consolidated statements of operations.
Debt Issuance Costs
Costs incurred in connection with obtaining debt financing are deferred and amortized over the term of the financing
arrangement using the effective interest method. Costs incurred to secure revolving lines of credit are recorded in other long-
term assets. All other debt issuance costs are recorded as a direct deduction from the related debt liability.
Customer and Other Deposits
Customer and other deposits include prepayments by customers for merchandise inventory to be purchased at a future date.
Income Taxes
The Company follows the asset and liability method of accounting for income taxes whereby deferred income tax assets are
recognized for deductible temporary differences and operating loss carry-forwards, and deferred income tax liabilities are
recognized for taxable temporary differences. Temporary differences are the differences between the amounts of assets and
liabilities recorded for income tax and financial reporting purposes.
Deferred income tax assets are recognized only to the extent that management determines that it is more likely than not that the
deferred income tax assets will be realized. Deferred income tax assets and liabilities are adjusted for the effects of changes in
tax laws and rates on the date of enactment. The income tax expense or benefit is the income tax payable or recoverable for
the year plus or minus the change in deferred income tax assets and liabilities during the year.
The Company is subject to ongoing tax exposures, examinations and assessments in various jurisdictions. Accordingly, the
Company may incur additional income tax expense based upon the outcomes of such matters. In addition, when applicable,
the Company adjusts income tax expense to reflect the Company’s ongoing assessments of such matters, which requires
judgment and can materially increase or decrease its effective rate as well as impact operating results. The evaluation of tax
positions taken or expected to be taken in a tax return is a two-step process, whereby (1) the Company determines whether it
is more likely than not that the tax positions will be sustained based on the technical merits of the position, and (2) for those
tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax
benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the related tax authority.
Stock Incentive Plan
The Company maintains a stock incentive plan under which stock options and other stock-based awards may be granted to
selected employees and directors. The Company measures stock-based awards at fair value as of the date of grant.
Compensation expense is recognized on a straight-line basis over vesting period of the entire stock-based award, based on the
SUNOPTA INC.
-F12-
December 28, 2019 10-K
SunOpta Inc.
Notes to Consolidated Financial Statements
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts)
____________________________________________________________________________________________________
number of awards that ultimately vest. When exercised, stock-based awards are settled through the issuance of common shares
and are therefore treated as equity awards.
Revenue Recognition
Revenue is recognized when the Company transfers control of promised goods to its customers in an amount that reflects the
consideration to which the Company expects to be entitled to in exchange for those goods.
See note 2 for further disclosures related to revenue.
Earnings Per Share
Basic earnings per share is computed by dividing earnings available to common shareholders by the weighted-average number
of common shares outstanding during the year. Earnings available to common shareholders is computed by deducting
dividends and accretion on convertible preferred stock from earnings attributable to SunOpta Inc. The potential diluted effect
of stock options and other stock-based awards is computed using the treasury stock method whereby the weighted-average
number of common shares used in the basic earnings per share calculation is increased to include the number of additional
common shares that would have been outstanding if the potential dilutive common shares had been issued at the beginning of
the year. The potential dilutive effect of convertible preferred stock is computed using the if-converted method whereby
dividends and accretion on the convertible preferred stock are added back to the numerator, and the common shares resulting
from the assumed conversion of the convertible preferred stock are included in the denominator of the diluted earnings per
share calculation.
Contingencies
In the normal course of business, the Company is subject to loss contingencies, such as accrued but unpaid bonuses; tax-related
matters; and claims or litigation. Accruals for loss contingencies are recorded when the Company determines that it is both
probable that a liability has been incurred and the amount of loss can be reasonably estimated. If the estimate of the amount of
the loss is a range and some amount within the range appears to be a better estimate than any other amount within the range,
that amount is accrued as a liability. If no amount within the range is a better estimate than any other amount, the minimum
amount of the range is accrued as a liability.
The Company recognizes an asset for insurance recoveries when a loss event has occurred and recovery is considered probable,
to the extent that the potential recovery does not exceed the loss recognized.
Recent Accounting Pronouncements
Adoption of New Accounting Standards
In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-
02, “Leases” (“ASC Topic 842”), which amends various aspects of legacy accounting guidance for leases, including the
recognition of right-of-use assets and lease liabilities for leases classified as operating leases. The Company adopted ASC
Topic 842 on a modified retrospective basis beginning the first quarter of 2019, and elected the transition option not to apply
the new guidance, including disclosure requirements, in comparative reporting periods. Upon adoption, the Company also
elected to apply the practical expedients available under the standard to not reassess its prior conclusions about lease
identification, lease classification and initial direct costs. As a result, the adoption of ASC Topic 842 did not result in any
cumulative-effect adjustment to the Company’s opening accumulated deficit. The adoption of the new guidance resulted in
the recognition of operating lease right-of-use assets and lease liabilities on the Company’s consolidated balance sheet as at
December 28, 2019, while the accounting for finance leases remained unchanged. The new guidance did not have any impact
on the consolidated results of operations or cash flows of the Company for the year ended December 28, 2019.
See note 10 for additional disclosures under ASC Topic 842.
SUNOPTA INC.
-F13-
December 28, 2019 10-K
SunOpta Inc.
Notes to Consolidated Financial Statements
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts)
____________________________________________________________________________________________________
Recently Issued Accounting Standards, Not Adopted as at December 28, 2019
In June 2016, the FASB issued ASU 2016-13, “Measurement of Credit Losses on Financial Instruments,” which requires
measurement and recognition of expected versus incurred credit losses for most financial assets, including trade receivables.
The adoption of this new guidance, effective the first quarter of 2020, is not expected to have a significant impact on the
Company’s consolidated financial statements.
2. Revenue
The Company procures, processes and sells organic and non-GMO ingredients, and processes and packages plant-based and
fruit-based foods and beverages. The Company’s customers include retailers, foodservice operators, branded food companies
and food manufacturers.
Revenue is recognized when performance obligations under the terms of a contract with a customer are satisfied, which is upon
the transfer of control of the contracted goods. Except for goods sold under bill-and-hold arrangements, control is transferred
when title and physical possession of the product has transferred to the customer, which is at the point in time that product is
shipped from the Company’s facilities or delivered to a specified destination, depending on the terms of the contract, and the
Company has a present right to payment. Under bill-and-hold arrangements – whereby the Company bills a customer for product
to be delivered at a later date – control typically transfers when the product is ready for physical transfer to the customer, and the
Company has a present right to payment.
A performance obligation is a promise within a contract to transfer distinct goods to the customer. A contract with a customer
may involve multiple products and/or multiple delivery dates, with the transfer of each product at each delivery date being
considered a distinct performance obligation, as each of the Company’s products has standalone utility to the customer. In these
cases, the contract’s transaction price is allocated to each performance obligation based on relative standalone selling prices, and
recognized as revenue when each individual product is transferred to the customer. Other promises in the contract—for example,
the promise to provide quality assurance testing to ensure the product meets specification and is fit for its intended use—are not
separable from the promise to deliver goods and are therefore not considered distinct.
Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring the goods.
Consideration is typically determined based on a fixed unit price for the quantity of product transferred. Certain contracts may
give rise to an element of variable consideration in the form of rebates or discounts. For contracts involving variable
consideration, the Company estimates the transaction price based on the amount of consideration to which it expects to be entitled.
These estimates are determined based on historical experience and the expected outcome of the variable consideration, and are
updated as new information becomes available, including actual claims paid, which indicate an estimate is not indicative of the
expected results. Changes to these estimates are recorded in the period the adjustment is identified. The Company does not
typically grant customers a general right of return for goods transferred, but will generally accept returns of product for quality-
related issues. The cost of satisfying this promise of quality is accounted for as an assurance-type warranty obligation rather than
variable consideration. The Company’s contracts do not typically include any significant payment terms, as payment is normally
due shortly after the time of transfer.
Within the Company’s Global Ingredients segment, arrangements with customers are in the form of written sales contracts,
specifying the quantity and timing of goods to be delivered. The duration of these sales contracts is typically one year or less
based on crop-year cycles, and may involve multiple delivery dates over the course of the contract. The Company has elected
not to disclose the value of remaining performance obligations for contracts with an original duration of one year or less. Some
contracts may extend beyond one year; however, for these contracts, the Company expects to satisfy substantially all of the
remaining performance obligations within the next 12 months. For contracts involving the delivery of raw material ingredients,
the Company evaluated whether it is acting as the principal (whereby revenues are reported on a gross basis) or agent (whereby
revenues are reported on a net basis). The Company determined that for these contracts it is the principal, since the Company is
primarily responsible for fulfilling the promise to deliver the goods to customers. That is, the Company controls access to the
goods through purchase commitments with selected suppliers, and bears responsibility and potential financial risk for quality-
related issues related to the delivered product. In addition, the Company has discretion in establishing prices for the product.
SUNOPTA INC.
-F14-
December 28, 2019 10-K
SunOpta Inc.
Notes to Consolidated Financial Statements
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts)
____________________________________________________________________________________________________
Within the Company’s Plant-Based and Fruit-Based Foods and Beverages segments, contracts are typically represented by short-
term, binding purchase orders from customers, identifying the quantity and pricing for products to be transferred. Customer
orders may be issued under long-term master supply arrangements. On their own, these master supply arrangements are typically
not considered contracts for purposes of revenue recognition, as they do not create enforceable rights and obligations regarding
the quantity, pricing or timing of goods to be transferred (for example, by imposing minimum purchase obligations on the part
of the customer). Certain master supply arrangements provide for the transfer of product on a bill-and-hold basis at the specific
request of the customer. Goods are produced under these bill-and-hold arrangements to meet individual customer specifications,
and, therefore, are identifiable as belonging to the customer and cannot be directed to another customer.
The timing of the Company’s revenue recognition, customer billings and cash collections, does not result in significant unbilled
receivables (contract assets) or customer advances (contract liabilities) on the consolidated balance sheet. Contract costs, such
as sales commissions, are generally expensed as incurred given the short-term nature of the associated contracts.
The following table presents a disaggregation of the Company’s revenues based on categories used by the Company to evaluate
sales performance:
December 28, 2019 December 29, 2018 December 30, 2017
$
$
$
Global Ingredients
Organic and non-GMO ingredients
Premium juice
Soy and corn
Total Global Ingredients
Plant-Based Foods and Beverages
Beverages and broths
Plant-based ingredients
Sunflower and roasted snacks
Flexible resealable pouch and nutrition bar products
Total Plant-Based Foods and Beverages
Fruit-Based Foods and Beverages
Frozen fruit
Fruit-based ingredients
Fruit snacks
Total Fruit-Based Foods and Beverages
Total revenues
3. Business Acquisition
394,880
73,546
10,346
478,772
286,381
22,944
52,073
-
361,398
258,298
47,762
43,792
349,852
403,988
72,892
104,427
581,307
244,888
14,788
51,297
3,103
314,076
271,417
50,830
43,222
365,469
367,209
76,621
112,336
556,166
217,285
14,904
57,383
53,142
342,714
283,657
61,715
35,341
380,713
1,190,022
1,260,852
1,279,593
On April 1, 2019, the Company acquired 100% of the outstanding shares of Sanmark B.V. (“Sanmark”) for $3.3 million, net
of cash acquired, which was financed through existing credit facilities. Sanmark is a sourcing and trading business focused on
organic oils for the food, pharmacy, and cosmetic industries. Sanmark sources raw materials globally and generates most of its
sales in the European and Asia-Pacific markets. Net assets acquired comprised working capital of $1.1 million and goodwill
of $2.2 million. The goodwill recognized is attributable to operating synergies expected to result from combining the operations
of Sanmark with the existing organic oils business unit within the Company’s international organic ingredients operations, in
addition to the opportunity to introduce the Company’s existing organic oils portfolio to new customers and markets, and the
ability to leverage the expertise within the Sanmark organization to grow the combined organic oils program. The operations
of Sanmark have been integrated into the consolidated organic ingredients operations of the Company’s subsidiary in the
Netherlands. The results of operations of Sanmark are included in the Company’s consolidated financial statements from the
SUNOPTA INC.
-F15-
December 28, 2019 10-K
SunOpta Inc.
Notes to Consolidated Financial Statements
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts)
____________________________________________________________________________________________________
date of acquisition and are reported within the Global Ingredients segment. The revenues and earnings of Sanmark since the
date of acquisition were not material to the results of operations of Global Ingredients or the Company.
4. Sale of Soy and Corn Business
On February 22, 2019, the Company’s subsidiary, SunOpta Grains and Foods Inc., completed the sale of its specialty and
organic soy and corn business to Pipeline Foods, LLC (“Pipeline Foods”) for $66.5 million, subject to certain post-closing
adjustments. The soy and corn business engaged in seed and grain conditioning and corn milling and formed part of the
Company’s Global Ingredients segment. The business included five facilities located in Hope, Minnesota, Blooming Prairie,
Minnesota, Ellendale, Minnesota, Moorhead, Minnesota, and Cresco, Iowa. The net proceeds from this transaction were
initially used to repay borrowings under the Company’s Global Credit Facility (see note 14).
The Company recognized a net gain on sale of the soy and corn business, which was recognized in other income, as follows:
Cash consideration
Post-closing adjustments
Transaction and related costs
Net proceeds
Current assets
Property, plant and equipment
Goodwill
Current liabilities
Net assets sold
Pre-tax gain on sale
$
66,500
(1,348)
(1,828)
63,324
22,810
8,423
1,526
(13,462)
19,297
44,027
As the soy and corn business did not qualify for presentation as discontinued operations, operating results for this business
prior to February 22, 2019 were reported in continuing operations on the consolidated statements of operations for the current
and comparative periods. For the period ended February 22, 2019, the soy and corn business generated revenues of $10.3
million and reported a loss before income taxes of $0.2 million. For the years ended December 29, 2018 and December 30,
2017, the soy and corn business generated revenues of $104.4 million and $112.3 million, respectively, and reported earnings
before income taxes of $6.8 million and $8.9 million, respectively. The reported pre-tax results exclude management fees
charged by Corporate Services and do not reflect other cost reduction measures associated with the sale of the soy and corn
business that were taken in connection with the Value Creation Plan (see note 5).
5. Value Creation Plan
Overview
In 2016, the Company established a Value Creation Plan with the objective of maximizing the Company’s ability to deliver
long-term value to its shareholders. Since 2016, the Company has identified and implemented a series of measures under the
Value Creation Plan, including the sale of the soy and corn business (as described in note 4). In 2019, the Company appointed
a new Chief Executive Officer (“CEO”) and new Chief Financial Officer (“CFO”) to continue to drive the Value Creation Plan.
Actions taken in 2019 included a workforce reduction program affecting approximately 30 employees, including certain
executive officers and members of senior management, and the Company initiated a plan to consolidate certain of the
Company’s corporate office functions in Edina, Minnesota. Prior to 2019, measures taken under the Value Creation Plan have
included the consolidation of the Company’s roasted snack operations and related disposal of its former roasting facility in
Wahpeton, North Dakota, in 2018; the exit from flexible resealable pouch and nutrition bar product lines and operations initiated
in 2017; and the closure of the Company’s juice processing facility in San Bernardino, California, in 2016. In addition, the
Company has made a series of organizational changes within its management and executive teams, including new leadership
additions to many corporate, commercial and operational functions. The Company also added new employees in the areas of
SUNOPTA INC.
-F16-
December 28, 2019 10-K
SunOpta Inc.
Notes to Consolidated Financial Statements
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts)
____________________________________________________________________________________________________
quality, food safety, sales, marketing, operations and engineering, and made capital investments at several of its manufacturing
facilities to enhance food safety and production efficiencies.
Costs Incurred Under the Value Creation Plan
The following table summarizes costs incurred under the Value Creation Plan for each of the three years in the period ended
December 28, 2019:
(a)
Asset
impairments
and facility
closure costs
$
(b)
Employee
recruitment,
retention and
termination
costs
$
(c)
Consulting
fees and
temporary
labor costs
$
477
308
(584)
-
201
(700)
1,364
1,068
(1,255)
477
-
21,766
(10,746)
(11,720)
(700)
436
7,988
(8,529)
4,131
4,026
4,427
600
(4,591)
-
436
1,803
11,618
(9,683)
689
4,427
-
1,353
(1,353)
-
-
-
410
(410)
-
-
1,657
16,528
(18,185)
-
-
Total
$
913
9,649
(10,466)
4,131
4,227
3,727
2,374
(3,933)
(1,255)
913
3,460
49,912
(38,614)
(11,031)
3,727
2019
Balance payable, beginning of year
Costs incurred and charged to expense
Cash payments, net
Non-cash adjustments
Balance payable, end of year(1)
2018
Balance payable (receivable), beginning of year
Costs incurred and charged to expense
Cash receipts (payments), net
Non-cash adjustments
Balance payable, end of year(1)
2017
Balance payable, beginning of year
Costs incurred and charged to expense
Cash payments, net
Non-cash adjustments
Balance payable (receivable), end of year
(1) Balance payable was included in accounts payable and accrued liabilities on the consolidated balance sheets.
(a) Asset impairments and facility closure costs
For the year ended December 28, 2019, costs incurred included costs to dismantle and move equipment from the
Company’s former soy extraction facility in Heuvelton, New York, which was closed in December 2016. As at December
28, 2019, the balance payable represented the remaining lease obligation related to the Company’s former nutrition bar
facility, which extends until December 2020.
For the year ended December 29, 2018, costs incurred included an accrual for the remaining lease payments (net of sublease
rentals) related to the vacated nutrition bar facility, and a loss on the disposal of the Company’s Wahpeton, North Dakota,
roasting facility. Net cash receipts included net proceeds on the sale of the roasting facility of $0.7 million and proceeds
on the sale of nutrition bar equipment of $0.7 million.
SUNOPTA INC.
-F17-
December 28, 2019 10-K
SunOpta Inc.
Notes to Consolidated Financial Statements
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts)
____________________________________________________________________________________________________
For the year ended December 30, 2017, costs incurred included an asset impairment loss of $3.7 million related to the
closure of the Company’s juice processing facility, and closure costs of $0.6 million incurred by the Company for rent and
maintenance of the facility prior to its disposal. In addition, costs incurred included asset impairment losses related to the
exits from flexible resealable pouch and nutrition bar operations of $16.1 million, and consolidation of the Company’s
roasted snack operations of $1.3 million. Cash payments in 2017 related to the early buy-out of equipment leases related
to exited operations, net of proceeds on the disposal of those assets.
(b) Employee recruitment, retention and termination costs
For the year ended December 28, 2019, costs incurred included severance benefits related to employee terminations in
connection with the workforce reduction program, and cost rationalizations associated with the sale of the soy and corn
business, as well as accrued severance benefits for employees affected by the corporate office consolidation. In addition,
recruitment, relocation and termination costs were incurred in connection with CEO transition in February 2019 and CFO
transition in September 2019. Employee termination costs were recognized net of the reversal of $4.1 million of previously
recognized stock-based compensation related to forfeited awards of terminated employees. As at December 28, 2019, the
balance payable included accrued severance benefits payable to the Company’s former CFO and other corporate office
employees in 2020, and payable to certain other former employees through salary continuance extending up to 24 months,
as well as accrued retention bonuses for certain employees who remain employed by the Company through specified dates
in 2020.
For the years ended December 29, 2018 and December 30, 2017, cost incurred included third-party recruiting fees incurred
to identify and retain new employees; reimbursement of relocation costs for new employees; retention and signing bonuses
accrued for certain existing and new employees; and severance benefits, net of forfeitures of stock-based awards, and legal
costs related to employee terminations.
(c) Consulting fees and temporary labor costs
Represents the cost for third-party consultants and temporary labor engaged to support the initial design and
implementation of the Value Creation Plan, which efforts were substantially completed during 2017, as well as other
professional fees incurred in support of other measures subsequently taken under the plan.
The following table summarizes costs incurred since the inception of the Value Creation Plan in 2016 to December 28, 2019:
Costs incurred and charged to expense
Cash payments, net
Non-cash adjustments
Balance payable, December 28, 2019
Asset
impairments
and facility
closure costs
$
34,960
(10,262)
(24,497)
201
Employee
recruitment,
retention and
termination
costs
$
22,969
(23,497)
4,554
4,026
Consulting
fees and
temporary
labor costs
$
22,332
(22,332)
-
-
Total
$
80,261
(56,091)
(19,943)
4,227
SUNOPTA INC.
-F18-
December 28, 2019 10-K
SunOpta Inc.
Notes to Consolidated Financial Statements
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts)
____________________________________________________________________________________________________
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017, costs incurred and charged to expense
were recorded in the consolidated statement of operations as follows:
Cost of goods sold(1)
Selling, general and administrative expenses(2)
Other expense(3)
December 28, 2019 December 29, 2018 December 30, 2017
$
3,189
22,894
23,829
49,912
$
-
3,556
6,093
9,649
$
100
613
1,661
2,374
(1) Inventory write-downs and facility closure costs recorded in cost of goods sold were allocated to Plant-Based Foods and Beverages.
(2) Consulting/professional fees and temporary labor costs, and employee recruitment, relocation and retention costs recorded in selling, general and
administrative expenses were allocated to Corporate Services.
(3) For the year ended December 28, 2019, costs recorded in other expense were allocated as follows: Global Ingredients – $0.2 million (December 29,
2018 – $nil; December 30, 2017 – $3.9 million); Plant-Based Foods and Beverages – $0.5 million (December 29, 2018 – $1.4 million; December
30, 2017 – $16.8 million); Fruit-Based Foods and Beverages – $1.0 million (December 29, 2018 – $0.1 million; December 30, 2017 – $1.3 million);
and Corporate Services – $4.3 million (December 29, 2018 – $0.2 million; December 30, 2017 – $1.8 million).
6. Derivative Financial Instruments and Fair Value Measurements
The following table presents for each of the fair value hierarchies, the assets and liabilities that are measured at fair value on a
recurring basis as at December 28, 2019 and December 29, 2018:
Commodity futures contracts(1)
Unrealized short-term derivative asset
Forward foreign currency contracts(2)
Not designated as hedging instruments
Commodity futures and forward contracts(1)
Unrealized short-term derivative asset
Unrealized long-term derivative asset
Unrealized short-term derivative liability
Unrealized long-term derivative liability
Forward foreign currency contracts(2)
Not designated as hedging instruments
Inventories carried at market(3)
(1) Commodity futures and forward contracts
Fair value
asset (liability)
$
Level 1
$
Level 2
$
Level 3
$
December 28, 2019
284
(73)
284
-
-
(73)
-
-
Fair value
asset (liability)
$
Level 1
$
Level 2
$
Level 3
$
December 29, 2018
620
7
(581)
(17)
583
3,239
-
-
(94)
-
-
-
620
7
(487)
(17)
583
3,239
-
-
-
-
-
-
As at December 28, 2019, outstanding contracts comprise exchange-traded commodity futures for cocoa and coffee. As
at December 29, 2018, outstanding contracts included exchange-traded commodity futures and forward commodity
purchase and sale contracts associated with the Company’s sold soy and corn business, in addition to cocoa and coffee
commodity futures. Exchange-traded futures are fair valued based on unadjusted quotes for identical assets priced in active
SUNOPTA INC.
-F19-
December 28, 2019 10-K
SunOpta Inc.
Notes to Consolidated Financial Statements
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts)
____________________________________________________________________________________________________
markets and are classified as level 1. Fair value for forward commodity purchase and sale contracts was estimated based
on exchange-quoted prices adjusted for differences in local markets and were classified as level 2.
Exchange-traded commodity futures for cocoa and coffee are used as part of the Company’s risk management strategy and
represent economic hedges to limit risk related to fluctuations in the price of these commodities. These contracts are not
designated as hedges for accounting purposes. Gains and losses on changes in fair value of these contracts are included in
cost of goods sold on the consolidated statement of operations. For the year ended December 28, 2019, the Company
recognized a gain of $0.4 million (December 29, 2018 – loss of $0.6 million; December 30, 2017 – loss of $0.0 million)
related to changes in the fair value of these derivatives. In addition, for the years ended December 29, 2018 and December
30, 2017, the Company recognized gains of $0.1 million and $0.6 million, respectively, related to changes in the fair value
of soy and corn futures and forward contracts. On the consolidated balance sheets, unrealized gains on short-term and
long-term contracts are included in other current assets and other assets, respectively, and unrealized losses on short-term
and long-term contracts are included in other current liabilities and long-term liabilities, respectively.
As at December 28, 2019, the Company had net open futures contracts to sell 3,210 metric tons (“MT”) of cocoa (December
29, 2018 – to sell 6,730 MT) and to sell 306 MT (December 29, 2018 – to purchase 85 MT) of coffee.
(2) Foreign forward currency contracts
As part of its risk management strategy, the Company enters into forward foreign exchange contracts to reduce its exposure
to fluctuations in foreign currency exchange rates. For any open forward foreign exchange contracts at period end, the
contract rate is compared to the forward rate, and a gain or loss is recorded. These contracts are included in level 2 of the
fair value hierarchy, as the inputs used in making the fair value determination are derived from and are corroborated by
observable market data. These contracts typically represent economic hedges that are not designated as hedging
instruments; however, certain of these contracts may be designated as cash flow hedges for accounting purposes.
As at December 28, 2019, the Company had open forward foreign exchange contracts to sell euros to buy U.S. dollars with
a notional value of €14.5 million ($16.4 million), to sell British pounds to buy euros with a notional value of £0.8 million
(€0.9 million), and to sell Swiss francs to buy U.S. dollars with a notional value of CHF 1.2 million ($1.2 million). As
these contracts were not designated as hedging instruments, gains and losses on changes in the fair value of the derivative
instruments are included in foreign exchange loss or gain on the consolidated statement of operations. For the year ended
December 28, 2019, the Company recognized a loss of $0.7 million (December 29, 2018 – gain of $1.6 million; December
30, 2017 – loss of $2.4 million) related to changes in the fair value of these derivatives. Unrealized gains and losses on
these contracts are included in accounts receivable and accounts payable, respectively, on the consolidated balance sheets.
From time to time, the Company enters into forward foreign exchange contracts to sell U.S. dollars to buy Mexican pesos.
As at December 28, 2019 and December 29, 2018, the Company had no open peso contracts. Prior to December 29, 2018,
the Company had designated forward exchange contracts to sell U.S. dollars to buy Mexican pesos as hedging instruments.
As a result, effective portion of the gains and losses on changes in the fair value of those contracts was included in other
comprehensive earnings and reclassified to cost of goods sold in the same period the hedged transaction affected earnings.
For the year ended December 29, 2018, the Company recognized a net gain of $0.5 million (December 30, 2017 – gain of
$1.8 million) in other comprehensive earnings related to changes in the fair value of open contracts. For the year ended
December 29, 2018, the Company reclassified from other comprehensive earnings to cost of goods sold a realized gain on
closed contracts of $0.1 million (December 30, 2017 – gain of $1.4 million). In addition, for the year ended December 30,
2017, the Company reclassified to foreign exchange loss an unrealized gain of $0.9 million related to the ineffective portion
of the hedge.
(3) Inventories carried at market
As at December 29, 2018, inventories carried at market represented inventories of commodity soy and corn associated
with the Company’s sold soy and corn business. The fair value of these inventories was determined using quoted market
prices from the Chicago Board of Trade, as adjusted for differences in local markets, and broker or dealer quotes, and
classified as level 2. Gains and losses on these inventories were included in cost of goods sold on the consolidated
SUNOPTA INC.
-F20-
December 28, 2019 10-K
SunOpta Inc.
Notes to Consolidated Financial Statements
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts)
____________________________________________________________________________________________________
statements of operations. Inventories carried at market were included in inventories on the consolidated balance sheet as
at December 29, 2018.
7. Accounts Receivable
Trade receivables
Product recall-related insurance recoveries(1)
Allowance for doubtful accounts
December 28, 2019 December 29, 2018
$
132,301
2,421
(2,591)
132,131
$
122,144
2,421
(3,120)
121,445
(1) Represents the remaining expected insurance recoveries related to the voluntary recall of certain roasted sunflower kernel products initiated by the
Company in 2016.
The change in the allowance for doubtful accounts provision for the years ended December 28, 2019 and December 29, 2018
is comprised as follows:
Balance, beginning of year
Net additions to provision
Accounts receivable written off, net of recoveries
Effects of foreign exchange rate differences
Balance, end of year
8. Inventories
Raw materials and work-in-process
Finished goods
Company-owned grain(1)
Inventory reserve
December 28, 2019 December 29, 2018
$
2,912
416
(717)
(20)
$
2,591
1,097
(552)
(16)
3,120
2,591
December 28, 2019 December 29, 2018
$
278,038
83,225
10,155
(9,461)
361,957
$
259,658
75,112
-
(11,224)
323,546
(1) Company-owned grain inventories as at December 29, 2018 were included in the sale of the soy and corn business.
The change in the inventory reserve for the years ended December 28, 2019 and December 29, 2018 is comprised as follows:
Balance, beginning of year
Additions to reserve during the year
Reserves applied and inventories written off during the year
Effect of foreign exchange rate differences
Balance, end of year
December 28, 2019 December 29, 2018
$
9,975
12,169
(12,612)
(71)
$
9,461
12,487
(10,697)
(27)
11,224
9,461
SUNOPTA INC.
-F21-
December 28, 2019 10-K
SunOpta Inc.
Notes to Consolidated Financial Statements
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts)
____________________________________________________________________________________________________
9. Property, Plant and Equipment
The major components of property, plant and equipment as at December 28, 2019 and December 29, 2018 were as follows:
Land
Buildings
Machinery and equipment
Enterprise software
Office furniture and equipment
Vehicles
Land
Buildings
Machinery and equipment
Enterprise software
Office furniture and equipment
Vehicles
Accumulated
depreciation
$
-
21,435
99,633
12,386
9,383
1,817
144,654
Accumulated
depreciation
$
-
24,059
94,920
8,878
8,472
2,180
138,509
December 28, 2019
Net book value
$
7,254
48,335
114,975
11,192
2,177
617
184,550
December 29, 2018
Net book value
$
7,075
49,733
98,062
12,118
3,033
1,011
171,032
Cost
$
7,254
69,770
214,608
23,578
11,560
2,434
329,204
Cost
$
7,075
73,792
192,982
20,996
11,505
3,191
309,541
As at December 28, 2019 property, plant and equipment included construction in process assets of $15.0 million (December
29, 2018 – $19.4 million), which were not being depreciated as they had not yet reached the stage of commercial viability. In
addition, as at December 28, 2019, machinery and equipment included equipment under finance leases (see note 10) with a
cost of $24.4 million (December 29, 2018 – $10.1 million) and a net book value of $17.9 million (December 29, 2018 – $3.4
million), as well as $5.6 million (December 29, 2018 – $4.9 million) of spare parts inventory.
Total depreciation expense included in cost of goods sold and selling, general and administrative expenses on the consolidated
statements of operations related to property, plant and equipment for the year ended December 28, 2019 was $23.0 million
(December 29, 2018 – $21.9 million; December 30, 2017 – $21.7 million).
10. Leases
The Company leases certain manufacturing plants, warehouses, offices, machinery and equipment, and farmland. The
Company subleases farmland to third-party growers. At the lease commencement date, the Company classifies a lease as a
finance lease if it has the right to obtain substantially all of the economic benefits from the right-of-use assets, otherwise the
lease is classified as an operating lease. The Company’s leases have remaining noncancelable lease terms of less than one year
to approximately 15 years, and typically require fixed monthly rental payments that may be adjusted annually to give effect to
inflation. Real estate leases typically include options to extend the leases for up to 10 years. Machinery and equipment
operating leases typically include purchase options for the fair market value of the underlying asset at the end of the lease term.
Certain other leases for machinery and equipment include nominal purchase options at the end of the lease term that are
reasonably certain of being exercised.
SUNOPTA INC.
-F22-
December 28, 2019 10-K
SunOpta Inc.
Notes to Consolidated Financial Statements
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts)
____________________________________________________________________________________________________
In 2019, the Company completed the expansion of its Allentown, Pennsylvania, plant-based beverage facility, including the
addition of new aseptic processing and packaging equipment under a seven-year finance lease. At the lease commencement
date, the Company recognized $14.5 million of right-of-use assets in property, plant and equipment, and a corresponding lease
liability in long-term debt. The right-of-use assets are being amortized on a straight-line basis over the term of the lease.
The following tables present supplemental information related to leases recognized in the consolidated financial statements:
Lease Costs
Operating lease cost
Finance lease cost
Depreciation of right-of-use assets
Interest on lease liabilities
Sublease income
Net lease cost
December 28, 2019
$
19,321
1,998
286
(476)
21,129
Total rental expense under operating leases was $22.7 million and $28.0 million for the years ended December 29, 2018 and
December 30, 2017, respectively.
Balance Sheet Classification
Operating leases
Operating lease right-of-use assets
Current portion of operating lease liabilities
Operating lease liabilities
Total operating lease liabilities
Finance leases
Property, plant and equipment, gross
Accumulated depreciation
Property, plant and equipment, net
Current portion of long-term debt
Long-term debt
Total finance lease liabilities
Cash Flow Information
Cash paid for amounts included in measurement of lease liabilities
Operating cash flows from operating leases
Operating cash flows from finance leases
Financing cash flows from finance leases
Right-of-use assets obtained in exchange for lease liabilities
Operating leases
Finance leases
December 28, 2019
$
68,433
17,215
52,020
69,235
24,445
(6,528)
17,917
2,493
13,730
16,223
December 28, 2019
$
19,534
286
1,917
2,760
14,549
SUNOPTA INC.
-F23-
December 28, 2019 10-K
SunOpta Inc.
Notes to Consolidated Financial Statements
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts)
____________________________________________________________________________________________________
Other Information
Weighted-average remaining lease term (years)
Operating leases
Finance leases
Weighted-average discount rate(1)
Operating leases
Finance leases
December 28, 2019
5.9
5.9
9.2%
4.5%
(1)
In determining the present value of lease payments, the Company uses the implicit rate in the lease when that rate is readily determinable, which is
the case for most of the Company’s machinery and equipment leases. In all other cases, including real estate leases, the Company uses its
incremental borrowing rate. The Company applied the incremental borrowing rate as at December 30, 2018 (the first day of fiscal 2019) to leases
that commenced prior to that date. Discount rates are determined on a lease-by-lease basis.
Maturities of Lease Liabilities
2020
2021
2022
2023
2024
Thereafter
Total lease payments
Less: imputed interest
Total lease liabilities
Operating leases
$
Finance leases
$
17,695
15,100
13,376
8,842
7,122
43,877
106,012
(36,777)
69,235
3,168
3,168
3,168
2,572
2,452
4,087
18,615
(2,392)
16,223
As at December 28, 2019, the Company did not have any material commitments for right-of-use assets for which the leases
had not commenced.
11. Goodwill
In connection with changes to the Company’s segment reporting structure in the fourth quarter of 2019 (see note 24), gross
goodwill and accumulated loss balances previously allocated to the Company’s former Consumer Products operating segment
were reallocated to the Global Ingredients and Fruit-Based Foods and Beverages operating segments. The net goodwill balance
reallocated to Global Ingredients, which relates to the Company’s premium juice program, amounted to $15.1 million as at
December 28, 2019, December 29, 2018 and December 30, 2017. The net goodwill balance reallocated to the Fruit-Based
Foods and Beverages operating segment, which relates to the Company’s frozen fruit and fruit snacks businesses, amounted to
$4.0 million as at December 28, 2019 and December 29, 2018, and $85.2 million as at December 30, 2017.
SUNOPTA INC.
-F24-
December 28, 2019 10-K
SunOpta Inc.
Notes to Consolidated Financial Statements
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts)
____________________________________________________________________________________________________
The following is a summary of changes in goodwill by segment:
Balance at December 30, 2017
Goodwill impairment
Foreign exchange
Balance at December 29, 2018
Acquisition of Sanmark (see note 3)
Sale of soy and corn business (see note 4)
Foreign exchange
Balance at December 28, 2019
Global
Ingredients
$
24,313
-
(352)
23,961
2,174
(1,526)
(185)
24,424
Plant-Based
Foods and
Beverages
$
-
-
-
-
-
-
-
-
Fruit-Based
Foods and
Beverages
$
85,220
(81,222)
-
3,998
-
-
-
3,998
Total
$
109,533
(81,222)
(352)
27,959
2,174
(1,526)
(185)
28,422
For the year ended December 28, 2019, the Company performed a qualitative assessment of goodwill and determined that the
fair values of the reporting units with goodwill significantly exceeded their carrying values. As a result, the Company
concluded that goodwill was not impaired in 2019.
Based on the results of quantitative testing performed for the years ended December 29, 2018 and December 30, 2017, the
Company recognized goodwill impairment charges of $81.2 million and $115.0 million, respectively, to fully write-off the
goodwill that arose from the Company’s acquisition of Sunrise Holdings (Delaware), Inc. (“Sunrise”) in October 2015. The
operations of Sunrise are included in the Fruit-Based Foods and Beverages segment. The goodwill impairment charges
reflected lower-than-expected revenues and operating performance for the Sunrise frozen fruit business since the acquisition,
reflecting weaker-than-expected consumption trends and lower sales pricing introduced over the preceding two fiscal years to
regain or maintain distribution volumes, as well as uncertainty of future revenue growth patterns and gross margin profile due
to market conditions and sales pricing limitations. In addition, while the Company had identified certain productivity measures
to reduce costs and increase profitability in the business, the ultimate timing and outcome of these measures was not fully
certain.
12. Intangible Assets
The major components of intangible assets as at December 28, 2019 and December 29, 2018 were as follows:
Customer relationships
Patents, trademarks and other
Customer relationships
Patents, trademarks and other
Cost
$
210,157
1,919
212,076
Cost
$
210,845
1,919
212,764
Accumulated
amortization
$
60,173
1,894
62,067
Accumulated
amortization
$
49,937
1,852
51,789
December 28, 2019
Net book value
$
149,984
25
150,009
December 29, 2018
Net book value
$
160,908
67
160,975
SUNOPTA INC.
-F25-
December 28, 2019 10-K
SunOpta Inc.
Notes to Consolidated Financial Statements
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts)
____________________________________________________________________________________________________
Total amortization expense included in selling, general and administrative expenses on the consolidated statements of
operations related to intangible assets for the year ended December 28, 2019 was $11.0 million (December 29, 2018 – $11.0
million; December 30, 2017 – $11.2 million). Amortization expense associated with intangible assets in each of the next five
fiscal years and thereafter will be as follows:
Amortization expense
2020
$
10,430
2021
$
10,112
2022
$
10,112
2023
$
10,112
2024 Thereafter
$
99,131
$
10,112
Total
$
150,009
13. Accounts Payable and Accrued Liabilities
Accounts payable
Payroll and commissions
Accrued product recall-related costs(1)
Accrued interest
Dividends payable on Series A Preferred Stock (see note 15)
Accrued grain liabilities(2)
Other accruals
December 28, 2019 December 29, 2018
$
115,297
8,817
3,792
5,346
1,700
15,322
5,097
155,371
$
102,896
15,577
3,213
5,022
1,700
-
5,121
133,529
(1) Represents the provision for remaining unsettled customer claims related to the voluntary recall of certain roasted sunflower kernel products initiated
by the Company in 2016.
(2) Accrued grain liabilities as at December 29, 2018 were included in the sale of the soy and corn business.
14. Bank Indebtedness and Long-Term Debt
Bank Indebtedness
Global Credit Facility(1)
Bulgarian credit facility(2)
Long-Term Debt
Senior Secured Second Lien Notes, net of unamortized debt issuance costs
of $5,094 (December 29, 2018 - $6,472)(3)
Finance lease liabilities (see note 10)
Asset-backed term loan(4)
Other
Less: current portion
(1) Global Credit Facility
December 28, 2019 December 29, 2018
$
$
241,666
3,870
245,536
218,404
16,223
4,386
6,178
245,191
2,987
242,204
276,776
3,558
280,334
217,026
3,706
3,103
5,028
228,863
1,840
227,023
On February 11, 2016, the Company entered into a five-year credit agreement for a senior secured asset-based revolving
credit facility with a syndicate of banks in the maximum aggregate principal amount of $350.0 million, subject to
borrowing base capacity (the “Global Credit Facility”). The Global Credit Facility is used to support the working capital
SUNOPTA INC.
-F26-
December 28, 2019 10-K
SunOpta Inc.
Notes to Consolidated Financial Statements
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts)
____________________________________________________________________________________________________
and general corporate needs of the Company’s global operations, in addition to funding future strategic initiatives. The
Global Credit Facility also includes borrowing capacity available for letters of credit and provides for borrowings on same-
day notice, including in the form of swingline loans. On January 28, 2020, the Company entered into a restatement
agreement, amending and restating the existing credit agreement to, among other things, extend the maturity date of the
Global Credit Facility to March 31, 2022.
Individual borrowings under the Global Credit Facility have terms of six months or less and bear interest based on various
reference rates plus an applicable margin. The margin ranges from 0.25% to 0.75% with respect to base rate and prime
rate borrowings and from 1.25% to 1.75% for eurocurrency rate and bankers’ acceptance rate borrowings. In addition,
under the restatement agreement, the margin is increased by an additional 0.50% while the Company’s total leverage ratio
exceeds a specific threshold.
On September 19, 2017, the Company entered into an amendment to the Global Credit Facility to add a $15.0 million U.S.
asset-based credit subfacility (the “U.S. Subfacility”). On October 22, 2018, the Global Credit Facility was further
amended to increase the commitment under the U.S. Subfacility to $20.0 million. Commencing on March 31, 2019,
quarterly amortization payments on the aggregate principal amount of the U.S. Subfacility are equal to $3.33 million, and
these payments may be funded through borrowings under the revolving facilities of the Global Credit Facility. Borrowings
repaid under the U.S. Subfacility may not be borrowed again. As at December 28, 2019, $10.0 million remained drawn
on the U.S. Subfacility. Borrowings under the U.S. Subfacility bear interest based on various reference rates plus a margin
of 3.50%. The applicable margin for the U.S. Subfacility is set quarterly based on average borrowing availability for the
preceding fiscal quarter ranges from 2.00% to 2.50% with respect to base rate and prime rate borrowings and from 3.00%
to 3.50% for eurocurrency rate and bankers’ acceptance rate borrowings.
As at December 28, 2019, the weighted-average interest rate on all borrowings under the Global Credit Facility was 3.37%.
Obligations under the Global Credit Facility are guaranteed by substantially all of the Company’s subsidiaries and, subject
to certain exceptions, such obligations are secured by first priority liens on substantially all of the assets of the Company.
The Global Credit Facility contains a number of covenants that, among other things, restrict, subject to certain exceptions,
the Company’s ability to create liens on assets; sell assets and enter into sale and leaseback transactions; pay dividends,
prepay junior lien and unsecured indebtedness and make other restricted payments; incur additional indebtedness and make
guarantees; make investments, loans or advances, including acquisitions; and engage in mergers or consolidations. The
foregoing covenants are subject to certain threshold amounts and exceptions as set forth in the credit agreement.
(2) Bulgarian credit facility
On August 30, 2019, a subsidiary of The Organic Corporation B.V. (“TOC”), a wholly-owned subsidiary of the Company,
amended its revolving credit facility agreement dated May 22, 2013, to increase the maximum principal amount from €4.5
million to €6.0 million. Borrowings under the facility are used to cover the working capital needs of TOC’s Bulgarian
operations, and are secured by the accounts receivable and inventories of the Bulgarian operations and fully guaranteed by
TOC. Interest accrues under the facility based on EURIBOR plus a margin of 2.75%, and borrowings under the facility
are repayable in full on April 30, 2020.
(3) Senior Secured Second Lien Notes
On October 20, 2016, the Company’s subsidiary, SunOpta Foods Inc. (“SunOpta Foods”) issued $231.0 million of 9.5%
Senior Secured Second Lien Notes due 2022 (the “Notes”). As at December 28, 2019, the outstanding principal amount
of the Notes was $223.5 million, reflecting the redemption of $7.5 million principal amount by SunOpta Foods in October
2017. Debt issuance costs are recorded as a reduction against the principal amount of the Notes and are being amortized
over the six-year term of the Notes. Interest on the Notes is payable semi-annually in arrears on April 15 and October 15
at a rate of 9.5% per annum. The Notes will mature on October 9, 2022. Giving effect to the amortization of debt issuance
costs, the effective interest rate on the Notes is approximately 10.4% per annum.
SUNOPTA INC.
-F27-
December 28, 2019 10-K
SunOpta Inc.
Notes to Consolidated Financial Statements
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts)
____________________________________________________________________________________________________
At any time after October 9, 2019, SunOpta Foods may redeem the Notes, in whole or in part, at a redemption price equal
to 104.750% from October 9, 2019 through October 8, 2020, 102.375% from October 9, 2020 through October 8, 2021
and at par thereafter, plus accrued and unpaid interest, if any, to but excluding the date of redemption. Certain additional
redemption rights were applicable prior to October 9, 2019. In the event of a change of control, SunOpta Foods will be
required to make an offer to repurchase the Notes at 101.000% of their principal amount, plus accrued and unpaid interest,
if any, to the date of purchase.
The Notes are secured by second-priority liens on substantially all of the assets that secure the credit facilities provided
under the Global Credit Facility, subject to certain exceptions and permitted liens. The Notes are senior secured obligations
and rank equally in right of payment with SunOpta Foods’ existing and future senior debt and senior in right of payment
to any future subordinated debt. The Notes are effectively subordinated to debt under the Global Credit Facility and any
future indebtedness secured on a first priority basis. The Notes are initially guaranteed on a senior secured second-priority
basis by the Company and each of its subsidiaries (other than SunOpta Foods) that guarantees indebtedness under the
Global Credit Facility, subject to certain exceptions.
The Notes are subject to covenants that, among other things, limit the Company’s ability to (i) incur additional debt or
issue preferred stock; (ii) pay dividends and make certain types of investments and other restricted payments; (iii) create
liens; (iv) enter into transactions with affiliates; (v) sell assets; and (vi) create restrictions on the ability of restricted
subsidiaries to pay dividends, make loans or advances or transfer assets to the Company, SunOpta Foods or any guarantor
of the Notes. The foregoing covenants are subject to certain threshold amounts and exceptions as set forth in the indenture
governing the Notes. In addition, the indenture provides for customary events of default (subject in certain cases to
customary grace and cure periods), which include nonpayment, breach of covenants in the indenture, certain payment
defaults or acceleration of other indebtedness, a failure to pay certain judgments and certain events of bankruptcy and
insolvency. If an event of default occurs and is continuing, the trustee or holders of at least 25% in principal amount of
the outstanding Notes may declare the principal of and accrued and unpaid interest on, if any, all the Notes to be due and
payable.
As at December 28, 2019, the estimated fair value of the outstanding Notes was approximately $230 million, based on
quoted prices of the most recent over-the-counter transactions (level 2).
(4) Asset-backed term loans
On December 28, 2017, TOC entered into a €3.0 million asset-backed term loan. Interest on this loan accrues at an
effective rate of 3.06% and the loan matures on December 28, 2027. Principal and accrued interest is repayable in equal
monthly installments. On January 8, 2019, TOC entered into a second asset-backed term loan for €1.6 million, which
accrues interest at an effective rate of 3.42% and matures on December 28, 2027. Principal and accrued interest on these
loans are repayable in equal monthly installments. These loans are secured by a first priority lien on equipment owned
by TOC for the second cocoa processing line at its facility in the Netherlands and are fully guaranteed by TOC.
Principal repayments of long-term debt are as follows:
2020
2021
2022
2023
2024
Thereafter
Total gross repayments
Less: imputed interest
Less: debt issuance costs
$
3,796
9,939
227,337
3,200
3,080
5,918
253,270
(2,985)
(5,094)
245,191
SUNOPTA INC.
-F28-
December 28, 2019 10-K
SunOpta Inc.
Notes to Consolidated Financial Statements
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts)
____________________________________________________________________________________________________
The components of interest expense, net are as follows:
Interest expense
Amortization of debt issuance costs
Interest income
Interest expense, net
15. Series A Preferred Stock
December 28, 2019 December 29, 2018 December 30, 2017
$
29,771
2,825
(92)
32,504
$
32,862
2,721
(906)
34,677
$
32,155
2,536
(285)
34,406
On October 7, 2016, the Company and SunOpta Foods entered into a subscription agreement (the “Subscription Agreement”)
with Oaktree Organics, L.P. and Oaktree Huntington Investment Fund II, L.P. (collectively, the “Investors”). Pursuant to the
Subscription Agreement, SunOpta Foods issued an aggregate of 85,000 shares of Series A Preferred Stock (the “Preferred
Stock”) to the Investors for consideration in the amount of $85.0 million. In connection with the issuance of the Preferred
Stock, the Company incurred direct and incremental expenses of $6.0 million, which reduced the carrying value of the Preferred
Stock. At any time on or after October 7, 2021, SunOpta Foods may redeem all of the Preferred Stock for an amount, per share
of Preferred Stock, equal to the value of the liquidation preference at such time. The carrying value of the Preferred Stock is
being accreted to the redemption amount of $85.0 million through charges to accumulated deficit over the period preceding
October 7, 2021. These accretion charges amounted to $1.2 million, $1.1 million and $1.0 million in the years ended December
28, 2019, December 29, 2018 and December 30, 2017, respectively.
In connection with the Subscription Agreement, the Company agreed to, among other things (i) ensure SunOpta Foods has
sufficient funds to pay its obligations under the terms of the Preferred Stock and (ii) grant each holder of Preferred Stock (the
“Holder”) the right to exchange the Preferred Stock for shares of common stock of the Company (the “Common Shares”). The
Preferred Stock is non-participating with the Common Shares in dividends and undistributed earnings of the Company.
The Preferred Stock has a stated value and initial liquidation preference of $1,000 per share. Cumulative preferred dividends
accrue daily on the Preferred Stock at an annualized rate of 8.0% of the liquidation preference prior to October 5, 2025 and
12.5% of the liquidation preference thereafter (subject to an increase of 1.0% per quarter, up to a maximum rate of 5.0% per
quarter on the occurrence of certain events of non-compliance). Prior to October 5, 2025, SunOpta Foods may pay dividends
in cash or elect, in lieu of paying cash, to add the amount that would have been paid to the liquidation preference. After October
4, 2025, the failure to pay dividends in cash will be an event of non-compliance. The Preferred Stock ranks senior to the shares
of common stock of SunOpta Foods with respect to dividend rights and rights on the distribution of assets on any liquidation,
winding up or dissolution of the Company or SunOpta Foods. SunOpta Foods paid cash dividends on the Preferred Stock of
$6.8 million in years ended December 28, 2019 and December 29, 2018, and $6.7 million in the year ended December 30,
2017. As at December 28, 2019, SunOpta Foods had accrued unpaid dividends of $1.7 million, which were recorded in
accounts payable and accrued liabilities on the Company’s consolidated balance sheet.
At any time, the Holders may exchange their shares of Preferred Stock, in whole or in part, into the number of Common Shares
equal to, per share of Preferred Stock, the quotient of the liquidation preference divided by $7.50 (such price, the “Exchange
Price” and such quotient, the “Exchange Rate”). As at December 28, 2019, the aggregate shares of Preferred Stock outstanding
were exchangeable into 11,333,333 Common Shares. The Exchange Price is subject to certain anti-dilution adjustments,
including a weighted-average adjustment for issuances of Common Shares below the Exchange Price, provided that the
Exchange Price may not be lower than $7.00 (subject to adjustment in certain circumstances). SunOpta Foods may cause the
Holders to exchange all of the Preferred Stock into a number of Common Shares based on the applicable Exchange Price if (i)
fewer than 10% of the shares of Preferred Stock issued on October 7, 2016 remain outstanding, or (ii) on or after October 7,
2019, the average volume-weighted average price of the Common Shares during the then preceding 20 trading day period is
greater than 200% of the Exchange Price.
In connection with the Subscription Agreement, the Company issued 11,333,333 Special Shares, Series 1 (the “Special Voting
Shares”) to the Investors, which entitle the Investors to one vote per Special Voting Share on all matters submitted to a vote of
the holders of Common Shares, together as a single class, subject to certain exceptions. Additional Special Voting Shares will
December 28, 2019 10-K
SUNOPTA INC.
-F29-
SunOpta Inc.
Notes to Consolidated Financial Statements
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts)
____________________________________________________________________________________________________
be issued, or existing Special Voting Shares will be redeemed, as necessary to ensure that the aggregate number of Special
Voting Shares outstanding is equal to the number of shares of Preferred Stock outstanding from time to time multiplied by the
Exchange Rate in effect at such time. As at December 28, 2019, 11,333,333 Special Voting Shares were issued and outstanding,
which represented an approximate 11.4% voting interest in the Company. The Special Voting Shares are not transferable, and
the voting rights associated with the Special Voting Shares will terminate upon the transfer of the Preferred Stock to a third
party, other than a controlled affiliate of the Investors. The Investors are entitled to designate up to two nominees for election
to the Board of Directors of the Company (the “Board”) and have the right to designate one individual to attend meetings of
the Board as a non-voting observer, subject to the Investors maintaining certain levels of beneficial ownership of Common
Shares on an as-exchanged basis. For so long as the Investors beneficially own or control at least 50% of the Preferred Stock
issued on October 7, 2016, including any corresponding Common Shares into which such Preferred Stock are exchanged, the
Investors will be entitled to (i) participation rights with respect to future equity offerings of the Company, and (ii) governance
rights, including the right to approve certain actions proposed to be taken by the Company and its subsidiaries.
16. Common Shares
The Company is authorized to issue an unlimited number of Common Shares without par value and an unlimited number of
special shares without par value.
17. Stock-Based Compensation
Stock Incentive Plan
On May 28, 2013, the Company’s shareholders approved the 2013 Stock Incentive Plan, as amended (the “2013 Plan”), which
permits the grant of a variety of stock-based awards, including stock options, restricted stock units (“RSUs”) and performance
share units (“PSUs”) to selected employees and directors of the Company. As at December 28, 2019, 3,876,211 securities
remained available for issuance under the 2013 Plan.
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017, gross stock-based compensation expense
amounted to $11.6 million $7.9 million and $6.4 million, respectively. For the years ended December 28, 2019 and December
30, 2017, net stock-based compensation expense was $7.5 million and $5.7 million, respectively, taking into account the
reversal of $4.1 million and $0.7 million, respectively, of previously recognized stock compensation related to forfeited awards
previously granted to employees who were terminated in connection with the Value Creation Plan (see note 5).
Stock Options
Stock options granted to selected employees during the three-year period ended December 28, 2019 vest ratably on each of the
first through third anniversaries of the grant date and expire on the tenth anniversary of the grant date. Stock options granted
by the Company contain an exercise price that is equal to the closing market price of the shares on the day prior to the grant
date. Any consideration paid by employees or directors on exercise of stock options or purchase of stock is credited to capital
stock.
SUNOPTA INC.
-F30-
December 28, 2019 10-K
SunOpta Inc.
Notes to Consolidated Financial Statements
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts)
____________________________________________________________________________________________________
The following table summarizes stock option activity for the year ended December 28, 2019:
Outstanding, beginning of year
Granted
Exercised
Forfeited
Expired
Outstanding, end of year
Exercisable, end of year
Stock options
2,698,550 $
12,400
(49,824)
(617,531)
(93,707)
1,949,888 $
1,370,188 $
Weighted-
average
exercise price
7.76
3.57
3.27
8.35
9.51
7.57
6.88
Weighted-
average
remaining
contractual
term (years)
Aggregate
intrinsic value
5.68 $
4.94 $
-
-
The following table summarizes non-vested stock option activity during the year ended December 28, 2019:
Non-vested, beginning of year
Granted
Vested
Forfeited
Non-vested, end of year
Stock options
1,433,648 $
12,400
(441,034)
(425,314)
579,700 $
Weighted-
average grant-
date fair value
3.74
1.70
3.08
3.84
4.14
The weighted-average grant-date fair values of all stock options granted in the years ended December 28, 2019, December 29,
2018 and December 30, 2017, were $1.70, $3.31 and $4.12, respectively. The weighted-average assumptions used in the Black-
Scholes option pricing model to determine the fair value of the stock options granted in those years were as follows:
Grant-date stock price
Dividend yield(1)
Expected volatility(2)
Risk-free interest rate(3)
Expected life of options (years)(4)
$
$
December 28, 2019 December 29, 2018 December 30, 2017
9.29
0%
42.1%
2.0%
6.4
3.57
0%
48.6%
2.3%
5.8
7.56
0%
41.1%
2.9%
6.0
$
(1) Determined based on expected annual dividend yield at the time of grant.
(2) Determined based on historical volatility of the Company’s Common Shares over the expected life of the option.
(3) Determined based on the yield on U.S. Treasury zero-coupon issues with maturity dates equal to the expected life of the option.
(4) Determined using simplified method, as the Company changed the vesting period of its stock option grants from five years to three years in 2016,
and, as a result, historical exercise data may not provide a reasonable basis upon which to estimate expected life.
SUNOPTA INC.
-F31-
December 28, 2019 10-K
SunOpta Inc.
Notes to Consolidated Financial Statements
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts)
____________________________________________________________________________________________________
The following table summarizes stock options outstanding and exercisable as at December 28, 2019:
$
$
Exercise price range
High
5.50
6.73
8.98
9.79
13.86
Low
3.27
5.51
6.74
8.99
9.80
Outstanding
options
325,115
469,455
331,610
559,761
263,947
1,949,888
Weighted-
average
remaining
(years)
Weighted-
contractual life average exercise
price
3.75
6.19
7.56
9.44
10.73
7.57
5.76 $
4.64
4.63
7.50
4.93
5.68 $
Weighted-
Exercisable average exercise
price
3.73
6.19
7.41
9.26
10.80
6.88
options
307,715 $
469,455
265,498
87,327
240,193
1,370,188 $
Total compensation costs related to non-vested stock option awards not yet recognized as an expense was $0.5 million as at
December 28, 2019, which will be amortized over a weighted-average remaining vesting period of 0.6 years.
Restricted Stock Units
RSUs granted to employees vest ratably on each of the first through third anniversaries of the grant date. RSUs granted to
directors vest 100% on the first anniversary of the grant date. Each vested RSU entitles the employee or director to receive
one common share of the Company. The weighted-average grant-date fair values of all RSUs granted in the years ended
December 28, 2019, December 29, 2018 and December 30, 2017, were $3.33, $7.65 and $9.18, respectively.
The following table summarizes non-vested RSU activity during the year ended December 28, 2019:
Non-vested, beginning of year
Granted
Vested
Forfeited
Non-vested, end of year
Weighted-
average grant-
date fair value
8.46
3.33
7.79
8.41
5.64
RSUs
597,837 $
274,086
(331,848)
(127,062)
413,013 $
Total compensation costs related to non-vested RSU awards not yet recognized as an expense was $0.8 million as at December
28, 2019, which will be amortized over a weighted-average remaining vesting period of 0.6 years.
Performance Share Units
For the year ended December 28, 2019, the Company granted a total of 2,846,962 PSUs to certain employees of the Company
under its Short-Term Incentive Plan. The vesting of these PSUs was subject to the Company achieving a predetermined
measure of adjusted earnings before interest, taxes, depreciation and amortization (“EBITDA”) for fiscal 2019, and is subject
to each employee’s continued employment with the Company through April 12, 2020 (the requisite service period). The
weighted-average grant-date fair value of the PSUs was estimated to be $3.42 based on the closing prices of the Common
Shares on the dates of grant. Each reporting period, the number of PSUs that are expected to vest is redetermined and the
aggregate grant-date fair value of the redetermined number of PSUs is amortized on a straight-line basis over the remaining
requisite service period less amounts previously recognized.
No PSUs were granted in the year ended December 29, 2018.
SUNOPTA INC.
-F32-
December 28, 2019 10-K
SunOpta Inc.
Notes to Consolidated Financial Statements
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts)
____________________________________________________________________________________________________
For the year ended December 30, 2017, the Company granted 1,560,535 PSUs to selected employees. The vesting of these
PSUs is subject to the satisfaction of certain stock price performance conditions during a three-year performance period ending
May 24, 2020. One-third of the PSUs will vest upon achieving a stock price of $11.00, one-third will vest upon achieving a
stock price of $14.00, and one-third will vest upon achieving a stock price of $18.00, in each case for 20 consecutive trading
days and subject to the employee’s continued employment throughout the performance period. Each vested PSU will entitle
the employee to receive one common share of the Company without payment of additional consideration. The fair value of the
PSUs granted was estimated using a Monte Carlo valuation model, which simulates the potential outcomes for the Company’s
stock price performance and determines the payouts that would occur under each scenario. Fair value is based on the average
of those results. The grant-date weighted-average fair value of the PSUs was determined to be $5.64, based on the following
inputs to the valuation model:
Grant-date stock price
Dividend yield
Expected volatility(1)
Risk-free interest rate(2)
Expected life (in years)(3)
$
December 30, 2017
9.33
0%
42.2%
1.5%
3.0
(1) Determined based on the historical volatility of the Common Shares over 6.5 years, which is consistent with the volatility assumption for stock
options granted to employees.
(2) Determined based on U.S. Treasury yields with a remaining term equal to the expected life of the PSUs.
(3) Determined based on vesting for the PSUs.
The following table summarizes non-vested PSU activity during the year ended December 28, 2019:
Non-vested, beginning of year
Granted
Forfeited or cancelled
Non-vested, end of year
Weighted-
average grant-
date fair value
5.60
3.42
4.23
4.08
PSUs
1,361,896 $
2,846,962
(1,272,743)
2,936,115 $
Total compensation costs related to non-vested PSU awards not yet recognized as an expense was $1.9 million as at December
28, 2019, which will be amortized over a weighted-average remaining vesting period of 0.3 years.
Chief Executive Officer
On April 1, 2019, Joseph D. Ennen was appointed CEO of the Company. In connection with his appointment, the Company
granted Mr. Ennen options to purchase 960,061 Common Shares, 512,619 RSUs (of which 215,000 were issued to equal the
number of Common Shares purchased by Mr. Ennen on the open market within the 60-day period after his employment began)
and 1,785,714 PSUs. The stock options vest on April 1, 2022, subject to Mr. Ennen’s continued employment during the vesting
period, and expire on April 1, 2029. Each vested stock option will entitle Mr. Ennen to purchase one Common Share at an
exercise price of $3.36, which was equal to the closing price of the Common Shares on April 1, 2019. The RSUs vest in three
equal annual installments beginning on April 1, 2020, and each vested RSU will entitle Mr. Ennen to receive one Common
Share of the Company.
The vesting of 892,857 of the PSUs granted is subject to the Company achieving annual adjusted EBITDA thresholds during
fiscal years 2019 through 2022, as follows: 297,619 PSUs will vest upon the Company achieving annual adjusted EBITDA of
$80 million, another 297,619 will vest upon the Company achieving annual adjusted EBITDA of $110 million, and the final
297,619 will vest upon the Company achieving annual adjusted EBITDA of $140 million, and subject to Mr. Ennen’s continued
employment with the Company through the end of the fiscal year during which the adjusted EBITDA performance condition
SUNOPTA INC.
-F33-
December 28, 2019 10-K
SunOpta Inc.
Notes to Consolidated Financial Statements
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts)
____________________________________________________________________________________________________
is achieved. The vesting of the other 892,857 PSUs that were granted is subject to the Common Shares achieving certain
volume-weighted average trading prices during a performance period commencing on April 1, 2019 and ending on December
31, 2022, as follows: 297,619 PSUs will vest upon achieving a trading price of $5.00 per share, another 297,619 will vest upon
achieving a trading price of $9.00 per share, and the final 297,619 will vest upon achieving a trading price of $14.00 per share,
in each case for 20 consecutive trading days, and subject to Mr. Ennen’s continued employment with the Company through the
date the stock price performance condition is achieved. Each vested PSU will entitle Mr. Ennen to receive one Common Share
without payment of additional consideration.
The weighted-average grant-date fair values of the RSUs and PSUs subject to the adjusted EBITDA performance condition
were estimated to be $3.46 and $3.36, respectively, based on the closing price of Common Shares on the dates of grant. A
grant-date fair value of $1.68 was estimated for the stock options using the Black-Scholes option pricing model, and a weighted-
average grant-date fair value of $1.77 was estimated for the PSUs subject to the stock price performance condition using a
Monte Carlo valuation model. The following table summarizes the inputs to the Black-Scholes option-pricing and Monte Carlo
valuation models:
Grant-date stock price
Exercise price
Dividend yield
Expected volatility(1)
Risk-free interest rate(2)
Expected life (in years)(3)
$
$
Stock Options
3.36 $
3.36
0%
47.9%
2.4%
6.5
PSUs
3.36
NA
0%
55.7%
2.3%
1.8
(1) Determined based on the historical volatility of the Common Shares over the expected life of the stock options and performance period of the PSUs.
(2) Determined based on U.S. Treasury yields with a remaining term equal to the expected life of the stock options and performance period of the
PSUs.
(3) Determined based on the mid-point of vesting (three years) and expiration (ten years) for the stock options and the derived service period for the
PSUs.
The aggregate grant-date fair value of the stock options, RSUs and PSUs awarded to Mr. Ennen was determined to be $8.0
million, which will be recognized on a straight-line basis over the vesting period for the stock options and RSUs and the derived
service period for the PSUs. Each reporting period, the number of PSUs subject to the adjusted EBITDA performance condition
that are expected to vest is redetermined and the aggregate grant-date fair value of the redetermined number of those PSUs is
amortized over the remaining service period less amounts previously recognized. Total compensation costs related to Mr.
Ennen’s non-vested equity awards not yet recognized as an expense was $5.7 million as at December 28, 2019, which will be
amortized over a weighted-average remaining vesting period of 2.4 years.
Chief Financial Officer
On September 3, 2019, Scott Huckins was appointed CFO of the Company. In connection with his appointment, the Company
granted Mr. Huckins options to purchase 262,182 Common Shares, 327,819 RSUs (of which 154,500 were issued to equal the
number of Common Shares purchased by Mr. Huckins on the open market prior to December 12, 2019) and 346,638 PSUs.
The stock options vest on September 3, 2022, subject to Mr. Huckins’ continued employment during the vesting period, and
expire on September 3, 2029. Each vested stock option will entitle Mr. Huckins to purchase one Common Share at an exercise
price of $2.38, which was equal to the closing price of the Common Shares on September 3, 2019. The RSUs vest in three
equal annual installments beginning on September 3, 2020, and each vested RSU will entitle Mr. Huckins to receive one
Common Share of the Company.
The vesting of 173,319 of the PSUs granted is subject to the Company achieving annual EBITDA thresholds during fiscal years
2019 through 2022, as follows: 57,773 PSUs will vest upon the Company achieving annual adjusted EBITDA of $80 million,
another 57,773 will vest upon the Company achieving annual adjusted EBITDA of $110 million, and the final 57,773 will vest
upon the Company achieving annual adjusted EBITDA of $140 million, and subject to Mr. Huckins’ continued employment
with the Company through the end of the fiscal year during which the adjusted EBITDA performance condition is achieved.
The vesting of the other 173,319 PSUs that were granted is subject to the Common Shares achieving certain volume-weighted
SUNOPTA INC.
-F34-
December 28, 2019 10-K
SunOpta Inc.
Notes to Consolidated Financial Statements
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts)
____________________________________________________________________________________________________
average trading prices during a performance period commencing on September 3, 2019 and ending on December 31, 2022, as
follows: 57,773 PSUs will vest upon achieving a trading price of $5.00 per share, another 57,773 will vest upon achieving a
trading price of $9.00 per share, and the final 57,773 will vest upon achieving a trading price of $14.00 per share, in each case
for 20 consecutive trading days, and subject to Mr. Huckins’ continued employment with the Company through the date the
stock price performance condition is achieved. Each vested PSU will entitle Mr. Huckins to receive one Common Share
without payment of additional consideration.
The weighted-average grant-date fair values of the RSUs and PSUs subject to the adjusted EBITDA performance condition
were estimated to be $2.45 and $2.38, respectively, based on the closing price of Common Shares on the dates of grant. A
grant-date fair value of $1.18 was estimated for the stock options using the Black-Scholes option pricing model, and a weighted-
average grant-date fair value of $0.79 was estimated for the PSUs subject to the stock price performance condition using a
Monte Carlo valuation model. The following table summarizes the inputs to the Black-Scholes option-pricing and Monte Carlo
valuation models:
Grant-date stock price
Exercise price
Dividend yield
Expected volatility(1)
Risk-free interest rate(2)
Expected life (in years)(3)
$
$
Stock Options
2.38 $
2.38
0%
49.7%
1.4%
6.5
PSUs
2.38
NA
0%
55.9%
1.4%
2.1
(1) Determined based on the historical volatility of the Common Shares over the expected life of the stock options and performance period of the PSUs.
(2) Determined based on U.S. Treasury yields with a remaining term equal to the expected life of the stock options and performance period of the
PSUs.
(3) Determined based on the mid-point of vesting (three years) and expiration (ten years) for the stock options and the derived service period for the
PSUs.
The aggregate grant-date fair value of the stock options, RSUs and PSUs awarded to Mr. Huckins was determined to be $1.7
million, which will be recognized on a straight-line basis over the vesting period for the stock options and RSUs and the derived
service period for the PSUs. Each reporting period, the number of PSUs subject to the adjusted EBITDA performance condition
that are expected to vest is redetermined and the aggregate grant-date fair value of the redetermined number of those PSUs is
amortized over the remaining service period less amounts previously recognized. Total compensation costs related to Mr.
Huckins’ non-vested equity awards not yet recognized as an expense was $1.5 million as at December 28, 2019, which will be
amortized over a weighted-average remaining vesting period of 2.7 years.
Employee Stock Purchase Plan
The Company maintains an Employee Stock Purchase Plan whereby employees can purchase common shares through payroll
deductions. For the year ended December 28, 2019, the Company’s employees purchased 185,415 Common Shares (December
29, 2018 – 112,158; December 30, 2017 – 61,796) for total proceeds of $0.5 million (December 29, 2018 – $0.6 million;
December 30, 2017 – $0.4 million). As at December 28, 2019, 814,500 Common Shares are remaining to be granted under
this plan.
SUNOPTA INC.
-F35-
December 28, 2019 10-K
SunOpta Inc.
Notes to Consolidated Financial Statements
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts)
____________________________________________________________________________________________________
18. Other Expense (Income), Net
The components of other expense (income) are as follows:
December 28, 2019 December 29, 2018 December 30, 2017
$
$
$
Gain on sale of soy and corn business (see note 4)
Employee termination and recruitment costs(1)
Impairment of long-lived assets and facility closure
costs(2)
Product withdrawal and recall costs(3)
Settlement gains(4)
Reserve for notes receivable(5)
Increase (decrease) in fair value of contingent
consideration (6)
Other
(1) Employee termination and recruitment costs
(44,027)
5,785
308
260
(3,065)
-
-
691
(40,048)
-
397
1,264
1,504
-
2,232
(2,635)
63
2,825
-
5,636
18,193
413
(1,024)
-
371
71
23,660
For the year ended December 28, 2019, expenses represent severance benefits of $8.6 million for employees terminated in
connection with the Value Creation Plan (see note 5), net of the reversal of $4.1 million of previously recognized stock-
based compensation expense related to forfeited awards previously granted to those employees. In addition, expenses
include recruitment, relocation and termination costs related to the Company’s CEO and CFO transitions.
For the year ended December 29, 2018, expenses represent severance benefits, net of forfeitures of stock-based awards,
incurred in connection with the Value Creation Plan.
For the year ended December 30, 2017, expenses represent severance benefits, net of forfeitures of stock-based awards,
and legal costs incurred in connection with the Value Creation Plan, including employees affected by the exits from flexible
resealable pouch and nutrition bar product lines and operations, and consolidation of roasted snack operations.
(2) Impairment of long-lived assets and facility closure costs
For the year ended December 28, 2019, expenses include costs to dismantle and move equipment from the Company’s
former soy extraction facility located in Heuvelton, New York, which was sold in April 2019.
For the year ended December 29, 2018, expenses include the remaining lease obligation (net of sublease rentals) related
to the vacated nutrition bar processing facility, and an additional impairment loss and closure costs related to the disposal
of the Company’s former roasting facility located in Wahpeton, North Dakota.
For the year ended December 30, 2017, expenses include the impairment of assets associated with the exits from flexible
resealable pouch and nutrition bar products lines and operations, and consolidation of roasted snack operations, as well as
the early buyout of equipment leases associated with the closure of the Company’s former juice processing facility.
(3) Product withdrawal and recall costs
For each of the years in the three-year period ended December 28, 2019, expenses represent product withdrawal and recall
costs that were not eligible for reimbursement under the Company’s insurance policies or exceeded the limits of those
policies, including certain costs related to the voluntary recall of certain roasted sunflower kernel products initiated by the
Company in 2016.
SUNOPTA INC.
-F36-
December 28, 2019 10-K
SunOpta Inc.
Notes to Consolidated Financial Statements
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts)
____________________________________________________________________________________________________
(4) Settlement gains
For the year ended December 28, 2019, the Company recognized gains on the settlement of certain legal matters and a
project cancellation.
For the year ended December 30, 2017, the Company recognized a gain on the early cash settlement of a rebate obligation
with a customer.
(5) Reserve for notes receivable
For the year ended December 29, 2018, loss represents a bad debt reserve for notes receivable associated with a previously
sold business. The face amount of the notes was $1.4 million, which represented the Company’s cash investment in the
notes. The notes had accelerated payment terms that entitled the Company to a multiple-times payout of the face amount
of the notes. The accelerated payment terms were originally fair-valued at $3.4 million. The Company had received cash
payments on the notes of $2.2 million through December 29, 2018, and a further $0.3 million was received in 2019.
(6) Contingent consideration
For the year ended December 29, 2018, the gain represents an adjustment to the final contingent consideration obligation
payable under an earn-out arrangement with the former unitholders of Citrusource, LLC (“Citrusource”), based on the
results for the business in 2018. The Company has accrued $4.3 million related to this obligation, which is recorded in the
current portion of long-term liabilities on the consolidated balance sheets as at December 28, 2019 and December 29, 2018.
The settlement of this obligation is pending the outcome of a dispute between the parties related to the Unit Purchase
Agreement by which the Company acquired Citrusource in March 2015.
SUNOPTA INC.
-F37-
December 28, 2019 10-K
SunOpta Inc.
Notes to Consolidated Financial Statements
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts)
____________________________________________________________________________________________________
19. Income Taxes
The recovery of income taxes differs from the amount that would have resulted from applying the combined Canadian federal
and provincial statutory income tax rate to loss from continuing operations before income taxes due to the following:
Earnings (loss) before income taxes
Canadian statutory rate
Income tax provision (recovery) at statutory rate
Impact of changes in enacted tax rates
Foreign tax rate differential
Impact of stock-based compensation and other non-
deductible expenses
Change in valuation allowance
Goodwill impairment loss
Change in unrecognized tax benefits
Other
Provision for (recovery of) income taxes
December 28, 2019 December 29, 2018 December 30, 2017
$
(170,397)
26.5%
(45,155)
(8,437)
(9,324)
$
(114,521)
26.5%
(30,348)
1,976
2,562
$
2,617
26.5%
694
(441)
126
1,975
774
-
-
93
3,221
2,019
(3,717)
22,239
-
(109)
(5,378)
1,590
72
30,475
(452)
(4,598)
(35,829)
The components of earnings (loss) before income taxes are shown below:
Canada
U.S.
Other
December 28, 2019 December 29, 2018 December 30, 2017
$
(3,286)
(178,033)
10,922
(170,397)
$
(13,408)
(107,068)
5,955
(114,521)
$
(11,295)
9,167
4,745
2,617
The components of the provision for (recovery of) income taxes are shown below:
December 28, 2019 December 29, 2018 December 30, 2017
$
$
$
Current income tax provision (recovery):
Canada
U.S.
Other
Deferred income tax provision (recovery):
Canada
U.S.
Other
Provision for (recovery of) income taxes
(1,023)
588
2,843
2,408
33
731
49
813
3,221
(1,334)
(3,655)
3,394
(1,595)
547
(4,226)
(104)
(3,783)
(5,378)
(658)
(10,346)
3,074
(7,930)
642
(28,606)
65
(27,899)
(35,829)
SUNOPTA INC.
-F38-
December 28, 2019 10-K
SunOpta Inc.
Notes to Consolidated Financial Statements
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts)
____________________________________________________________________________________________________
Deferred income taxes of the Company are comprised of the following:
Differences in property, plant and equipment
and intangible assets
Capital and non-capital losses
Tax benefit of scientific research expenditures
Inventory basis differences
Interest expense limitation (163j)
Other accrued reserves
Less: valuation allowance
Net deferred income tax liability
The components of the net deferred income tax liability are shown below:
Canada
U.S.
Other
The components of the deferred income tax valuation allowance are as follows:
Balance, beginning of year
Increase (decrease) in valuation allowance
Balance, end of year
December 28, 2019 December 29, 2018
$
$
(54,541)
26,540
1,506
2,248
19,118
2,321
(2,808)
6,219
(9,027)
(54,841)
25,169
2,004
3,755
20,025
1,366
(2,522)
5,445
(7,967)
December 28, 2019 December 29, 2018
$
(148)
(7,147)
(672)
(7,967)
$
(223)
(8,446)
(358)
(9,027)
December 28, 2019 December 29, 2018
$
9,162
(3,717)
5,445
$
5,445
774
6,219
As at December 28, 2019, the Company had approximately $0.6 million (December 29, 2018 – $1.1 million) in U.S. federal
scientific research investment tax credits and $0.9 million (December 29, 2018 – $0.9 million) in U.S. State research and
development tax credits, which will expire in varying amounts up to 2029.
As at December 28, 2019, the Company had U.S. federal non-capital loss carry-forwards of approximately $78.0 million
(December 29, 2018 – $72.0 million). In addition, the Company had state loss carry-forwards of approximately $14.4 million as
at December 28, 2019 (December 29, 2018 – $15.1 million). These amounts are available to reduce future federal and state income
taxes.
As at December 28, 2019, the Company had Canadian capital losses of approximately $28.9 million (December 29, 2018 – $29.7
million) for which a full valuation allowance exists. These amounts are available to reduce future capital gains and do not expire.
The Company records net deferred tax assets to the extent it believes these assets will more likely than not be realized. In making
such determinations, the Company considers all available positive and negative evidence, including future reversals of existing
temporary differences, projected future taxable income, tax planning strategies and recent financial operations. Based on this
evaluation, as at December 28, 2019, a valuation allowance of $6.2 million (December 29, 2018 – $5.4 million) had been recorded
against certain assets to reduce the net benefit recorded in the consolidated financial statements.
SUNOPTA INC.
-F39-
December 28, 2019 10-K
SunOpta Inc.
Notes to Consolidated Financial Statements
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts)
____________________________________________________________________________________________________
Undistributed earnings of the Company’s non-Canadian affiliates and associated companies are considered to be indefinitely
reinvested; accordingly, no provision for deferred taxes has been provided thereon.
The Company believes it has adequately examined its tax positions taken or expected to be taken in a tax return; however, amounts
asserted by taxing authorities could differ from the Company’s positions. Accordingly, additional provisions on federal,
provincial, state and foreign tax-related matters could be recorded in the future as revised estimates are made or the underlying
matters are settled or otherwise resolved.
Consistent with its historical financial reporting, the Company has classified interest and penalties related to income tax
liabilities, when applicable, as part of interest expense in its consolidated statements of operations, and with the related liability
on the consolidated balance sheets.
The number of years with open tax audits varies depending on the tax jurisdiction. The Company’s major taxing jurisdictions
include Canada (including Ontario), the U.S. (including multiple states), and the Netherlands. The Company’s 2014 through
2018 tax years (and any tax year for which available non-capital loss carry-forwards were generated up to the amount of non-
capital loss carry-forward) remain subject to examination by the Internal Revenue Service for U.S. federal tax purposes, and
the 2010 through 2018 tax years remain subject to examination by the appropriate governmental agencies for Canadian federal
tax purposes. There are other ongoing audits in various other jurisdictions that are not considered material to the Company’s
consolidated financial statements.
SUNOPTA INC.
-F40-
December 28, 2019 10-K
SunOpta Inc.
Notes to Consolidated Financial Statements
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts)
____________________________________________________________________________________________________
20. Loss Per Share
Basic and diluted loss per share were calculated as follows (shares in thousands):
Basic Loss Per Share
Numerator for basic loss per share
Loss attributable to SunOpta Inc.
Less: dividends and accretion on Series A Preferred Stock
Loss attributable to common shareholders
Denominator for basic loss per share
Basic weighted-average number of shares outstanding
Basic loss per share
Diluted Loss Per Share
Numerator for diluted loss per share
Loss attributable to SunOpta Inc.
Less: dividends and accretion on Series A Preferred Stock (1)
Loss attributable to common shareholders
Denominator for diluted loss per share
Basic weighted-average number of shares outstanding
Dilutive effect of the following:
Series A Preferred Stock (1)
Stock options and restricted stock units (2)
Diluted weighted-average number of shares outstanding
$
$
$
$
$
December 28,
2019
December 29,
2018
December 30,
2017
(758) $
(8,022)
(8,780) $
(109,205) $
(7,909)
(117,114) $
(135,320)
(7,809)
(143,129)
87,787
87,082
86,355
(0.10) $
(1.34) $
(1.66)
(758) $
(8,022)
(8,780) $
(109,205) $
(7,909)
(117,114) $
(135,320)
(7,809)
(143,129)
87,787
87,082
86,355
-
-
87,787
-
-
87,082
-
-
86,355
Diluted loss per share
$
(0.10) $
(1.34) $
(1.66)
(1) For the years ended December 28, 2019, December 29, 2018 and December 30, 2017, it was more dilutive to assume the
Preferred Stock was not converted into Common Shares, and, therefore, the numerator of the diluted loss per share
calculation was not adjusted to add back the dividends and accretion on the Preferred Stock and the denominator was not
adjusted to include 11,333,333 Common Shares issuable on an if-converted basis.
(2) For the years ended December 28, 2019, December 29, 2018 and December 30, 2017, stock options and RSUs to purchase
or receive 370,670, 452,316 and 815,952 Common Shares, respectively, were excluded from the calculation of diluted
loss per share due to their anti-dilutive effect of reducing the loss per share. In addition, for the years ended December
28, 2019, December 29, 2018 and December 30, 2017, options to purchase 3,528,899, 2,384,249 and 2,540,189 Common
Shares were anti-dilutive because the exercise prices of these options were greater than the average market price.
SUNOPTA INC.
-F41-
December 28, 2019 10-K
SunOpta Inc.
Notes to Consolidated Financial Statements
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts)
____________________________________________________________________________________________________
21. Supplemental Cash Flow Information
Changes in Non-Cash Working Capital, Net of
Businesses Acquired or Sold
Accounts receivable
Inventories
Income tax recoverable/payable
Prepaid expenses and other current assets
Accounts payable and accrued liabilities
Customer and other deposits
December 28, 2019 December 29, 2018 December 30, 2017
$
$
$
5,065
21,965
(1,387)
(8,423)
(5,917)
(1,408)
9,895
(3,059)
(16,032)
5,744
3,662
(6,225)
(3,457)
(19,367)
35,773
27,475
(13,515)
(11,994)
(20,437)
2,328
19,630
Non-Cash Investing and Financing Activities
Accrued cash dividends on Series A Preferred Stock
(1,700)
(1,700)
(1,700)
Cash Paid
Interest
Income taxes
22. Related Party Transactions
32,278
4,554
32,020
2,936
29,683
4,150
The following table summarizes transactions and balances between the Company and related parties:
December 28, 2019 December 29, 2018 December 30, 2017
$
$
$
Transactions
Purchases of fruits, grains and seeds(1)
Sales of agronomy products(2)
Sales of coffee beans(3)
Rent and other
Balances
Grower loans(4)
29,609
115
1,726
156
19,975
1,136
1,626
59
18,487
1,141
1,954
220
3,100
1,500
-
(1) Represents purchases of raw fruit, and fruit processing and freight services from companies related to the Managing Director
of the Company’s Mexican operations, as well as purchases of sunflower seeds and grains (prior to the sale of the soy and
corn business) from employees of the Company, which are included in cost of goods sold on the consolidated statements of
operations.
(2) Represents sales of agronomy products to employees of the Company, which are included in revenues on the consolidated
statements of operations.
(3) Represents the sale of coffee beans from TOC to a company that is owned by the non-controlling shareholder of Trabocca
B.V., a less-than-wholly-owned subsidiary of TOC. These sales are included in revenues on the consolidated statement of
operations.
(4) Represents loans made to the Managing Director of the Company’s Mexican operations, to provide operating funds for farms
owned by the director. These loans are secured by the crops grown on the farms, as well as other pledged assets of the
director.
SUNOPTA INC.
-F42-
December 28, 2019 10-K
SunOpta Inc.
Notes to Consolidated Financial Statements
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts)
____________________________________________________________________________________________________
23. Commitments and Contingencies
Product Recall
On November 20, 2017, Treehouse Foods, Inc., several of its related entities, and its insurer filed a lawsuit against the Company
in the Circuit Court of Cook County, Illinois titled Treehouse Foods, Inc. et al. v. SunOpta Grains and Food, Inc. The Company
was served with the Summons and Complaint on January 24, 2018. After the Company removed the case to the United States
District Court for the Northern District of Illinois, the plaintiffs filed an Amended Complaint on April 23, 2018 and a second
Amended Complaint on October 12, 2018. The plaintiffs allege economic damages resulting from the Company’s 2016
voluntary recall of certain roasted sunflower kernel products due to the potential for listeria monocytogenes contamination.
The plaintiffs brought claims for breach of contract, express and implied warranties and product guarantees, negligence, strict
liability, negligent misrepresentation, and indemnity seeking $16.2 million in damages. There are no allegations of personal
injury. On March 29, 2019, the court dismissed the plaintiffs’ claims for negligence, strict liability, negligent misrepresentation,
and common law indemnity. The Company is vigorously defending itself against the remaining contract and warranty-based
claims. The Company cannot reasonably predict the outcome of this claim, nor can it estimate the amount of loss, or range of
loss, if any, that may result from this claim.
Other Claims
In addition, various claims and potential claims arising in the normal course of business are pending against the Company. It
is the opinion of management that these claims or potential claims are without merit and the amount of potential liability, if
any, to the Company is not determinable. Management believes the final determination of these claims or potential claims will
not materially affect the financial position or results of the Company.
Environmental Laws
The Company believes that, with respect to both its operations and real property, it is in material compliance with current
environmental laws. Based on known existing conditions and the Company’s experience in complying with emerging
environmental issues, the Company is of the view that future costs relating to environmental compliance will not have a material
adverse effect on its consolidated financial position, but there can be no assurance that unforeseen changes in the laws or
enforcement policies of relevant governmental bodies, the discovery of changed conditions on the Company’s real property or
in its operations, or changes in the use of such properties and any related site restoration requirements, will not result in the
incurrence of significant costs.
Letters of Credit
The Company has outstanding letters of credit at December 28, 2019 totaling $10.7 million (December 29, 2018 – $10.9
million).
24. Segmented Information
Effective the fourth quarter of 2019, the Company implemented changes to its organization and leadership structure to align
with the operational and strategic objectives established by the Company’s CEO. As a result, the Company established two
new segments – a Plant-Based Foods and Beverages segment and a Fruit-Based Foods and Beverages segment – based on the
synergistic nature of the underlying principal product ingredients. In addition, the Company realigned the Global Ingredients
segment to combine its international organic ingredients operations and its co-manufactured premium juice program, based on
shared raw material sourcing. Each segment has dedicated management, sales, marketing, plant operations, product
development and business support teams, with full accountability to the CEO.
SUNOPTA INC.
-F43-
December 28, 2019 10-K
SunOpta Inc.
Notes to Consolidated Financial Statements
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts)
____________________________________________________________________________________________________
With these changes, the composition of the Company’s three operating segments is as follows:
(cid:120) Global Ingredients includes the sourcing and sale of organic and non-GMO ingredients, including fruits, vegetables,
oils, fats, coffee, nuts, dried fruits, sugars, liquid sweeteners, seeds, grains, rice and pulses, and the processing of
value-added ingredients including cocoa liquor, butter and powder, sunflower kernel, oil and cakes, sesame seeds, and
avocado oil. In addition, it includes partnerships with third-party co-manufacturers to produce consumer-packaged
premium juice products (including private label orange juices, lemonades, and functional waters), utilizing internally-
sourced raw materials. It also included the operations of the soy and corn business that was sold in 2019.
(cid:120) Plant-Based Foods and Beverages includes plant-based beverages and liquid and dry ingredients (utilizing almond,
soy, coconut, oat, hemp, and other bases), as well as broths, teas and nutritional beverages. In addition, it includes
packaged dry- and oil-roasted in-shell sunflower and sunflower kernels, as well as corn-, soy- and legume-based
roasted snacks, and the processing and sale of raw sunflower inshell and kernel for food and feed applications. It also
included flexible resealable pouch and nutrition bar product lines that were exited in 2017.
(cid:120) Fruit-Based Foods and Beverages includes individually quick frozen (“IQF”) fruit for retail (including strawberries,
blueberries, mango, pineapple, blends, and other berries), IQF and bulk frozen fruit for foodservice (including purées,
fruit cups and smoothies), and custom fruit preparations for industrial use. In addition, it includes fruit snacks,
including bars, twists, ropes and bite-sized varieties.
Corporate Services provides a variety of management, financial, information technology, treasury and administration services
to each of the Company’s operating segments.
The segment information presented below for the years ended December 29, 2018 and December 30, 2017 has been restated
to reflect the new segment structure.
When reviewing the operating results of the Company’s operating segments, management uses segment revenues from external
customers and segment operating income/loss to assess performance and allocate resources. Segment operating income/loss
excludes other income/expense items. In addition, interest expense and income taxes are not allocated to the operating
segments.
SUNOPTA INC.
-F44-
December 28, 2019 10-K
SunOpta Inc.
Notes to Consolidated Financial Statements
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts)
____________________________________________________________________________________________________
Segment Revenues and Operating Income
Reportable segment operating results for the years ended December 28, 2019, December 29, 2018 and December 30, 2017
were as follows:
December 28, 2019
Segment revenues from external customers
Segment operating income (loss)
Corporate Services
Other income, net (see note 18)
Interest expense, net
Earnings before income taxes
Segment revenues from external customers
Segment operating income (loss)
Corporate Services
Other expense, net (see note 18)
Goodwill impairment (see note 11)
Interest expense, net
Loss before income taxes
Segment revenues from external customers
Segment operating income (loss)
Corporate Services
Other expense, net (see note 18)
Goodwill impairment (see note 11)
Interest expense, net
Loss before income taxes
Global
Ingredients
$
478,772
15,965
Plant-Based
Foods and
Beverages
$
361,398
29,476
Fruit-Based
Foods and
Beverages
$
349,852
(26,873)
Consolidated
$
1,190,022
18,568
(21,322)
40,048
(34,677)
2,617
December 29, 2018
Global
Ingredients
$
581,307
23,266
Plant-Based
Foods and
Beverages
$
314,076
10,766
Fruit-Based
Foods and
Beverages
$
365,469
(16,029)
Consolidated
$
1,260,852
18,003
(14,071)
(2,825)
(81,222)
(34,406)
(114,521)
December 30, 2017
Global
Ingredients
$
556,166
25,589
Plant-Based
Foods and
Beverages
$
342,714
(7,094)
Fruit-Based
Foods and
Beverages
$
380,713
13,570
Consolidated
$
1,279,593
32,065
(31,298)
(23,660)
(115,000)
(32,504)
(170,397)
SUNOPTA INC.
-F45-
December 28, 2019 10-K
SunOpta Inc.
Notes to Consolidated Financial Statements
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts)
____________________________________________________________________________________________________
Segment Assets
Total assets by reportable segment as at December 28, 2019 and December 29, 2018 were as follows:
Segment Assets
Global Ingredients
Plant-Based Foods and Beverages
Fruit-Based Foods and Beverages
Total segment assets
Corporate Services
Total assets
December 28, 2019 December 29, 2018
$
$
293,453
189,013
342,099
824,565
98,794
923,359
354,986
103,386
364,306
822,678
74,060
896,738
Segment Capital Expenditures, Depreciation and Amortization
Capital expenditures, depreciation and amortization by reportable segment for the years ended December 28, 2019, December
29, 2018 and December 30, 2017 were as follows:
December 28, 2019 December 29, 2018 December 30, 2017
$
$
$
Segment Capital Expenditures
Global Ingredients
Plant-Based Foods and Beverages
Fruit-Based Foods and Beverages
Total segment capital expenditures
Corporate Services
Total capital expenditures
Segment Depreciation and Amortization
Global Ingredients
Plant-Based Foods and Beverages
Fruit-Based Foods and Beverages
Total segment depreciation and amortization
Corporate Services
Total depreciation and amortization
4,469
15,289
9,689
29,447
3,317
32,764
5,480
7,134
16,702
29,316
4,636
33,952
5,391
12,241
5,586
23,218
8,385
31,603
6,117
5,827
16,871
28,815
3,973
32,788
9,531
17,401
9,182
36,114
5,025
41,139
5,828
6,792
17,510
30,130
2,694
32,824
SUNOPTA INC.
-F46-
December 28, 2019 10-K
SunOpta Inc.
Notes to Consolidated Financial Statements
For the years ended December 28, 2019, December 29, 2018 and December 30, 2017
(All tabular dollar amounts expressed in thousands of U.S. dollars, except per share amounts)
____________________________________________________________________________________________________
Geographic Information
The Company’s assets, operations and employees are principally located in the U.S., Canada, Europe, Mexico and Ethiopia.
Revenues from external customers are attributed to countries based on the location of the customer. Revenues from external
customers by geographic area for the years ended December 28, 2019, December 29, 2018 and December 30, 2017 were as
follows:
December 28, 2019 December 29, 2018 December 30, 2017
$
$
$
Revenues from External Customers
U.S.
Canada
Europe and other
Total revenues from external customers
929,320
22,807
237,895
1,190,022
984,122
29,055
247,675
1,260,852
1,001,417
27,929
250,247
1,279,593
Long-lived assets consist of property, plant and equipment, net of accumulated depreciation, which are attributed to countries
based on the physical location of the assets. Long-lived assets by geographic area as at December 28, 2019 and December 29,
2018 were as follows:
Long-Lived Assets
U.S.
Canada
Europe and other
Total long-lived assets
Major Customers
December 28, 2019 December 29, 2018
$
$
147,465
2,401
34,684
184,550
134,598
2,787
33,647
171,032
For the year ended December 28, 2019, one customer accounted for approximately 11% of the Company’s consolidated
revenues and approximately 36% of Plant-Based Foods and Beverages segment revenues. The Company did not have any
customers that exceeded 10% of total revenues for the years ended December 29, 2018 and December 30, 2017.
SUNOPTA INC.
-F47-
December 28, 2019 10-K
Supplemental Financial Information (unaudited)
Summarized below is the Consolidated Statement of Operations for the quarters ended December 28, 2019, September 28,
2019, June 29, 2019 and March 30, 2019, as well as the fiscal 2018 quarterly comparatives.
Quarter ended
December 28, 2019 December 29, 2018
$
$
Revenues(1)
Cost of goods sold
Gross profit
Selling, general and administrative expenses
Intangible asset amortization
Other expense (income), net
Goodwill impairment
Foreign exchange loss (gain)
Earnings (loss) before the following
Interest expense, net
Loss before income taxes
Recovery of income taxes
Net loss
Earnings attributable to non-controlling interests
Loss attributable to SunOpta Inc.
Dividends and accretion on Series A Preferred Stock
Loss attributable to common shareholders
Basic and diluted loss per share
(1) Fourth quarter of 2018 included revenues from sold soy and corn business of $26.5 million.
295,802
262,407
33,395
27,156
2,769
(304)
-
480
3,294
8,820
(5,526)
(18)
(5,508)
95
(5,603)
(2,017)
(7,620)
(0.09)
320,521
299,209
21,312
25,792
2,745
1,508
81,222
(331)
(89,624)
8,920
(98,544)
(1,525)
(97,019)
43
(97,062)
(1,987)
(99,049)
(1.13)
SUNOPTA INC.
-F48-
December 28, 2019 10-K
Supplemental Financial Information (unaudited) continued
Revenues(1)
Cost of goods sold
Gross profit
Selling, general and administrative expenses
Intangible asset amortization
Other expense, net
Foreign exchange gain
Earnings (loss) before the following
Interest expense, net
Loss before income taxes
Recovery of income taxes
Net loss
Earnings (loss) attributable to non-controlling interests
Loss attributable to SunOpta Inc.
Dividends and accretion on Series A Preferred Stock
Loss attributable to common shareholders
Basic and diluted loss per share
Quarter ended
September 28, 2019 September 29, 2018
$
$
295,941
269,616
26,325
27,674
2,768
3,323
(590)
(6,850)
8,864
(15,714)
(3,935)
(11,779)
(30)
(11,749)
(2,009)
(13,758)
(0.16)
308,371
274,243
34,128
27,220
2,754
1,136
(368)
3,386
8,792
(5,406)
(870)
(4,536)
70
(4,606)
(1,981)
(6,587)
(0.08)
(1) Third quarter of 2018 included revenues from the sold soy and corn business of $27.0 million.
SUNOPTA INC.
-F49-
December 28, 2019 10-K
Supplemental Financial Information (unaudited) continued
Revenues(1)
Cost of goods sold
Gross profit
Selling, general and administrative expenses
Intangible asset amortization
Other expense, net
Foreign exchange gain
Earnings (loss) before the following
Interest expense, net
Loss before income taxes
Recovery of income taxes
Net loss
Earnings attributable to non-controlling interests
Loss attributable to SunOpta Inc.
Dividends and accretion on Series A Preferred Stock
Loss attributable to common shareholders
Basic and diluted loss per share
(1) Second quarter of 2018 included revenues from the sold soy and corn business of $29.5 million.
June 29, 2019
$
293,004
265,677
27,327
27,262
2,692
445
(90)
(2,982)
8,254
(11,236)
(2,324)
(8,912)
143
(9,055)
(2,001)
(11,056)
(0.13)
Quarter ended
June 30, 2018
$
319,308
284,962
34,346
26,948
2,768
583
(11)
4,058
8,474
(4,416)
(1,290)
(3,126)
48
(3,174)
(1,974)
(5,148)
(0.06)
SUNOPTA INC.
-F50-
December 28, 2019 10-K
Supplemental Financial Information (unaudited) continued
Revenues(1)
Cost of goods sold
Gross profit
Selling, general and administrative expenses
Intangible asset amortization
Other income, net(2)
Foreign exchange loss (gain)
Earnings before the following
Interest expense, net
Earnings (loss) before income taxes
Provision for (recovery of) income taxes
Net loss
Earnings (loss) attributable to non-controlling interests
Loss attributable to SunOpta Inc.
Dividends and accretion on Series A Preferred Stock
Earnings (loss) attributable to common shareholders
Basic earnings (loss) per share
Diluted earnings (loss) per share
March 30, 2019
$
Quarter ended
March 31, 2018
$
305,275
277,069
28,206
26,248
2,742
(43,512)
(1,104)
43,832
8,739
35,093
9,498
25,595
(54)
25,649
(1,995)
23,654
0.27
0.26
312,652
278,968
33,684
28,288
2,771
(402)
962
2,065
8,220
(6,155)
(1,693)
(4,462)
(99)
(4,363)
(1,967)
(6,330)
(0.07)
(0.07)
(1) First quarters of 2019 and 2018 included revenues from the sold soy and corn business of $10.3 million and $21.4 million, respectively.
(2) First quarter of 2019 included a gain on sale of the soy and corn business of $45.6 million, subject to post-closing adjustments.
SUNOPTA INC.
-F51-
December 28, 2019 10-K
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO RULE 13a-14(a)
AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
Exhibit 31.1
I, Joseph D. Ennen, certify that:
(1)
(2)
(3)
(4)
I have reviewed this Annual Report on Form 10-K of SunOpta Inc.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a
material fact necessary to make the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this report;
Based on my knowledge, the financial statements, and other financial information included in this report, fairly
present in all material respects the financial condition, results of operations and cash flows of the registrant as of,
and for, the periods presented in this report;
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls
and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial
reporting (as defined in Exchange Act Rules 13a -15(f) and 15d -15(f)) for the registrant and have:
a.
b.
c.
d.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be
designed under our supervision, to ensure that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those entities, particularly during the
period in which this report is being prepared;
Designed such internal control over financial reporting, or caused such internal control over financial
reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability
of financial reporting and the preparation of financial statements for external purposes in accordance with
generally accepted accounting principles;
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this
report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of
the period covered by this report based on such evaluation; and
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred
during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an
annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s
internal control over financial reporting; and
(5)
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal
control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of
directors (or persons performing the equivalent functions):
a.
b.
All significant deficiencies and material weaknesses in the design or operation of internal control over
financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process,
summarize and report financial information; and
Any fraud, whether or not material, that involves management or other employees who have a significant
role in the registrant’s internal control over financial reporting.
/s/ Joseph D. Ennen
Joseph D. Ennen
Chief Executive Officer
SunOpta Inc.
Date: February 27, 2020
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
PURSUANT TO RULE 13a-14(a)
AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
Exhibit 31.2
I, Scott Huckins, certify that:
(1)
(2)
(3)
(4)
I have reviewed this Annual Report on Form 10-K of SunOpta Inc.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a
material fact necessary to make the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this report;
Based on my knowledge, the financial statements, and other financial information included in this report, fairly
present in all material respects the financial condition, results of operations and cash flows of the registrant as of,
and for, the periods presented in this report;
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls
and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial
reporting (as defined in Exchange Act Rules 13a -15(f) and 15d -15(f)) for the registrant and have:
a.
b.
c.
d.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be
designed under our supervision, to ensure that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those entities, particularly during the
period in which this report is being prepared;
Designed such internal control over financial reporting, or caused such internal control over financial
reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability
of financial reporting and the preparation of financial statements for external purposes in accordance with
generally accepted accounting principles;
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this
report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of
the period covered by this report based on such evaluation; and
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred
during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an
annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s
internal control over financial reporting; and
(5)
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal
control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of
directors (or persons performing the equivalent functions):
a.
b.
All significant deficiencies and material weaknesses in the design or operation of internal control over
financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process,
summarize and report financial information; and
Any fraud, whether or not material, that involves management or other employees who have a significant
role in the registrant’s internal control over financial reporting.
/s/ Scott Huckins
Scott Huckins
Chief Financial Officer
SunOpta Inc.
Date: February 27, 2020
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Exhibit 32
In connection with the annual report of SunOpta Inc. (the “Company”) on Form 10-K for the year ended December 28, 2019,
as filed with the Securities and Exchange Commission (the “Report”), I, Joseph D. Ennen, Chief Executive Officer of the
Company, and I, Scott Huckins, Chief Financial Officer of the Company, certify pursuant to 18 U.S.C. Section 1350, that to
our knowledge:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of
operations of the Company.
A signed original of this written statement, or other document authenticating, acknowledging, or otherwise adopting the
signature that appears in typed form within the electronic version of this written statement, has been provided to the Company
and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
Date: February 27, 2020
/s/ Joseph D. Ennen
Joseph D. Ennen
Chief Executive Officer
SunOpta Inc.
/s/ Scott Huckins
Scott Huckins
Chief Financial Officer
SunOpta Inc.
The foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and should not
be deemed to be filed under the Exchange Act by the Company or the certifying officers.
[This page intentionally left blank]
[This page intentionally left blank]
EXTENSIVE GLOBAL CAPABILITIES
Publicly Held NASDAQ - STKL
TSX - SOY
Employees Approximately 1,900
Headquarters Mississauga, Ontario, Canada
Locations Processing and Packaging: 18
Other: 13
Geography Americas: 23
Europe: 5
Africa: 2
Asia: 1
Currently doing business in
approximately 60 countries
2019 Annual Report
DIRECTORS AND LEADERSHIP TEAM
Directors
Leadership Team
Shareholder Information
Dr. Albert Bolles (4)
Independent Director
Joseph D. Ennen
Chief Executive Officer
Derek Briffett (1)(6)
Independent Director
Scott Huckins
Chief Financial Officer
Michael Detlefsen (2)(4)
Independent Director
Jill Barnett
Chief Administrative Officer
Joseph D. Ennen
Chief Executive Officer and
Director
Michael Buick
General Manager, Beverage and Snacks
Rob Duchscher
Chief Information Officer
David Largey
Chief Quality Officer
Barend Reijn
GM, Healthy Fruit
Gerard Versteegh
General Manager, Tradin
Chris Whitehair
Senior Vice President, Supply Chain
Becky Fisher (4)(6)
Independent Director
R. Dean Hollis (2)(6)
Chair
Kathy Houde (3)
Independent Director
Leslie Keating (2)(4)
Independent Director
Brendan Springstubb (2)(5)
Independent Director
(1) Chair of Audit Committee
(2) Member of Audit Committee
(3) Chair of Corporate Governance
Committee
(4) Member of Corporate Governance
Committee
(5) Chair of Compensation Committee
(6) Member of Compensation
Committee
Corporate Head Office
2233 Argentia Road
Suite 401, West Tower
Mississauga, ON, Canada
L5N 2X7
T: (905) 821-9669
F: (905) 819-7971
www.sunopta.com
TRANSFER AGENTS
TSX Trust Company
100 Adelaide Street West, Suite 301
Toronto, ON, Canada M5H 4H1
T: (416) 361-0930
American Stock Transfer & Trust Company,
LLP
6201 15th Ave.
Brooklyn, NY, USA 11219
T: (800) 937-5449
CORPORATE LEGAL COUNSEL
Stoel Rives, LLP
Minneapolis, MN
Wildeboer Dellelce LLP
Toronto, ON, Canada
AUDITORS
Ernst & Young LLP
Toronto, ON, Canada
ANNUAL MEETING
June 18, 2020 at 3:00 pm Eastern
SunOpta Inc.
2233 Argentia Road
Suite 401, West Tower
Mississauga, ON, Canada L5N 2X7
Listed on NASDAQ: STKL and TSX: SOY
SHAREHOLDER COMMUNICATIONS
Copies of SunOpta’s Annual Report,
Form 10K (Annual Information Form) and
other regulatory filings are available on
the Company website www.sunopta.com.
Additional financial information has been
filed electronically with various securities
commissions in Canada through SEDAR
(www.sedar.com) and in the USA through
EDGAR (www.sec.gov). Paper copies are
available without charge.
Please Contact:
SunOpta Inc.
Attn: Corporate Secretary
7301 Ohms Lane, Ste 600
Edina, MN 55439
2019 Annual Report